Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,transmitter-gated ion channel activity (GO:0022824),-0.7688709962640217,-2.201811783165518,0.0,0.0,0.0,21/29,17.12%,GRID2;GRIK2;GRIA4;GABRG3;GRIK1;GABRB3;GRIA2;GABRB1;GABRA3;GABRA2;GRIK4;GABRB2;GLRA3;GABRG2;GRID1;GABRA4;GABRG1;GLRA2;GRIK3;GABRA5;GABRE
prerank,glutamate receptor activity (GO:0008066),-0.8386155593615273,-2.178541287397886,0.0,0.0,0.0,13/19,9.49%,GRID2;GRIK2;GRIA4;GRM7;GRM5;GRM3;GRIK1;GRIA1;GRIA2;GRM8;GRIK4;GRM1;GRID1
prerank,retinoid binding (GO:0005501),0.8831922035924438,2.114818441241259,0.0,0.002010453379249284,0.001,9/22,7.54%,PTGDS;ALDH1A2;ABCA4;RBP1;CRABP2;NR2F2;CYP26B1;CRABP1;RBP4
prerank,ligand-gated ion channel activity (GO:0015276),-0.7284796575827517,-2.1136267441008028,0.0,0.0,0.0,13/30,9.49%,GRID2;GRIK2;GRIA4;GRIK1;GRIN2B;GRIA1;GRIA2;GABRB1;GRIA3;GRIK4;GRIN3A;GRIN2A;GRID1
prerank,ionotropic glutamate receptor activity (GO:0004970),-0.8297078313359204,-2.1124222371043735,0.0,0.0,0.0,11/17,7.11%,GRIK2;GRIA4;GRIK1;GRIN2B;GRIA1;GRIA2;PTK2B;GRIA3;GRIK4;GRIN3A;GRIN2A
prerank,transmembrane receptor protein tyrosine phosphatase activity (GO:0005001),-0.8335733319385972,-2.1060532838664936,0.0,0.0,0.0,11/16,8.75%,PTPRB;PTPRM;PTPRD;PTPRG;PTPRK;PTPRT;PTPRN2;PTPRC;PTPRF;PTPRZ1;PTPRE
prerank,transmembrane receptor protein phosphatase activity (GO:0019198),-0.8335733319385972,-2.1060532838664936,0.0,0.0,0.0,11/16,8.75%,PTPRB;PTPRM;PTPRD;PTPRG;PTPRK;PTPRT;PTPRN2;PTPRC;PTPRF;PTPRZ1;PTPRE
prerank,cell adhesion mediator activity (GO:0098631),-0.7624042625246817,-2.1057377703371603,0.0,0.0,0.0,12/24,9.63%,LRRC4C;BSG;CNTN4;ESAM;NPTN;NTNG1;DSCAML1;CNTN6;BCAM;ROBO4;EMB;CD47
prerank,anion channel activity (GO:0005253),-0.6064274022394294,-2.097867641257489,0.0,0.0,0.0,34/61,22.02%,SLC26A7;CLIC4;ANO4;GABRG3;GABRB3;ANO1;LRRC8C;GABRB1;GABRA3;LRRC8D;GLRB;GABRA2;ANO3;GABRB2;GLRA3;LRRC8B;SLC1A4;GLRA1;VDAC1;GABRG2;GABRA4;GABRG1;GLRA2;ANO5;ANO2;CLCN3;GABRA5;GABRE;GPR89A;GPR89B;CFTR;GABRA1;BEST1;VDAC3
prerank,ligand-gated channel activity (GO:0022834),-0.731823622276417,-2.09775326758652,0.0,0.0,0.0,13/29,9.49%,GRID2;GRIK2;GRIA4;GRIK1;GRIN2B;GRIA1;GRIA2;GABRB1;GRIA3;GRIK4;GRIN3A;GRIN2A;GRID1
prerank,ligand-gated anion channel activity (GO:0099095),-0.7887598116169544,-2.0322604629918866,0.0,0.0010916682321000081,0.01,17/17,21.21%,GABRG3;GABRB3;GABRB1;GABRA3;GLRB;GABRA2;GABRB2;GLRA3;GLRA1;GABRG2;GABRA4;GABRG1;GLRA2;GABRA5;GABRE;CFTR;GABRA1
prerank,chloride channel activity (GO:0005254),-0.584583150286696,-1.9828833842887081,0.0,0.0018946308160413363,0.018,31/59,21.27%,SLC26A7;CLIC4;ANO4;GABRG3;GABRB3;ANO1;GABRB1;GABRA3;GLRB;GABRA2;ANO3;GABRB2;GLRA3;SLC1A4;GLRA1;GABRG2;GABRA4;GABRG1;TTYH2;GLRA2;CLCN1;TTYH1;ANO5;ANO2;CLCN3;GABRA5;GABRE;CLCN6;CFTR;GABRA1;BEST1
prerank,neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential (GO:0099529),-0.7506040559760221,-1.951466091956327,0.0,0.0033907876906136615,0.036,14/19,17.12%,GRID2;GRIK2;GABRG3;GRIK1;GABRA3;GABRA2;GRIK4;GABRG2;GRID1;GABRA4;GABRG1;GRIK3;GABRA5;GABRE
prerank,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential (GO:1904315),-0.6704352608636518,-1.9231347706466606,0.0,0.005038468763538499,0.057,15/28,17.12%,GRID2;GRIK2;GABRG3;GRIK1;GABRA3;GABRA2;GRIK4;GABRG2;GRID1;GABRA4;GABRG1;GRIK3;CHRNA7;GABRA5;GABRE
prerank,cell-cell adhesion mediator activity (GO:0098632),-0.6091271742553006,-1.9216500677276873,0.0,0.004962128327727309,0.061,15/42,9.63%,STXBP6;LRRC4C;BSG;CD200;CNTN4;ESAM;NPTN;NTNG1;DSCAML1;ANXA1;CNTN6;ROBO4;EMB;PDLIM1;CD47
prerank,GABA receptor activity (GO:0016917),-0.7083480016619373,-1.9125148306031314,0.0,0.005292936882909131,0.069,13/21,17.12%,GABRG3;GABRB3;GABRB1;GABRA3;GABRA2;GABRB2;GABRG2;GPR156;GABBR2;GABRA4;GABRG1;GABRA5;GABRE
prerank,inhibitory extracellular ligand-gated ion channel activity (GO:0005237),-0.7932662160073909,-1.8848553184643078,0.0,0.008435618157136426,0.111,12/13,17.12%,GABRG3;GABRA3;GLRB;GABRA2;GLRA3;GLRA1;GABRG2;GABRA4;GABRG1;GLRA2;GABRA5;GABRE
prerank,monocarboxylate:sodium symporter activity (GO:0140161),0.8822348688042202,1.8623667257167678,0.0,0.1558101368918195,0.238,4/10,5.12%,SLC6A13;SLC6A1;SLC6A12;SLC10A4
prerank,GABA-A receptor activity (GO:0004890),-0.7207983581878632,-1.8602087137558747,0.004545454545454545,0.011792352025893136,0.161,11/18,17.12%,GABRG3;GABRB3;GABRB1;GABRA3;GABRA2;GABRB2;GABRG2;GABRA4;GABRG1;GABRA5;GABRE
prerank,GABA-gated chloride ion channel activity (GO:0022851),-0.7941382934152883,-1.849396205910783,0.0020325203252032522,0.013177207448075857,0.188,11/12,17.12%,GABRG3;GABRB3;GABRB1;GABRA3;GABRA2;GABRB2;GABRG2;GABRA4;GABRG1;GABRA5;GABRE
prerank,aldehyde dehydrogenase [NAD(P)+] activity (GO:0004030),0.8229733352112802,1.8465392216142977,0.001876172607879925,0.14006158542103345,0.304,7/15,8.15%,ALDH1A2;ALDH7A1;ALDH1A1;ALDH4A1;ALDH3B1;ALDH2;ALDH1L1
prerank,potassium ion transmembrane transporter activity (GO:0015079),-0.6071149631379441,-1.8095602295276,0.0,0.02141550120387576,0.298,12/31,16.01%,SLC12A7;HCN1;ABCC9;KCNK5;SLC12A2;KCNK9;SLC12A8;SLC12A4;KCNK1;SLC12A6;TMEM38A;SLC12A5
prerank,carboxylic acid transmembrane transporter activity (GO:0046943),0.6237567494503998,1.804987857870552,0.0015384615384615385,0.20933845811433172,0.5,12/55,5.94%,SLC16A6;SLC13A3;SLC6A13;SLC6A12;SLC16A12;SLC16A11;SLC38A4;SLC38A3;SLC7A2;PDPN;SLC16A13;SLC19A1
prerank,cAMP binding (GO:0030552),-0.7901025696657276,-1.8042056350096076,0.008714596949891068,0.02208147105838653,0.317,5/11,2.10%,PDE4D;PDE4B;PDE10A;RAPGEF4;HCN1
prerank,glutamate receptor binding (GO:0035254),-0.7082157512421211,-1.7803246005041424,0.0,0.02925292795107814,0.404,10/17,13.89%,HIP1;SHANK3;GNAS;IGSF11;SYNDIG1;SHISA6;NSF;SHANK2;HOMER1;SHANK1
prerank,AMP binding (GO:0016208),0.8426051846246201,1.7752842661199695,0.001941747572815534,0.2657819367367553,0.677,3/11,2.80%,PRKAG2;MPPED2;PRKAG3
prerank,store-operated calcium channel activity (GO:0015279),-0.7932303596291521,-1.7708545809659486,0.0,0.031667400782405195,0.452,7/10,15.04%,STIM2;TRPC3;TRPC4;TRPC1;TRPC6;TRPC5;TRPC7
prerank,"3',5'-cyclic-AMP phosphodiesterase activity (GO:0004115)",-0.7405696735539651,-1.7688389082387923,0.004395604395604396,0.031153536109731456,0.459,9/12,15.66%,PDE4D;PDE4B;PDE3A;PDE8A;PDE3B;PDE7B;PDE2A;PDE8B;PDE4C
prerank,aldehyde dehydrogenase (NAD+) activity (GO:0004029),0.8039349546918951,1.7579414543663876,0.0019157088122605363,0.2821336242213162,0.757,6/13,8.15%,ALDH1A2;ALDH7A1;ALDH1A1;ALDH4A1;ALDH2;ALDH1L1
prerank,protein serine/threonine phosphatase inhibitor activity (GO:0004865),0.8401416746698691,1.7426754185444568,0.003913894324853229,0.2988395344441257,0.817,1/11,0.03%,PPP1R1A
prerank,monocarboxylic acid transmembrane transporter activity (GO:0008028),0.6950806238866483,1.7309117610268139,0.0035587188612099642,0.302196273568408,0.866,6/26,1.42%,SLC16A6;SLC6A13;SLC6A1;SLC6A12;SLC16A12;SLC16A11
prerank,cadherin binding (GO:0045296),-0.4043909049424192,-1.7303809768082128,0.0,0.04916642151389809,0.619,110/315,17.56%,STXBP6;CDH11;COBLL1;CTNND2;DOCK9;SPTBN1;CTNNA2;PTPRB;PTPRM;FMNL2;PTPRJ;AHNAK;MRTFB;CDH8;CDH2;CDH13;ITGA6;BSG;ANK3;MYO1B;BMPR2;CTNNA3;FNBP1L;ESYT2;RTN4;NOTCH3;LRRFIP1;PTPRT;IQGAP1;PROM1;FXYD5;CLINT1;CDH10;CDH12;F11R;EHD4;MYH9;YWHAE;EPN2;HSP90AB1;SHTN1;KDR;TRPC4;ANXA1;OLA1;DAB2IP;YWHAB;LIMA1;CDH6;FLNA;SH3GLB1;HSPA8;PSEN1;ITGB1;CDH20;CDH19;CDH7;CD2AP;TAGLN2;RPL14;BZW1;BZW2;HSPA5;RPL34;RDX;ANLN;PDLIM1;ABI1;RPL7A;RPS2;EFHD2;RPL23A;PCBP1;CALD1;MB21D2;RPL29;ERC1;MARK2;HNRNPK;CDH1;PAICS;AHSA1;CTNNB1;RANBP1;TNKS1BP1;RPL6;TES;ARGLU1;GAPVD1;ACVR1;GCN1;TMPO;CDK5R1;NCK1;RPS26;ALDOA;CCT8;CDH9;CBL;PKM;SEPTIN9;USP8;CAPZA1;APC;WASF2;PRDX1;SCRIB;PPP1CA;EMD;SCYL1
prerank,semaphorin receptor binding (GO:0030215),-0.6369921097157019,-1.7267460831137527,0.004555808656036446,0.04910522193118945,0.634,11/23,14.99%,SEMA3C;SEMA6A;SEMA6D;RIT2;SEMA5A;SEMA7A;SEMA3E;SEMA4D;SEMA3D;SEMA3G;SEMA4C
prerank,frizzled binding (GO:0005109),0.6490882026882332,1.7156317969553199,0.004918032786885246,0.32167254067988543,0.912,4/34,1.96%,WNT5B;RNF43;WNT4;WNT6
prerank,amyloid-beta binding (GO:0001540),-0.47678417569070625,-1.7099559972654528,0.0,0.05889664622833261,0.707,21/79,7.96%,NLGN1;APBB2;GRIA4;COL25A1;GRIN2B;CST3;GRIA1;GRIA2;TGFB2;GRIA3;APBA2;FZD4;APOE;GSAP;ITM2A;LDLR;GRIN2A;CACNA1B;HSPG2;SORL1;EPHB2
prerank,extracellular ligand-gated ion channel activity (GO:0005230),-0.7751974472250514,-1.7016524476042032,0.010080645161290322,0.0630374080152025,0.741,9/10,21.21%,GABRG3;GABRA3;GABRA2;GABRG2;GABRA4;GABRG1;GABRA5;GABRE;GABRA1
prerank,pentosyltransferase activity (GO:0016763),0.6308932966107399,1.6773887932537763,0.013008130081300813,0.44360653813135453,0.976,19/36,14.45%,LACC1;LARGE1;ART5;PARP10;PARP14;TIPARP;SIRT5;PARP4;TNKS2;SIRT3;PARP9;SIRT1;ZC3HAV1;PARP11;PARP6;LARGE2;SIRT4;ART4;QPRT
prerank,phosphatidylcholine transporter activity (GO:0008525),-0.64412220899389,-1.6643570113402542,0.004301075268817204,0.09169304274164677,0.871,10/17,14.29%,ATP10A;ATP8B1;PITPNC1;PLTP;ABCG1;PITPNB;MTTP;PITPNA;ATP8B2;ABCB4
prerank,CoA-ligase activity (GO:0016405),0.7566834789719763,1.6567208926136754,0.01615798922800718,0.4999632017214924,0.991,3/14,4.33%,ACSL1;ACSS3;ACSBG2
prerank,histone demethylase activity (GO:0032452),0.6683473444458897,1.6522152221360697,0.015463917525773196,0.48049835764057885,0.992,14/27,21.00%,KDM7A;JARID2;FBXL19;KDM2B;KDM2A;JMJD6;HR;RIOX2;KDM3B;PHF2;KDM6B;KDM1A;KDM6A;RIOX1
prerank,chemorepellent activity (GO:0045499),-0.5951437933643048,-1.6493315089377742,0.013793103448275862,0.1038282575608597,0.913,11/25,12.46%,NRG3;SEMA3C;SEMA6A;SEMA6D;SEMA5A;SEMA7A;SEMA3E;EPHA7;SEMA4D;SEMA3D;SEMA3G
prerank,amino acid:sodium symporter activity (GO:0005283),0.77258585679134,1.648281687702865,0.013232514177693762,0.461631025927624,0.993,5/11,8.27%,SLC6A13;SLC6A1;SLC6A12;SLC38A1;SLC1A3
prerank,histone acetyltransferase binding (GO:0035035),0.6827089905756413,1.6313390731409845,0.027624309392265192,0.5078548839796495,0.999,6/21,7.92%,EPAS1;KANSL1L;GLI3;TP53;BCAS3;MEF2A
prerank,histone methyltransferase activity (H3-K4 specific) (GO:0042800),0.7344188216655732,1.630184451128276,0.02734375,0.47888999493717943,0.999,9/15,19.69%,KMT2A;CXXC1;ASH2L;KMT2C;WDR82;KMT2D;SETD1B;SETD3;SETD1A
prerank,BMP binding (GO:0036122),-0.7084048485619991,-1.6267092359999686,0.019801980198019802,0.12345775279385547,0.953,3/11,1.86%,GREM2;BMPR2;ENG
prerank,voltage-gated sodium channel activity (GO:0005248),-0.6027504599489857,-1.6247165383057265,0.011037527593818985,0.12155613716374578,0.956,10/22,16.27%,HCN1;SCN1A;SCN2A;CACNA1G;SCN7A;SCN3A;SCN9A;SCN8A;CACNA1H;SCN2B
prerank,NAD+ ADP-ribosyltransferase activity (GO:0003950),0.653160152715014,1.6234052157024927,0.02142857142857143,0.47974443762336033,1.0,15/25,13.20%,ART5;PARP10;PARP14;TIPARP;SIRT5;PARP4;TNKS2;SIRT3;PARP9;SIRT1;ZC3HAV1;PARP11;PARP6;SIRT4;ART4
prerank,diacylglycerol kinase activity (GO:0004143),-0.7275436770259219,-1.6139141651134434,0.012269938650306749,0.13006978879055212,0.967,6/11,13.00%,DGKH;DGKB;DGKI;DGKK;DGKG;DGKZ
prerank,acetylation-dependent protein binding (GO:0140033),0.6779549994132247,1.6013531428244898,0.03208556149732621,0.5193671229727317,1.0,7/20,12.51%,ZMYND8;KMT2A;PHIP;ATAD2B;SMARCA4;BRD7;BRD9
prerank,lysine-acetylated histone binding (GO:0070577),0.6779549994132247,1.6013531428244898,0.03208556149732621,0.5193671229727317,1.0,7/20,12.51%,ZMYND8;KMT2A;PHIP;ATAD2B;SMARCA4;BRD7;BRD9
prerank,fatty acid synthase activity (GO:0004312),-0.7209548113261135,-1.5941558814844201,0.025691699604743084,0.1521719353836375,0.984,3/10,10.29%,ELOVL7;ELOVL5;ELOVL6
prerank,sodium channel activity (GO:0005272),-0.5212394412041075,-1.5940240877304404,0.009925558312655087,0.14787142416627383,0.984,14/37,15.42%,GRIK2;HCN1;GRIK1;SCN1A;SCN2A;GRIK4;CACNA1G;SCN7A;SCN3A;SCN9A;KCNK1;SCN8A;CACNA1H;GRIK3
prerank,ionotropic glutamate receptor binding (GO:0035255),-0.7272913693384193,-1.5871772859429731,0.0288659793814433,0.15317381272218816,0.988,7/10,13.89%,SHANK3;GNAS;IGSF11;SHISA6;NSF;SHANK2;SHANK1
prerank,sodium:proton antiporter activity (GO:0015385),-0.6851751064216487,-1.5863491065747195,0.020366598778004074,0.14996654501575873,0.988,4/11,8.67%,SLC9A2;SLC9B2;SLC9A6;SLC9A7
prerank,protein phosphatase inhibitor activity (GO:0004864),0.6342919697489532,1.5831540603566687,0.022968197879858657,0.5746722264580454,1.0,1/26,0.03%,PPP1R1A
prerank,sulfotransferase activity (GO:0008146),0.6159915309811914,1.5830850228756523,0.016778523489932886,0.5462904444765116,1.0,5/33,3.35%,HS3ST3A1;UST;CHST15;CHST11;HS2ST1
prerank,phospholipase C activity (GO:0004629),-0.5452985121954628,-1.5727954747545938,0.024330900243309004,0.16364294555386116,0.996,8/25,9.32%,PLCB4;EDNRA;PLCL1;PLCE1;CHRM3;PLCG2;PDIA3;PLCH1
prerank,amino acid binding (GO:0016597),-0.5267366776793,-1.5657941395474138,0.02056555269922879,0.16988760406245343,0.998,10/31,15.27%,GRM7;NOS3;GRIN2B;GLRB;GRIN3A;GLRA3;GLRA1;NOS1;GLRA2;GRIN1
prerank,inorganic anion transmembrane transporter activity (GO:0015103),0.6116522555310056,1.559450145772114,0.03558718861209965,0.6271657184505742,1.0,3/27,1.22%,SLC22A6;SLC22A8;SLC5A5
prerank,active ion transmembrane transporter activity (GO:0022853),0.5833991531883836,1.5467404207926003,0.03636363636363636,0.6614848538952701,1.0,3/37,1.25%,SLC22A6;SLC22A8;ATP13A3
prerank,metal ion:proton antiporter activity (GO:0051139),-0.6445324878597265,-1.5464447873932117,0.021052631578947368,0.1945408772588476,1.0,4/13,8.67%,SLC9A2;SLC9B2;SLC9A6;SLC9A7
prerank,monovalent cation:proton antiporter activity (GO:0005451),-0.6490164113605394,-1.5337604137651988,0.032989690721649485,0.21044386237891521,1.0,4/12,8.67%,SLC9A2;SLC9B2;SLC9A6;SLC9A7
prerank,transmembrane receptor protein tyrosine kinase activity (GO:0004714),-0.4542335259133675,-1.5281587087770983,0.0030211480362537764,0.21453338228608362,1.0,19/60,9.84%,NRP1;TEK;ERBB4;NTRK3;ROR1;EPHB1;EPHA5;MERTK;NRP2;EPHA6;TIE1;NTRK2;KDR;ROR2;MET;EPHA7;EPHB2;FLT4;ERBB2
prerank,cAMP-dependent protein kinase regulator activity (GO:0008603),0.7457809086893388,1.5265465934179787,0.05142857142857143,0.737180807560819,1.0,1/10,0.04%,PRKAG2
prerank,cyclic nucleotide binding (GO:0030551),-0.55696433896703,-1.5257211910169177,0.04225352112676056,0.21358418073489122,1.0,6/21,2.15%,PDE4D;PDE4B;PDE10A;RAPGEF4;HCN1;PDE11A
prerank,acid-thiol ligase activity (GO:0016878),0.6983867261518772,1.5241570151736614,0.05776173285198556,0.7180669319552027,1.0,2/13,3.76%,ACSL1;ACSS3
prerank,acylglycerol O-acyltransferase activity (GO:0016411),0.6358237045267197,1.515152569851074,0.059726962457337884,0.735866145872823,1.0,4/20,4.25%,LPGAT1;AGPAT4;MOGAT3;GPAT2
prerank,delayed rectifier potassium channel activity (GO:0005251),-0.49541383825782287,-1.5079033201232142,0.030303030303030304,0.2378590443979426,1.0,9/32,10.93%,KCNB2;KCNQ5;KCNC2;KCNQ3;KCNS3;KCNA6;KCNQ1;KCNC1;KCNB1
prerank,LRR domain binding (GO:0030275),0.6690599132844397,1.5060206608031712,0.06576402321083172,0.7551185567330339,1.0,2/14,0.75%,ROBO1;PAWR
prerank,glycine binding (GO:0016594),-0.6560018950248644,-1.5052489042140031,0.05179282868525897,0.23700929303526622,1.0,7/11,15.27%,GRIN2B;GLRB;GRIN3A;GLRA3;GLRA1;GLRA2;GRIN1
prerank,outward rectifier potassium channel activity (GO:0015271),0.7092892030579839,1.5042824909364918,0.07127882599580712,0.7360865511321776,1.0,4/11,1.80%,KCNK2;KCNT1;KCND3;KCNA5
prerank,ion channel activity (GO:0005216),-0.41942119726710014,-1.5012988110651133,0.006472491909385114,0.23871145341920175,1.0,20/80,9.54%,GRID2;GRIK2;PIEZO2;GRIA4;GRIK1;GRIN2B;GRIA1;GRIA2;GABRB1;ABCC9;GRIA3;UNC80;GRIK4;GRIN3A;TRPC1;GRIN2A;TRPC6;PIEZO1;GRID1;TRPV4
prerank,R-SMAD binding (GO:0070412),0.636269477589408,1.5008723115031763,0.05935251798561151,0.7263121842070047,1.0,5/18,6.17%,SMAD3;DDX5;PMEPA1;SMAD6;LDLRAD4
prerank,fibroblast growth factor receptor binding (GO:0005104),0.6277247286168463,1.4902185781904245,0.06474820143884892,0.7536427133041023,1.0,3/21,3.11%,FGF1;KL;FRS2
prerank,phospholipid transfer activity (GO:0120014),-0.5470541066611445,-1.4897398623838864,0.050808314087759814,0.25460033215439126,1.0,9/21,13.42%,CERT1;PITPNC1;PLTP;GLTP;PITPNB;TNFAIP8L3;MTTP;PITPNA;PLEKHA3
prerank,thyroid hormone receptor binding (GO:0046966),0.5837053323492757,1.4880835595198179,0.059233449477351915,0.7395117680005283,1.0,15/28,20.46%,BRD8;NSD1;NCOA3;MED12;TRIP12;MED17;TRIP6;THRAP3;TAF11;HMGN3;NCOR1;TAF7;MED1;NCOA6;MED13
prerank,G protein-coupled serotonin receptor activity (GO:0004993),-0.5478236509755343,-1.4867779723794938,0.05104408352668213,0.24429874240427274,1.0,9/22,15.27%,CHRM3;HTR2C;HTR2A;CHRM2;HTR1F;HTR7;HTR4;HTR1B;HRH1
prerank,G protein-coupled amine receptor activity (GO:0008227),-0.5478236509755343,-1.4867779723794938,0.05104408352668213,0.24429874240427274,1.0,9/22,15.27%,CHRM3;HTR2C;HTR2A;CHRM2;HTR1F;HTR7;HTR4;HTR1B;HRH1
prerank,serotonin receptor activity (GO:0099589),-0.5478236509755343,-1.4867779723794938,0.05104408352668213,0.24429874240427274,1.0,9/22,15.27%,CHRM3;HTR2C;HTR2A;CHRM2;HTR1F;HTR7;HTR4;HTR1B;HRH1
prerank,acidic amino acid transmembrane transporter activity (GO:0015172),-0.6042109899228821,-1.484001748188146,0.04805491990846682,0.2440970166975618,1.0,8/15,15.38%,SLC1A5;SLC1A2;SLC1A1;SLC25A13;SLC1A4;SLC17A6;SLC38A7;SLC1A6
prerank,histone demethylase activity (H3-K36 specific) (GO:0051864),0.7428336005077122,1.4829821102735496,0.05845511482254697,0.7396847102267002,1.0,4/10,11.82%,KDM7A;KDM2B;KDM2A;RIOX2
prerank,metal ion transmembrane transporter activity (GO:0046873),0.580772701549281,1.4816778555258614,0.05952380952380952,0.7224752698336606,1.0,5/27,6.34%,SLC41A1;ITPR2;ITPR1;CNNM2;MRS2
prerank,mRNA 3'-UTR binding (GO:0003730),0.48807920861905224,1.4815668843995755,0.025069637883008356,0.701069462476095,1.0,27/79,18.47%,CPEB2;CELF2;DDX5;CPEB4;RBMS2;LARP4B;IGF2BP1;TP53;HNRNPA2B1;PABPC4L;LARP1;CPEB3;IGF2BP2;CSDC2;RBMS1;HNRNPC;RSL1D1;PABPC5;ZFP36L1;RBM4;DAZAP1;ILF3;CRYZ;RBMS3;BOLL;RNF20;LARP4
prerank,phosphatidate phosphatase activity (GO:0008195),-0.6112100891931226,-1.4789769877393497,0.05636743215031315,0.24804803840603928,1.0,5/13,13.67%,PLPP1;PLPPR1;PLPPR5;PLPPR4;LPIN3
prerank,secondary active transmembrane transporter activity (GO:0015291),0.5247309783289906,1.4769815853999062,0.03210272873194221,0.700022127360078,1.0,7/51,7.02%,SLC22A6;SLC22A8;SLC5A5;MCU;TMEM241;SLC5A8;SLC20A2
prerank,retinoic acid binding (GO:0001972),0.6878913920252929,1.4754660199144123,0.07942238267148015,0.6861964591003414,1.0,2/12,4.67%,NR2F2;CYP26B1
prerank,NAD binding (GO:0051287),0.5968675321632829,1.473879700571564,0.06712564543889846,0.6744233398473327,1.0,10/26,9.51%,SORD;ALDH1A1;CRYL1;SIRT5;BDH2;ALDH2;SIRT3;PARP9;SIRT1;ZC3HAV1
prerank,ribosomal small subunit binding (GO:0043024),0.6341959037719291,1.4700589474188952,0.08411214953271028,0.6731486942926961,1.0,3/17,8.31%,CPEB2;DDX3X;LARP1
prerank,MAP kinase activity (GO:0004707),0.6562035678243588,1.4686154109192817,0.08445297504798464,0.6618624151160143,1.0,1/14,0.10%,MAPK4
prerank,acylglycerol lipase activity (GO:0047372),-0.6404823235348724,-1.4625541592059907,0.055900621118012424,0.27324150487719956,1.0,3/11,13.46%,ABHD2;MGLL;LIPE
prerank,cyclin-dependent protein kinase activity (GO:0097472),-0.5371050837444626,-1.4596369429412013,0.049107142857142856,0.2680835774687343,1.0,4/21,16.28%,CDK14;CDK19;CDK8;CDKL4
prerank,cyclin-dependent protein serine/threonine kinase activity (GO:0004693),-0.5371050837444626,-1.4596369429412013,0.049107142857142856,0.2680835774687343,1.0,4/21,16.28%,CDK14;CDK19;CDK8;CDKL4
prerank,"oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor (GO:0016620)",0.6169013583088641,1.4568264281291095,0.09506398537477148,0.6954879940036338,1.0,5/18,7.88%,ALDH1A2;ALDH1A1;AKR1B10;ALDH3B1;ALDH2
prerank,2-oxoglutarate-dependent dioxygenase activity (GO:0016706),0.553100208915521,1.4531162297562796,0.08388157894736842,0.6931540638306719,1.0,12/32,18.13%,KDM7A;TET2;BBOX1;TMLHE;KDM2B;KDM2A;RIOX2;TET1;HIF1AN;ALKBH5;TET3;PHYH
prerank,calcium ion binding (GO:0005509),-0.34301432991324227,-1.4512199843847058,0.0,0.2784205094430269,1.0,95/323,18.89%,KCNIP4;ADGRL3;CDH11;SLC8A1;NRXN1;SLIT2;SYT1;ASTN2;CDH8;CDH2;CDH13;GSN;SPOCK2;LTBP4;MCTP1;PLA2G4A;ESYT2;RYR2;RASGRP3;THBS1;TPD52;ACER3;STIM2;IQGAP1;TPT1;CDH10;PCLO;DNER;CDH12;KCNIP1;S100A6;RYR3;SLC25A13;ANXA1;ASPN;CALM1;CDH6;MICU3;CALM2;GLCE;ENPP1;TKT;PPP3R1;CDH20;CDH19;CDH7;PAM;PPP3CA;HSPA5;SPOCK1;DYSF;CALR;CRACR2A;S100B;TPM4;CAMKK2;EFHD2;TUBB4A;ESYT3;AGRN;CALM3;ENPP2;SPARCL1;CDH1;ASAH2;S100A16;SNCA;PITPNM3;RET;CETN3;CDK5R1;SDF4;MAN1B1;SYT7;TRPM2;PCP4;GRIN1;CDH9;RASGRP2;AOC3;CLEC3B;AMY1A;AMY1C;AMY1B;AOAH;SYT6;GCA;ITPR3;CETN2;EFCAB11;PLA2G4E;CASQ2;SYT10;EML1;MCTP2
prerank,intracellular calcium activated chloride channel activity (GO:0005229),-0.5833317398135478,-1.449780873321734,0.04439252336448598,0.27110631645979627,1.0,7/16,15.40%,ANO4;ANO1;ANO3;TTYH2;TTYH1;ANO5;ANO2
prerank,intracellular chloride channel activity (GO:0061778),-0.5833317398135478,-1.449780873321734,0.04439252336448598,0.27110631645979627,1.0,7/16,15.40%,ANO4;ANO1;ANO3;TTYH2;TTYH1;ANO5;ANO2
prerank,sialyltransferase activity (GO:0008373),-0.5418558070494445,-1.4426544779085515,0.06382978723404255,0.2801720318558861,1.0,9/20,8.77%,ST6GALNAC3;ST3GAL4;ST8SIA4;ST3GAL1;ST6GAL2;ST8SIA1;ST6GALNAC5;ST3GAL6;ST8SIA6
prerank,potassium channel activity (GO:0005267),-0.3941101222879261,-1.4376798278895733,0.010033444816053512,0.2850111945254628,1.0,25/89,11.64%,GRIK2;KCNT2;KCND2;KCNB2;KCNQ5;KCNC2;KCNH7;HCN1;KCNMA1;GRIK1;KCNN2;ABCC9;KCNQ3;KCNK5;KCNMB2;GRIK4;KCNS3;KCNK13;KCNA6;KCNQ1;KCNK9;KCNC1;KCNH5;KCNB1;KCNK1
prerank,phosphoric diester hydrolase activity (GO:0008081),-0.47328633190272607,-1.4366127559132673,0.06005221932114883,0.2817827273038748,1.0,12/35,11.86%,PLCB4;PLCL1;PLCE1;PDE11A;PLCXD3;GPCPD1;ENPP6;ENPP1;GDPD1;PDIA3;ENPP2;SMPDL3A
prerank,peptidase inhibitor activity (GO:0030414),0.5541377562684643,1.4336420691573724,0.06840390879478828,0.7606378736320706,1.0,6/33,8.46%,ITIH2;TFPI;SERPIND1;RENBP;KNG1;HRG
prerank,alkali metal ion binding (GO:0031420),0.6743361699557497,1.4332337038038878,0.10634328358208955,0.7444900335110504,1.0,4/13,12.70%,ATP1A2;ATP4A;HDAC4;TDG
prerank,endopeptidase regulator activity (GO:0061135),0.5232862516271546,1.4315137928952024,0.06913183279742766,0.7343064080883634,1.0,7/40,9.31%,ITIH2;TFPI;SERPIND1;RENBP;KNG1;HRG;APH1B
prerank,protein tyrosine kinase activator activity (GO:0030296),-0.546288848405126,-1.4269104959353764,0.05491990846681922,0.29546627068805137,1.0,6/19,13.17%,NRG3;GRM5;EFNA5;GAS6;ABI1;ERCC6
prerank,phosphotyrosine residue binding (GO:0001784),-0.4675108664693417,-1.4202596038128976,0.053164556962025315,0.30328208201757856,1.0,16/37,23.23%,PIK3R1;NCK2;BCAR3;SHE;PLCG2;CRK;RASA1;PTPN3;SAMSN1;VAV1;SYK;LDLRAP1;IRS1;SHC1;YES1;SHC3
prerank,transcription coactivator binding (GO:0001223),0.5986148818850064,1.4177008226773007,0.10458715596330276,0.7794390674982707,1.0,7/20,8.89%,RORA;THRB;SMAD3;VGLL4;CCNT2;TERT;TEAD2
prerank,ribosomal large subunit binding (GO:0043023),0.681508578598025,1.4175440513995103,0.13001912045889102,0.7627436737162977,1.0,1/11,0.33%,CPEB2
prerank,nucleotide diphosphatase activity (GO:0004551),0.6333791812785088,1.4120454753030176,0.11786372007366483,0.7692169451040739,1.0,4/14,5.04%,NUDT4;FHIT;CILP2;NUDT13
prerank,potassium:proton antiporter activity (GO:0015386),-0.6216727225738886,-1.4084711610109664,0.08982035928143713,0.32205000486367336,1.0,3/10,8.67%,SLC9A2;SLC9A6;SLC9A7
prerank,quaternary ammonium group transmembrane transporter activity (GO:0015651),0.6670375411484657,1.4049178709174792,0.10019646365422397,0.7837987764824309,1.0,6/11,19.67%,SLC25A48;SLC25A20;SLC22A5;SLC25A47;SLC25A29;SLC22A4
prerank,ligand-gated cation channel activity (GO:0099094),-0.40065721320797815,-1.4047300352824648,0.03058103975535168,0.3241665396598106,1.0,13/75,4.76%,GRIK2;GRIA4;KCNJ3;GRIK1;GRIN2B;GRIA1;KCNJ2;GRIA2;KCNN2;PTK2B;GRIA3;GRIK4;GRIN3A
prerank,histone demethylase activity (H3-K9 specific) (GO:0032454),0.6533317267835521,1.4036686467661688,0.1318267419962335,0.7722654043041313,1.0,4/12,12.83%,KDM7A;HR;KDM3B;PHF2
prerank,death receptor activity (GO:0005035),-0.6045988575207871,-1.402842453238081,0.08958333333333333,0.32298111582998,1.0,5/11,18.20%,TNFRSF11A;TNFRSF19;TNFRSF1B;FAS;TNFRSF25
prerank,neutral amino acid transmembrane transporter activity (GO:0015175),-0.465480910685001,-1.401866171670291,0.08353808353808354,0.3200572771384115,1.0,13/32,13.39%,SLC6A6;SLC1A5;SLC7A5;SLC38A6;SLC1A1;SLC1A4;SLC38A5;SLC43A2;SLC6A7;SLC43A1;SFXN1;SLC38A7;SFXN3
prerank,G protein-coupled chemoattractant receptor activity (GO:0001637),0.6282739986465646,1.3976069426265643,0.1268939393939394,0.7823740869839791,1.0,2/15,1.57%,CCR9;ACKR2
prerank,vitamin D receptor binding (GO:0042809),0.6165223644196411,1.3944582330204789,0.11985688729874776,0.7803574791556096,1.0,9/14,24.29%,MED12;MED17;THRAP3;TAF11;TAF7;RXRA;MED1;MED13;MED24
prerank,kinase activator activity (GO:0019209),0.5446194265488747,1.3907599996043447,0.09466437177280551,0.7807457726023862,1.0,2/30,2.35%,PRKAG2;GPRC5C
prerank,muscle alpha-actinin binding (GO:0051371),-0.555825301562606,-1.3890864865688375,0.11349036402569593,0.3414536782411043,1.0,8/15,30.32%,PDLIM1;SYNPO2;PDLIM3;LDB3;PDLIM2;TTN;PDLIM4;NRAP
prerank,calcium-activated potassium channel activity (GO:0015269),-0.6050217558857174,-1.3888294956136105,0.09650924024640657,0.33684094648219504,1.0,3/11,4.51%,KCNMA1;KCNN2;KCNMB2
prerank,methylated histone binding (GO:0035064),0.476325760432959,1.3885514327357835,0.07726597325408618,0.7747591397457,1.0,18/62,18.47%,KDM7A;ZMYND8;CXXC1;ZCWPW2;TDRD3;ATRX;CBX5;PHF1;PHF2;MPHOSPH8;TAF7;MORC4;LRWD1;NCAPD3;SGF29;KMT2E;CHD8;TAF1
prerank,ubiquitin-specific protease binding (GO:1990381),0.5982703548292234,1.3821739696245487,0.13097345132743363,0.7864286690301161,1.0,10/19,23.60%,PRKN;LCOR;PTEN;CLTC;AMFR;SYVN1;SUMO1;DERL1;SELENOS;BAG6
prerank,protein phosphorylated amino acid binding (GO:0045309),-0.4388179977813988,-1.3812834055931118,0.05714285714285714,0.34734898294091165,1.0,17/42,21.38%,PIK3R1;NCK2;BCAR3;SHE;YWHAE;YWHAB;PLCG2;CRK;RASA1;PTPN3;SAMSN1;VAV1;SYK;LDLRAP1;IRS1;SHC1;YES1
prerank,organic anion transmembrane transporter activity (GO:0008514),0.42710132886636626,1.3789109583123418,0.036,0.7863665009224768,1.0,20/134,8.49%,SLC22A6;SLC13A3;SLC6A13;SLC6A1;SLC16A12;SLC16A11;SLC38A3;SLC7A2;PDPN;SFXN2;SLC6A9;SLC26A3;SLC25A23;SLC25A2;SLC19A1;SLC27A1;SLC26A1;SLC38A1;SLC1A3;CTNS
prerank,carboxylic acid binding (GO:0031406),-0.4509708277066017,-1.3777611047583296,0.06493506493506493,0.34983004710477533,1.0,14/38,15.27%,GRM7;NOS3;SESN3;GRIN2B;GLRB;GRIN3A;GLRA3;PSAP;EPDR1;GLRA1;GLUD1;NOS1;GLRA2;GRIN1
prerank,transforming growth factor beta receptor binding (GO:0005160),0.5960283000606017,1.369065722444607,0.13508771929824562,0.812515594799147,1.0,5/18,7.34%,TGFBR3;SMAD3;TGFBR1;SMAD6;TGFBR2
prerank,actinin binding (GO:0042805),0.5716991452447364,1.3685937481112584,0.10954063604240283,0.7998911877922085,1.0,5/21,4.75%,CACNA1D;KCNA5;CSRP3;DAG1;CACNA1C
prerank,voltage-gated ion channel activity (GO:0005244),-0.5559268868245764,-1.363721712293806,0.12101910828025478,0.3743960767835944,1.0,9/14,22.95%,KCND2;CACNA1E;HCN1;VDAC1;CACNA1H;GPR89A;GPR89B;VDAC3;HVCN1
prerank,phosphatidylinositol phospholipase C activity (GO:0004435),-0.48834710231579287,-1.3627900761715435,0.0893719806763285,0.3711947662936013,1.0,6/23,9.32%,PLCB4;EDNRA;PLCE1;CHRM3;PLCG2;PLCH1
prerank,sulfuric ester hydrolase activity (GO:0008484),0.6225677845230062,1.3613094488435036,0.16318785578747627,0.8162793430871259,1.0,4/12,13.29%,SULF2;ARSG;ARSB;SULF1
prerank,histone-lysine N-methyltransferase activity (GO:0018024),0.4936777706888024,1.3598441248338198,0.09615384615384616,0.8084795623725913,1.0,21/44,18.15%,KMT2A;CXXC1;SMYD3;KMT5C;NSD1;KMT5B;SETD7;NSD3;ASH2L;KMT2C;WDR82;KMT2D;KMT5A;DOT1L;SETD1B;SETDB2;EHMT2;EHMT1;ASH1L;KMT2E;SETD3
prerank,glycerophospholipid flippase activity (GO:0140333),-0.5975209273338635,-1.3587459689480306,0.12421052631578948,0.3752728502974922,1.0,8/11,14.29%,ATP10A;ATP8A1;ATP8B1;ATP11A;ATP8A2;ATP11C;ATP8B2;ABCB4
prerank,pre-mRNA binding (GO:0036002),0.5287655237751712,1.358021310176772,0.11774744027303755,0.8014723509598778,1.0,2/28,1.27%,CELF2;DDX5
prerank,methylation-dependent protein binding (GO:0140034),0.47074161313320706,1.3578527926288309,0.1062874251497006,0.7887176144576545,1.0,16/57,18.45%,KDM7A;ZMYND8;CXXC1;ZCWPW2;TDRD3;ATRX;CBX5;PHF1;PHF2;MPHOSPH8;MORC4;LRWD1;NCAPD3;SGF29;KMT2E;CHD8
prerank,insulin-like growth factor I binding (GO:0031994),-0.5664482830692411,-1.3563223061437377,0.10425531914893617,0.37584769293123743,1.0,5/13,10.38%,ITGA6;ITGB4;IGFBP4;IGFBP6;ITGB3
prerank,amino acid transmembrane transporter activity (GO:0015171),0.4877526305728384,1.3556156578691976,0.09287925696594428,0.7838296310163294,1.0,7/47,3.73%,SLC6A13;SLC6A1;SLC38A4;SLC38A3;SLC7A11;SLC7A2;PDPN
prerank,transmembrane receptor protein serine/threonine kinase binding (GO:0070696),0.6240023514230513,1.355066166597292,0.13740458015267176,0.7732138843257931,1.0,2/13,0.46%,BMP6;BMP7
prerank,transmembrane receptor protein kinase activity (GO:0019199),-0.39969008761709524,-1.3543707731015084,0.061971830985915494,0.3751104368917701,1.0,18/60,9.84%,TEK;ERBB4;NTRK3;ROR1;EPHB1;EPHA5;MERTK;EPHA6;TIE1;ACVRL1;NTRK2;KDR;ROR2;MET;EPHA7;EPHB2;FLT4;ERBB2
prerank,carbohydrate kinase activity (GO:0019200),0.6347106062678425,1.3511750749852822,0.16729323308270677,0.776497727787035,1.0,6/11,23.83%,HK2;GALK2;GALK1;HK1;NAGK;GNE
prerank,sodium-independent organic anion transmembrane transporter activity (GO:0015347),0.6477101405458503,1.3507641452202301,0.1680327868852459,0.7661712174982819,1.0,1/10,0.09%,SLC22A6
prerank,platelet-derived growth factor receptor binding (GO:0005161),-0.5580855702361709,-1.3477444967651215,0.1288981288981289,0.3843821301446871,1.0,7/13,18.17%,PTPRJ;IL1R1;PDGFC;PDGFA;ITGB3;VEGFA;ITGA5
prerank,BMP receptor binding (GO:0070700),0.6240026351680454,1.346565236995241,0.15849056603773584,0.7701273644604295,1.0,2/12,0.46%,BMP6;BMP7
prerank,heparan sulfate sulfotransferase activity (GO:0034483),0.6000043141967659,1.3458761735507625,0.161231884057971,0.7611089111200395,1.0,5/15,4.34%,HS3ST3A1;HS3ST3B1;NDST1;HS2ST1;HS3ST6
prerank,lipid phosphatase activity (GO:0042577),-0.5567059856064609,-1.345793028754948,0.12527964205816555,0.3835660754108175,1.0,4/14,10.21%,PLPP1;PLPPR1;PLPPR5;PLPPR4
prerank,nuclear receptor coactivator activity (GO:0030374),0.47261868136364643,1.3449407537437101,0.10174880763116058,0.7534399089488101,1.0,15/52,11.91%,PPARGC1B;PPARGC1A;BRD8;PRKCB;NCOA3;HMGA1;MED12;TMF1;CALCOCO1;CCAR1;MED17;THRAP3;ZMIZ2;ZMIZ1;CCDC62
prerank,monocarboxylic acid binding (GO:0033293),0.5830507691170213,1.344274834709902,0.16638655462184873,0.7447694977938102,1.0,3/18,4.67%,NAPEPLD;NR2F2;CYP26B1
prerank,nuclear receptor binding (GO:0016922),0.42274555006468956,1.3432325831520084,0.0674931129476584,0.7375304516267754,1.0,26/111,11.91%,PPARGC1B;SMAD3;DDX5;PPARGC1A;BRD8;NCOR2;PRKCB;NSD1;NCOA3;LCOR;HMGA1;BCAS3;MED12;WIPI1;SMARCD3;TRIP12;SMARCA4;TMF1;SMARCE1;SIRT1;TCF7L2;MED17;TRIP6;THRAP3;TAF11;CCDC62
prerank,RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977),0.36116747325916315,1.3413136972282884,0.0010384215991692627,0.7334995550378209,1.0,142/831,12.98%,AEBP1;EPAS1;HLF;ZKSCAN2;RORA;MAF;THRB;SMAD3;TFDP2;GLIS3;OSR1;ZIC2;MXI1;NFYC;CUX1;PPARA;PKNOX2;CREBRF;ZFHX2;FOXP4;IKZF2;ZNF423;CREB5;HOXB4;DNMT3A;GLI2;ZBTB20;ZNF160;HOXB6;NPAS3;FOXD1;HOXC6;HOXA1;ZNF568;NFAT5;SOX5;NR2F2;KCNIP3;ZNF697;ELF1;NR6A1;GLI3;MITF;ARNT2;FOXC1;NFIB;RFX8;HOXB3;VEZF1;ZBTB38;MAFG;ASCL3;ATOH1;NACC2;NFYB;NHLH2;FOXP2;SALL4;CUX2;RREB1;MEIS1;NSD1;TEF;OTP;ESRRA;TEAD3;STAT2;HOXB9;HOXA3;HOXB5;TP53;BHLHE41;RORC;SOX12;MGA;ZSCAN29;ZIC5;MEF2A;NR1D2;HOXC4;RBL2;ZSCAN25;ZIC1;IRX1;NEUROD4;TEAD2;KLF3;CALCOCO1;HDAC4;GLI1;ZBTB26;ZIC4;TFDP1;TCF7;NR2C2;HDAC1;SOX13;CCAR1;ZFP90;FOXC2;TCF7L2;TCF4;HBP1;ZBTB8B;ZNF219;MYBL1;HIVEP2;FOXL1;ZFP28;RBL1;ZFP3;THRAP3;PRDM5;ZBTB6;ZKSCAN5;ZNF569;ZNF367;NFATC3;RARG;MNT;ATF2;TFAP2D;ZNF467;ZBTB1;SKOR1;MYBL2;TEAD1;ZSCAN22;ZNF148;HES6;ZNF235;HOXB2;FOXA2;DEAF1;MLXIPL;NR3C2;IRF1;ZKSCAN7;ZNF483;PBX4;ZBTB48;FOXJ2
prerank,acetyltransferase activity (GO:0016407),0.5198282907404382,1.3408135217816433,0.12887438825448613,0.7248250757089231,1.0,9/31,16.31%,SPHK1;PAFAH2;NAA80;SAT1;KAT6B;SMARCE1;KAT2B;NAA16;CREBBP
prerank,metalloexopeptidase activity (GO:0008235),0.4701528598409603,1.3383141487021921,0.0959119496855346,0.7235956787481381,1.0,13/51,15.78%,AEBP1;ACE;CPQ;CPA4;METAP2;PEPD;NPEPPS;MMP14;FOLH1;ERAP1;AGBL3;ZMPSTE24;ANPEP
prerank,"phosphotransferase activity, alcohol group as acceptor (GO:0016773)",0.45156313328841496,1.3382529454171381,0.08588957055214724,0.7139725839773706,1.0,12/74,9.41%,NADK2;FAM20A;HK2;SPHK1;PI4KA;GK5;TKFC;GALK2;GK;PANK1;PIK3CA;DCAKD
prerank,protein tyrosine kinase activity (GO:0004713),-0.3612947044755683,-1.3365124324452156,0.028985507246376812,0.3995658410357652,1.0,26/108,10.49%,TEK;ERBB4;NTRK3;ROR1;EPHB1;EPHA5;MERTK;PEAK1;EPHA6;TIE1;PTK2B;NTRK2;KDR;LYN;ROR2;BMX;MET;EPHA7;EPHB2;PTK2;TEC;JAK1;FLT4;ERBB2;CAMKK2;HIPK1
prerank,metal ion binding (GO:0046872),-0.30668196022983374,-1.3355516910296392,0.0,0.396505459260904,1.0,133/477,19.06%,KCNIP4;ADGRL3;CDH11;SLC8A1;NRXN1;SLIT2;SYT1;MARK1;ASTN2;CDH8;CDH2;CSGALNACT1;CDH13;GSN;SPOCK2;LTBP4;SNRK;MAP3K5;HMGCLL1;MCTP1;PLA2G4A;ESYT2;ADCY2;RYR2;RASGRP3;THBS1;CDC42BPA;TPD52;ACER3;STIM2;IQGAP1;TPT1;CDH10;PCLO;DNER;CDH12;KCNIP1;S100A6;RYR3;SLC25A13;ANXA1;NLK;ASPN;CALM1;CDH6;APOE;MICU3;CALM2;GLCE;GNAI1;ENPP1;TKT;PPP3R1;CDH20;CDH19;CDH7;PAM;PPP3CA;HSPA5;SPOCK1;DYSF;CALR;IRAK3;CRACR2A;PDE2A;S100B;RAP2A;TPM4;CAMKK2;EFHD2;TUBB4A;ESYT3;AGRN;CALM3;MT1A;MT1H;MT1M;MT1E;MT1B;MT1G;MT1X;MT1F;ENPP2;SPARCL1;TRIM27;MARK2;CDH1;ASAH2;S100A16;SNCA;DUT;PITPNM3;RPE;RET;CETN3;PINK1;CDK5R1;SDF4;MT3;MAN1B1;SYT7;MAPK12;TRPM2;PCP4;GRIN1;CDH9;RASGRP2;AOC3;CLEC3B;PDXK;TOP2A;TPPP;ENDOV;AMY1A;AMY1C;AMY1B;AOAH;SYT6;GCA;ITPR3;CETN2;EFCAB11;PLA2G4E;CASQ2;HPRT1;IMPA1;SYT10;HSPE1;EML1;EXD2;MCTP2;RHEB;RAN
prerank,NAD+ binding (GO:0070403),0.632154451913654,1.3316638927390319,0.16984732824427481,0.7270777477766126,1.0,6/12,9.51%,CRYL1;SIRT5;SIRT3;PARP9;SIRT1;ZC3HAV1
prerank,alpha-actinin binding (GO:0051393),0.5464918731643884,1.3316360667437097,0.1564748201438849,0.7174771989639561,1.0,4/24,4.75%,CACNA1D;KCNA5;DAG1;CACNA1C
prerank,histone acetyltransferase activity (GO:0004402),0.5233189127318942,1.3299306643066526,0.12048192771084337,0.7140283896407457,1.0,11/30,18.47%,ARRB1;NCOA3;SRCAP;KAT6B;ATF2;BAZ1A;KAT14;KAT7;KAT2B;CREBBP;TAF1
prerank,adenylyltransferase activity (GO:0070566),0.5513469579007505,1.3293716809973544,0.14575645756457564,0.7066221432378311,1.0,13/21,22.77%,OAS2;NMNAT1;TENT2;FLAD1;ABL1;OAS3;TENT4B;PAPOLG;NMNAT2;TUT1;SELENOO;KARS1;NMNAT3
prerank,chloride channel inhibitor activity (GO:0019869),0.6307336044670017,1.321846260475649,0.1917808219178082,0.7227451023184557,1.0,1/10,0.45%,WNK4
prerank,5'-nucleotidase activity (GO:0008253),0.5975683028336196,1.3187748143819769,0.18018018018018017,0.7239031848029812,1.0,7/13,18.55%,NT5C1B-RDH14;NT5C1B;NT5DC1;NT5C2;NT5C3A;NT5C3B;NT5C
prerank,calcium-dependent phospholipase A2 activity (GO:0047498),-0.5437126983224156,-1.3168054385277106,0.14255765199161424,0.43230061991160323,1.0,4/15,23.28%,PLA2G4A;PLA2G12A;PLA2G4E;PLA2G4F
prerank,"oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen (GO:0016702)",0.5816725851655695,1.3140248547629811,0.1725417439703154,0.731139067364863,1.0,8/16,27.68%,ALOX12;ADI1;BCO2;ETHE1;ALOXE3;CDO1;HAAO;PIR
prerank,Toll-like receptor binding (GO:0035325),-0.5752620890703002,-1.3135349045251183,0.16155419222903886,0.43435163295373047,1.0,7/11,34.07%,DAB2IP;TIRAP;CD36;TOLLIP;TLR1;TLR2;MYD88
prerank,inorganic cation transmembrane transporter activity (GO:0022890),0.4662540855621502,1.3082727453944598,0.12844036697247707,0.7414849907616433,1.0,3/48,1.13%,TRPM3;SLC41A1;TRPM6
prerank,"phosphatidylinositol-3,5-bisphosphate binding (GO:0080025)",-0.4653733201383913,-1.3072335050429782,0.12895927601809956,0.4434327312185388,1.0,10/23,19.58%,HIP1;CLVS1;PLEKHA5;JPH2;SESTD1;PHLDA3;CLVS2;PLA2G4E;HIP1R;COMMD1
prerank,ubiquitin-like protein ligase activity (GO:0061659),0.37733705479021445,1.3067039793433188,0.04562268803945746,0.7379222022189674,1.0,33/232,11.44%,RNF220;RNF152;PDZRN3;SH3RF2;RNF43;ASB2;PRKN;TRIM63;KCMF1;DTX1;NEDD4;NHLRC4;RNF151;PIAS1;RNF135;TRIM56;RNF181;UBR4;MGRN1;UBR2;SMURF2;RNF8;HUWE1;TRIP12;RNF217;RNF19A;RNF34;UBR5;SH3RF1;RNF41;RNF13;CDC42;WWP2
prerank,ubiquitin protein ligase activity (GO:0061630),0.37786127732568686,1.306086268076246,0.0530209617755857,0.7310541378207547,1.0,32/228,11.44%,RNF220;RNF152;PDZRN3;SH3RF2;RNF43;ASB2;PRKN;TRIM63;KCMF1;DTX1;NEDD4;NHLRC4;RNF151;RNF135;TRIM56;RNF181;UBR4;MGRN1;UBR2;SMURF2;RNF8;HUWE1;TRIP12;RNF217;RNF19A;RNF34;UBR5;SH3RF1;RNF41;RNF13;CDC42;WWP2
prerank,tropomyosin binding (GO:0005523),0.5702726239976613,1.3050790339306182,0.2066420664206642,0.725917273721795,1.0,3/16,5.16%,NEBL;TMOD2;TMOD3
prerank,G protein-coupled receptor binding (GO:0001664),0.4002323767173214,1.3026023555325286,0.07651006711409396,0.7254661888039299,1.0,17/132,10.18%,WNT5B;ACE;RNF43;WNT4;TULP3;WNT6;PRKN;GNAT2;ARRB1;ARHGEF11;ARHGEF12;GNAT3;RYK;GPRC5B;ADM;PICK1;CCL25
prerank,cyclic-nucleotide phosphodiesterase activity (GO:0004112),-0.46335610745081135,-1.3020746928457032,0.1357142857142857,0.44934164471323446,1.0,9/23,5.56%,PDE4D;PDE4B;PDE3A;PDE10A;PDE8A;PDE3B;PDE11A;PDE7B;PDE1C
prerank,anion transmembrane transporter activity (GO:0008509),0.6080073605944564,1.299472512920491,0.20362903225806453,0.7273165759907411,1.0,2/12,5.94%,SLC22A6;SLC19A1
prerank,ADP binding (GO:0043531),0.5249052879677019,1.2992992915787116,0.15855855855855855,0.7195689948247567,1.0,2/25,4.15%,PRKAG2;MYO18A
prerank,MHC class II protein complex binding (GO:0023026),-0.586461466194742,-1.2962409921340488,0.15198237885462554,0.45794537169294824,1.0,7/11,17.31%,ATP1B1;YWHAE;HSP90AB1;HSPA8;HSP90AA1;PKM;CD74
prerank,rRNA binding (GO:0019843),-0.4170535709542506,-1.2934580788547076,0.11263736263736264,0.45960983910820136,1.0,20/42,26.10%,CAVIN1;RPLP0;RPS3;RPL5;RPL12;RPS9;RPL23;RPS5;EMG1;NOP53;RCC1L;MRPL16;ERI1;UTP23;RPS13;RPL11;FASTKD5;RRS1;DDX28;FASTKD2
prerank,phosphoric ester hydrolase activity (GO:0042578),0.45267812542205754,1.2924468539497567,0.12962962962962962,0.7336669840286578,1.0,9/49,10.90%,ATP1A2;MPPED2;PPP1CB;LHPP;PXYLP1;PTPN22;SAMHD1;PRUNE1;DUSP10
prerank,bHLH transcription factor binding (GO:0043425),0.5402485679897808,1.284505588969763,0.19320214669051877,0.751593312745867,1.0,4/19,9.35%,SMAD3;FHL2;BHLHE41;SIRT1
prerank,DNA binding (GO:0003677),0.34625268430901357,1.2840110344026356,0.010395010395010396,0.7451522066478666,1.0,176/694,20.44%,DENND4A;EPAS1;HLF;RORA;THRB;SMAD3;APLP2;ZIC2;PPARGC1A;NFYC;CUX1;PPARA;SSBP2;SPO11;POLR2A;ZNF423;DNMT3A;GLI2;SPHK1;FOXD1;HOXA1;ARID4A;NUPR1;NR2F2;TSHZ3;NR6A1;CXXC5;FOXC1;NFIB;PCBP2;ASCL3;NFYB;FOXP2;CUX2;CHD4;TIGD3;MEIS1;POLG;DDX3X;OTP;ARID3A;NHEJ1;ESRRA;HMGA1;TP53;TSHZ1;COLEC11;BCLAF3;CAMTA2;DNASE1L1;SOX12;PARP4;POLR2D;HUWE1;SAMHD1;MEF2A;KDM2B;SMARCA4;FBH1;TWNK;TERT;SLTM;SIRT3;XRCC4;IRX1;CALCOCO1;HDAC4;SSBP1;GLI1;C1D;RBMS1;ZIC4;NR2C2;DDX60;SOX13;WDR76;FOXC2;TCF7L2;TCF4;ZNF219;HIVEP2;FOXL1;SURF6;THRAP3;ABL1;PRDM5;RTF1;ZBTB6;MAU2;ZDHHC1;RARG;RBBP8;PRKDC;MSH3;TEAD1;ZNF148;IGHMBP2;HOXB2;FOXA2;MLXIPL;RAD50;TOP3A;PNKP;TDG;IRF1;PHF1;KMT2D;PBX4;MTERF2;ZMYM6;MCM7;MCM2;DDB2;MBD6;PSIP1;TAF4;ZBTB32;ILF2;SDE2;ZKSCAN3;HOXA7;E2F4;PURB;DEDD;TDP2;TET1;ZMYM4;FUBP3;NKX2-1;POLL;RXRA;DNASE1L2;RFX2;CREBBP;CENPC;CLSPN;ILF3;SMAD4;TCF7L1;MBD4;BARX2;CHD2;MSH4;CRY1;OGG1;TINF2;EZH1;FOXO3;CHD8;TAF1;HES7;NBN;FEN1;MBD1;FOXD2;RAD51D;CARF;ZGPAT;PDS5B;APTX;RFC1;POU4F1;HDGFL2;XPA;BCL6;ZNF76;NR1H3;RTF2;LIG4;NR5A1;GTF3C3;SPDEF;MCM9;IKZF3;POLR2G;GTF2A1
prerank,protein serine/threonine kinase inhibitor activity (GO:0030291),0.49857538555925623,1.2830415321899853,0.16526138279932545,0.740156144083621,1.0,1/29,0.04%,PRKAG2
prerank,GTPase activator activity (GO:0005096),0.36208126083263625,1.2815823164237947,0.04880817253121453,0.7371480284296356,1.0,72/313,13.69%,RANBP3L;DENND4A;DOCK11;RAPGEF5;ARHGAP28;ARHGAP29;ERRFI1;SIPA1L1;SMAP2;RIN2;ARHGEF10L;ARHGEF18;FNIP1;ARHGEF16;SRGAP2;ARHGAP18;FGD4;SYDE2;RGL1;ARHGAP9;ALS2;ALDH1A1;DOCK5;NGEF;NPRL3;AKAP13;RGS16;TBC1D16;ASAP3;LRRK2;GMIP;RAPGEF3;ARHGAP26;DENND2A;RAB3IP;IQSEC2;ARRB1;WDR41;RIN3;ASAP1;NPRL2;RAB3IL1;ARHGAP17;ARFGEF2;ARHGEF11;ARFGAP3;ELMOD3;DENND5A;SH3BP5;NUCB1;DNM1L;EPS8L2;OPHN1;GRTP1;HPS1;RALGAPB;FGD1;MTSS2;RANBP3;OCRL;RALBP1;EPS8L1;RGPD1;RGP1;GNB5;ANKRD27;RIC8B;MON1A;RAP1GAP;HACD3;DENND4C;DEPDC5
prerank,transcription cis-regulatory region binding (GO:0000976),0.35781606076206857,1.2784613280804784,0.032079646017699116,0.7396414746701573,1.0,83/406,16.45%,AEBP1;EPAS1;RORA;SMAD3;TFDP2;OSR1;FOXN3;MXI1;NFYC;CUX1;CREBRF;ZBTB20;NPAS3;GABPB1;GABPB2;ZNF568;ARID4A;SOX5;GLI3;FOXC1;VEZF1;ASCL3;NFYB;CREB3L2;SMAD6;CUX2;RREB1;BNC2;OTP;TIPARP;HMGA1;TP53;TBL1X;SOX12;BCOR;MEF2A;RBL2;TBL1XR1;CALCOCO1;HDAC4;GLI1;TFDP1;TCF7;NR2C2;HDAC1;SOX13;ASH2L;ZFP90;FOXC2;TCF7L2;ZBTB8B;RBL1;ZFP3;PRDM5;MNT;ATF2;HNRNPL;TFAP2D;TEAD1;BRD7;FOXA2;DEAF1;IRF1;KMT2D;ZBTB48;TBP;ATF6B;TAF4;NCOR1;SNAI1;PER2;NFKB1;PURB;TAF7;HOXB8;HSF2;MZF1;NKX2-1;STAT6;RXRA;ZBTB8A;RB1;PER3
prerank,C-C chemokine receptor activity (GO:0016493),0.533688576037791,1.2761257693727106,0.19298245614035087,0.7396329655446674,1.0,2/21,1.57%,CCR9;ACKR2
prerank,P-type ion transporter activity (GO:0015662),-0.5480205521535031,-1.272776525535436,0.2053941908713693,0.5019250502662775,1.0,5/12,11.59%,ATP2C1;ATP2B2;ATP2A3;ATP2B4;ATP2B1
prerank,protein serine/threonine phosphatase activity (GO:0004722),0.4378283198435202,1.2726338897594698,0.14084507042253522,0.7432011263070103,1.0,15/60,14.71%,LRRK1;CTDSPL;MTMR3;PPEF2;PPP1CB;PPM1E;LRRK2;CDC14A;PTEN;PP2D1;CDC14B;PHLPP2;CTDSP2;PPM1B;CTDP1
prerank,cis-regulatory region sequence-specific DNA binding (GO:0000987),0.34357696235050605,1.2717026863849954,0.013555787278415016,0.7386217235357565,1.0,126/732,12.98%,HLF;ZKSCAN2;RORA;MAF;THRB;SMAD3;GLIS3;ZIC2;FOXN3;MXI1;NFYC;PPARA;PKNOX2;ZFHX2;FOXP4;IKZF2;ZNF423;CREB5;HOXB4;DNMT3A;GLI2;ZBTB20;ZNF160;HOXB6;FOXD1;HOXC6;HOXA1;ZNF568;NFAT5;SOX5;NR2F2;KCNIP3;ZNF697;ELF1;NR6A1;GLI3;MITF;ARNT2;FOXC1;NFIB;RFX8;HOXB3;ZBTB38;MAFG;ATOH1;NACC2;NFYB;NHLH2;FOXP2;SALL4;RREB1;MEIS1;NSD1;TEF;TIPARP;ESRRA;TEAD3;STAT2;HMGA1;HOXB9;HOXA3;HOXB5;TP53;BHLHE41;RORC;SOX12;MGA;ZSCAN29;ZIC5;MEF2A;NR1D2;HOXC4;ZSCAN25;ZIC1;IRX1;NEUROD4;TEAD2;KLF3;CALCOCO1;HDAC4;GLI1;ZBTB26;ZIC4;TCF7;NR2C2;HDAC1;SOX13;CCAR1;FOXC2;TCF7L2;TCF4;HBP1;ZNF219;MYBL1;HIVEP2;FOXL1;ZFP28;THRAP3;PRDM5;ZBTB6;ZKSCAN5;ZNF569;ZNF367;NFATC3;RARG;MNT;ATF2;ZNF467;ZBTB1;SKOR1;MYBL2;TEAD1;ZSCAN22;ZNF148;HES6;ZNF235;HOXB2;FOXA2;MLXIPL;NR3C2;IRF1;ZKSCAN7;ZNF483;PBX4;ZBTB48;FOXJ2
prerank,flavin adenine dinucleotide binding (GO:0050660),0.4461290255992994,1.2703229082984722,0.13479623824451412,0.7353285050413,1.0,19/53,18.94%,DDO;MICAL3;PRODH;DPYD;POR;MTHFR;DLD;LDHD;NOX4;ACOXL;MTRR;GCDH;ACOX3;SQOR;MICAL1;KDM1A;CRY1;MMACHC;ETFDH
prerank,calcium activated cation channel activity (GO:0005227),-0.48953608616857214,-1.269362200758152,0.16812227074235808,0.5043347531620226,1.0,4/17,4.51%,KCNMA1;ANO1;KCNN2;KCNMB2
prerank,"3',5'-cyclic-nucleotide phosphodiesterase activity (GO:0004114)",-0.4649962454894627,-1.2693248614207042,0.16464891041162227,0.49869389693659466,1.0,9/21,5.56%,PDE4D;PDE4B;PDE3A;PDE10A;PDE8A;PDE3B;PDE11A;PDE7B;PDE1C
prerank,tRNA methyltransferase activity (GO:0008175),0.5465572513595598,1.2681934596705489,0.21052631578947367,0.7344514431684043,1.0,2/16,7.49%,TRMT9B;TRMT44
prerank,insulin-like growth factor binding (GO:0005520),-0.5099476865413604,-1.2678301279360313,0.1831578947368421,0.4964916040270977,1.0,5/15,10.38%,ITGA6;ITGB4;IGFBP4;IGFBP6;ITGB3
prerank,N-acyltransferase activity (GO:0016410),0.4876580911768768,1.2670900177248303,0.18106312292358803,0.7303428821345581,1.0,7/32,9.35%,NMT2;NAA80;CERS6;CERS5;SAT1;SMARCE1;SIRT1
prerank,sequence-specific DNA binding (GO:0043565),0.34443758671368785,1.2666404711699875,0.025559105431309903,0.7244166138779982,1.0,87/590,12.45%,EPAS1;HLF;RORA;MAF;THRB;SMAD3;OSR1;PPARGC1A;CUX1;KMT2A;PPARA;PKNOX2;ZNF423;CREB5;HOXB4;GLI2;ZBTB20;HOXB6;CXXC1;FOXD1;HOXA1;NFAT5;NR2F2;ELF1;NR6A1;GLI3;ARNT2;CXXC5;FOXC1;CXXC4;NFIB;ZBTB38;MAFG;ATOH1;MBNL2;SMG1;NHLH2;FOXP2;CUX2;FBXL19;TEF;ACD;ESRRA;HOXB9;HOXB5;BHLHE41;RORC;SOX12;ZSCAN29;ZIC5;ELF2;MEF2A;KDM2B;NR1D2;HOXC4;ZIC1;KDM2A;TERT;SLTM;SIRT3;IRX1;TEAD2;KLF3;CALCOCO1;HDAC4;ZBTB26;ZIC4;TCF7;NR2C2;SOX13;FOXC2;TCF7L2;TCF4;FOXL1;ABL1;PRDM5;NFATC3;RARG;ATF2;SKOR1;MYBL2;TEAD1;ZNF148;HES6;HOXB2;FOXA2;NR3C2
prerank,MAP-kinase scaffold activity (GO:0005078),0.5887413847681039,1.2661155637975223,0.19883040935672514,0.71890627965314,1.0,5/11,14.02%,KSR1;AKAP13;SH3RF1;MAP2K1;MAP2K2
prerank,potassium channel regulator activity (GO:0015459),-0.37691250518312525,-1.2654699259334117,0.12332439678284182,0.4972824471011522,1.0,12/49,7.27%,KCNIP4;DPP10;DPP6;ABCC9;KCNIP1;KCNAB1;KCNMB2;NEDD4L;YWHAE;KCNS3;FLNA;WNK2
prerank,actin binding (GO:0003779),-0.31664975989028926,-1.2653637244343234,0.0410958904109589,0.49202501457965997,1.0,46/170,13.54%,UTRN;SYNE1;ACTN4;MYRIP;MAP1B;GSN;ABLIM1;TMSB4X;FMN2;KCNMA1;NOS3;PARVB;MICAL2;FXYD5;MOBP;KLHL2;CCDC88A;MYH9;CAP2;LIMA1;SMTN;KLHL1;MRTFA;CORO2B;ITGB1;PTK2;RDX;ANLN;CEACAM1;PDLIM1;MYO6;TRPV4;ADD2;TLNRD1;PACRG;EPS8;CALD1;SYNPO2;SPEF1;MAPT;PFN2;MTSS1;PDLIM3;DMTN;SNCA;SPTB
prerank,"N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity (GO:0008532)",-0.5374304169561542,-1.2634995875552506,0.2028397565922921,0.49106732144158766,1.0,7/12,27.83%,B3GALT1;B3GALNT1;B3GALT5;B3GNT3;B3GNT2;B4GAT1;B3GNT6
prerank,voltage-gated cation channel activity (GO:0022843),-0.34212478284971354,-1.2625236641340833,0.066006600660066,0.48810268754891867,1.0,23/97,11.64%,KCND2;CACNB2;KCNB2;CACNA1E;KCNQ5;KCNC2;KCNH7;HCN1;KCNMA1;CACNA2D1;GRIN2B;KCNQ3;PTK2B;GRIN3A;KCNS3;GRIN2A;CACNA1B;KCNA6;KCNQ1;KCNC1;KCNH5;KCNB1;KCNK1
prerank,FAD binding (GO:0071949),0.5092816439947595,1.2590512589665916,0.19725557461406518,0.73384504891686,1.0,9/24,18.08%,DDO;MICAL3;PRODH;MTHFR;MTRR;SQOR;MICAL1;CRY1;MMACHC
prerank,androgen receptor binding (GO:0050681),0.5132490796805405,1.2571323544847073,0.19387755102040816,0.7330640032793759,1.0,6/25,8.52%,DDX5;PRKCB;NSD1;WIPI1;SMARCA4;TMF1
prerank,acetylglucosaminyltransferase activity (GO:0008375),-0.3891514935977539,-1.2535649361739092,0.141643059490085,0.5049018362061769,1.0,12/46,12.19%,MGAT4C;GCNT2;EXT1;MGAT4A;B3GALT1;HEXB;MGAT5;B3GALNT1;EXT2;LFNG;MFNG;B3GALT5
prerank,RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978),0.33672686727243023,1.2478971956832756,0.020833333333333332,0.7554665198179039,1.0,124/731,12.98%,HLF;ZKSCAN2;RORA;MAF;THRB;SMAD3;GLIS3;ZIC2;MXI1;NFYC;PPARA;PKNOX2;ZFHX2;FOXP4;IKZF2;ZNF423;CREB5;HOXB4;DNMT3A;GLI2;ZBTB20;ZNF160;HOXB6;FOXD1;HOXC6;HOXA1;ZNF568;NFAT5;SOX5;NR2F2;KCNIP3;ZNF697;ELF1;NR6A1;GLI3;MITF;ARNT2;FOXC1;NFIB;RFX8;HOXB3;ZBTB38;MAFG;ATOH1;NACC2;NFYB;CREB3L2;NHLH2;FOXP2;SALL4;RREB1;MEIS1;NSD1;TEF;ESRRA;TEAD3;STAT2;HOXB9;HOXA3;HOXB5;TP53;BHLHE41;RORC;SOX12;MGA;ZSCAN29;ZIC5;MEF2A;NR1D2;HOXC4;ZSCAN25;ZIC1;IRX1;NEUROD4;TEAD2;KLF3;CALCOCO1;HDAC4;GLI1;ZBTB26;ZIC4;TCF7;NR2C2;HDAC1;SOX13;CCAR1;FOXC2;TCF7L2;TCF4;HBP1;ZNF219;MYBL1;HIVEP2;FOXL1;ZFP28;THRAP3;PRDM5;ZBTB6;ZKSCAN5;ZNF569;ZNF367;NFATC3;RARG;MNT;ATF2;ZNF467;ZBTB1;SKOR1;MYBL2;TEAD1;ZSCAN22;ZNF148;HES6;ZNF235;HOXB2;FOXA2;MLXIPL;NR3C2;IRF1;ZKSCAN7;ZNF483;PBX4;ZBTB48;FOXJ2
prerank,filamin binding (GO:0031005),0.5826697914252541,1.2475153545556708,0.2540983606557377,0.7494682990215723,1.0,1/11,0.50%,NEBL
prerank,vascular endothelial growth factor receptor binding (GO:0005172),-0.5277338907321228,-1.2469017695265932,0.21505376344086022,0.5151629396916727,1.0,6/12,18.17%,VEGFC;CCDC88A;DAB2IP;ITGB3;VEGFA;ITGA5
prerank,MAP kinase kinase kinase activity (GO:0004709),-0.5405599802046822,-1.246310670444019,0.18471337579617833,0.5112025954294072,1.0,2/11,7.01%,MAP3K5;MAP3K7
prerank,calcium channel regulator activity (GO:0005246),-0.40245311345002904,-1.2462645252670763,0.16230366492146597,0.5060654710811875,1.0,12/37,15.66%,PRKG1;NRXN1;STIM2;YWHAE;CALM1;CALM2;FKBP1A;NRXN2;SLC30A1;MCUB;CACNG8;STIMATE
prerank,low-density lipoprotein particle binding (GO:0030169),-0.49620764068468,-1.2458060565947744,0.22247706422018348,0.5018534561983312,1.0,8/16,9.02%,CDH13;THBS1;SCARB1;PLTP;LDLR;SORL1;STAB1;SCARF1
prerank,lipoprotein particle binding (GO:0071813),-0.46143708566503416,-1.2439491945917307,0.17824074074074073,0.5004932949867503,1.0,8/20,9.02%,CDH13;THBS1;SCARB1;PLTP;LDLR;SORL1;STAB1;SCARF1
prerank,chloride channel regulator activity (GO:0017081),0.5524623608317976,1.2404109886307992,0.2342857142857143,0.7655370237731058,1.0,1/14,0.45%,WNK4
prerank,myosin II binding (GO:0045159),-0.5581313372453346,-1.2402256181957785,0.23625254582484725,0.5042117836370273,1.0,4/10,9.85%,GSN;STXBP5L;SHROOM4;SHROOM1
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides (GO:0016811)",0.43369224015197205,1.2365451181197475,0.1819620253164557,0.7713470780526283,1.0,11/54,9.56%,UPB1;ASPA;HDAC8;NGLY1;ASPG;PM20D1;NAAA;SIRT5;HDAC4;SIRT1;HDAC1
prerank,protein serine/threonine/tyrosine kinase activity (GO:0004712),0.4778120453123553,1.2348005450466581,0.21354166666666666,0.7692962625079252,1.0,9/28,14.68%,PRKAA2;LRRK2;MAP2K5;MAPKAPK3;AURKB;MAPK10;MAP2K1;MAP2K2;MAP2K6
prerank,protein kinase regulator activity (GO:0019887),0.396727167784166,1.2343515224377026,0.15491009681881052,0.7638892837458598,1.0,21/95,16.60%,PRKAG2;GPRC5C;CCNA2;PRKAG3;CCNA1;CCNT2;CCND3;SH3BP5;GPRC5B;CCNB2;TRIB1;SOCS3;GPRC5A;WNK1;PRKAR1A;PARVA;CCNG1;FAF1;CCNL1;RPTOR;CCNE1
prerank,C-C chemokine binding (GO:0019957),0.5113681961646356,1.2315742493372772,0.22916666666666666,0.7659370453717216,1.0,2/22,1.57%,CCR9;ACKR2
prerank,mechanosensitive ion channel activity (GO:0008381),-0.5226155760812634,-1.2313104155458663,0.22698072805139186,0.5201587867027735,1.0,2/12,7.63%,PIEZO2;PIEZO1
prerank,transcription coregulator binding (GO:0001221),0.4391502575616301,1.228845311076805,0.16037735849056603,0.7680203591621353,1.0,16/50,17.01%,RORA;THRB;SMAD3;VGLL4;LCOR;USP11;CCNT2;TERT;TEAD2;PHF1;PER2;EHMT2;PER3;EHMT1;SMAD4;CTBP2
prerank,potassium ion leak channel activity (GO:0022841),0.550065351600031,1.2282808711414896,0.2247191011235955,0.7628862802804013,1.0,1/15,0.26%,KCNK2
prerank,carboxypeptidase activity (GO:0004180),0.4610098099315741,1.2243242224317972,0.20465890183028287,0.7685002521237451,1.0,5/35,7.48%,AEBP1;CPA4;NAALADL1;PEPD;SCPEP1
prerank,sodium channel regulator activity (GO:0017080),-0.4019447553963117,-1.2222533420072594,0.16756756756756758,0.536902285060095,1.0,14/37,21.74%,FGF14;FGF12;CAMK2D;FXYD5;NEDD4L;FGF13;ATP2B4;PTPN3;NOS1;SCN2B;FXYD6;COMMD1;SCN1B;PKP2
prerank,protein kinase activator activity (GO:0030295),0.42398863043064006,1.2210849347719488,0.17177914110429449,0.7721816354133292,1.0,16/60,15.84%,PRKAG2;FAM20A;GPRC5C;ALS2;DDX3X;AFAP1L2;RICTOR;NRG1;GPRC5B;IRGM;GPRC5A;WNK1;MAP2K1;MAP2K2;STK4;RPTOR
prerank,GDP binding (GO:0019003),-0.35923443328808885,-1.2187764083813286,0.15269461077844312,0.5403902276904585,1.0,18/63,19.06%,RIT2;RAB31;KRAS;RAP1B;RAP1A;RASL12;RAB27A;GNAI1;RERG;RALB;RAP2A;RAB18;RAB27B;RRAS;ARF6;ARL8B;RHEB;RAN
prerank,histone methyltransferase activity (H3-K9 specific) (GO:0046974),-0.5478069772376516,-1.218654848597348,0.23858921161825727,0.5354518167796822,1.0,2/10,5.64%,MECOM;PRDM16
prerank,myosin binding (GO:0017022),-0.3591375299898051,-1.2154681104951652,0.16279069767441862,0.5384996177979728,1.0,11/55,11.41%,MYRIP;GSN;STXBP5L;MOBP;SHROOM4;RAB3C;NKD2;MYOC;SHROOM1;CALD1;RAB27B
prerank,guanyl-nucleotide exchange factor activity (GO:0005085),0.36563414416830015,1.2132695971875362,0.14705882352941177,0.7902043301631066,1.0,26/147,8.94%,DENND4A;DOCK11;RAPGEF5;RIN2;ARHGEF18;FNIP1;ARHGEF16;FGD4;RGL1;ALS2;DOCK5;NGEF;AKAP13;RAPGEF3;DENND2A;RAB3IP;IQSEC2;WDR41;RIN3;RAB3IL1;ARFGEF2;ARHGEF11;DENND5A;SH3BP5;NUCB1;EPS8L2
prerank,metallocarboxypeptidase activity (GO:0004181),0.48617423359286616,1.2131953803069058,0.23487544483985764,0.783660862035652,1.0,3/26,6.04%,AEBP1;CPA4;PEPD
prerank,GDP-dissociation inhibitor activity (GO:0005092),-0.5131600945450147,-1.2130272821132266,0.20905172413793102,0.5391305615544328,1.0,6/13,17.40%,CCDC88A;ARHGDIB;SH3BP4;RANBP1;ARHGDIA;GDI1
prerank,calcium-release channel activity (GO:0015278),0.514213391241888,1.2120768231063521,0.24862888482632542,0.7803308449441752,1.0,3/17,3.73%,ITPR2;ITPR1;TPCN1
prerank,dipeptidyl-peptidase activity (GO:0008239),-0.5406571944068261,-1.210904288681638,0.21413276231263384,0.5391561115715674,1.0,4/10,8.39%,DPP10;DPP6;FAP;NAALAD2
prerank,semaphorin receptor activity (GO:0017154),-0.5370928282766059,-1.2086199060773102,0.26434426229508196,0.539677401273009,1.0,4/11,8.86%,NRP1;NRP2;PLXNC1;PLXNA4
prerank,actin monomer binding (GO:0003785),-0.4463243767070467,-1.2021065708785754,0.21852731591448932,0.5510693890563219,1.0,7/22,15.91%,TMSB4X;NOS3;LIMA1;MRTFA;PFN2;MTSS1;COBL
prerank,platelet-derived growth factor binding (GO:0048407),0.5550995085953405,1.2006557823384394,0.28823529411764703,0.8108601459765418,1.0,3/11,8.19%,COL5A1;PDGFRB;COL1A2
prerank,chemokine receptor activity (GO:0004950),0.4928462113062114,1.1974663427327008,0.26278659611992944,0.8142505131621722,1.0,2/24,1.57%,CCR9;ACKR2
prerank,"oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0016616)",0.39538609858325585,1.1963118599997093,0.19258202567760344,0.8112263154161664,1.0,11/75,9.00%,ME2;SORD;CRYL1;AKR1B10;LDHB;BDH1;DHDH;DHRS11;DHRS3;BDH2;LDHD
prerank,"oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor (GO:0016628)",0.5049047842731584,1.196088985385449,0.26929982046678635,0.8051865783893383,1.0,7/17,15.44%,DPYD;BDH2;PTGR2;MECR;TM7SF2;LBR;DECR1
prerank,hormone receptor binding (GO:0051427),-0.49429311349158717,-1.1960392467736456,0.23542116630669546,0.5602784205094431,1.0,3/14,12.44%,SOCS2;JAK1;PTHLH
prerank,high voltage-gated calcium channel activity (GO:0008331),0.5712318309653927,1.19275409424719,0.289272030651341,0.8089602982569455,1.0,3/10,6.76%,CACNA1D;CACNA1C;CACNB3
prerank,poly-pyrimidine tract binding (GO:0008187),0.4954163927791436,1.1907401705840093,0.27303754266211605,0.809419972090359,1.0,10/23,21.21%,RBMS2;HNRNPH1;PABPC4L;RBMS1;HNRNPC;PABPC5;DAZAP1;RBMS3;FMR1;U2AF2
prerank,poly(U) RNA binding (GO:0008266),0.5103021209585461,1.1867688250475719,0.2465034965034965,0.8154577252905836,1.0,8/20,17.54%,RBMS2;HNRNPH1;PABPC4L;RBMS1;HNRNPC;PABPC5;DAZAP1;RBMS3
prerank,ubiquitin-protein transferase activity (GO:0004842),0.32972542428750645,1.1862122014663452,0.12716763005780346,0.8108480151053041,1.0,77/346,18.79%,RNF220;RNF152;PDZRN3;SH3RF2;UBE2E2;RNF43;ASB2;PRKN;TRIM63;RNF213;KCMF1;DTX1;NEDD4;NHLRC4;RNF151;RNF135;TRIM56;RNF181;UBR4;MGRN1;UBR2;SMURF2;TTC3;RNF8;FBXW11;BCOR;RNF141;HUWE1;TRIP12;RNF217;BTRC;RNF19A;RNF34;UBR5;FBXO22;SH3RF1;UBE2M;RNF41;FBXW8;FBXO4;RNF13;CDC42;WWP2;CUL4A;FBXO10;TRIM62;ASB12;DDB2;PML;FBXO11;DTX3;DZIP3;UBE2H;RNF115;RMND5A;AMFR;RNF31;HECTD1;RNF146;BIRC6;BIRC3;MAEA;RNF19B;UBR1;RNF7;UBE2E1;KCTD13;SYVN1;CDC34;RNF25;RNF20;TAF1;ARIH1;MIB2;ASB1;NHLRC3;RNF214
prerank,sterol binding (GO:0032934),0.41240179711067526,1.1858975008334767,0.2283464566929134,0.8054578300357449,1.0,10/56,9.11%,RORA;OSBPL8;GRAMD1B;INSIG2;VDAC2;OSBPL11;OSBPL9;RORC;SIDT1;SULT2B1
prerank,MAP kinase kinase activity (GO:0004708),0.517404586027045,1.185151559781807,0.2870544090056285,0.801545599828493,1.0,8/15,18.76%,LRRK2;MAP2K5;MAPKAPK3;MAPK10;MAP2K1;MAP2K2;MAP2K6;MAPK14
prerank,GABA receptor binding (GO:0050811),0.5518501128300972,1.1839764026363293,0.27613412228796846,0.7993908182569711,1.0,3/11,10.11%,TRAK1;ARFGEF2;SHISA7
prerank,GTPase regulator activity (GO:0030695),0.3490521672981026,1.1827381780808417,0.15613382899628253,0.7971603497822577,1.0,49/212,14.46%,RANBP3L;CPEB2;ARHGAP28;ARHGAP29;ERRFI1;SIPA1L1;SMAP2;RIN2;ARHGEF10L;SRGAP2;ARHGAP18;SYDE2;ARHGAP9;ALS2;ALDH1A1;NPRL3;RGS16;TBC1D16;ASAP3;LRRK2;GMIP;ARHGAP26;ARRB1;GPS2;ASAP1;NPRL2;ARHGAP17;ARFGAP3;ELMOD3;DNM1L;OPHN1;WASL;GRTP1;RALGAPB;MTSS2;RANBP3;OCRL;PDE6D;RALBP1;RGPD1;GNB5;KRIT1;RIC8B;RAP1GAP;HACD3;DEPDC5;SGSM2;FLCN;LLGL2
prerank,leak channel activity (GO:0022840),0.5097132714758845,1.1789941068851222,0.2577696526508227,0.8027353717692535,1.0,1/18,0.26%,KCNK2
prerank,pyridoxal phosphate binding (GO:0030170),0.49629524406906794,1.1752701391399885,0.27289719626168224,0.8073198075474729,1.0,5/20,12.61%,PYGM;SRR;CTH;ABAT;ACCS
prerank,RNA methyltransferase activity (GO:0008173),0.5019165938733585,1.1744340513693052,0.27827648114901254,0.8039681217958539,1.0,1/19,0.80%,TRMT9B
prerank,nucleotidase activity (GO:0008252),0.5230438166842838,1.1739145284997476,0.29143897996357016,0.7994499839726082,1.0,7/15,18.55%,NT5C1B-RDH14;NT5C1B;NT5DC1;NT5C2;NT5C3A;NT5C3B;NT5C
prerank,DNA-(apurinic or apyrimidinic site) endonuclease activity (GO:0003906),-0.5228237403398849,-1.1726012814210423,0.2955032119914347,0.6143293685161644,1.0,6/11,31.97%,RPS3;HMCES;HMGA2;APEX1;APEX2;NEIL2
prerank,hexosyltransferase activity (GO:0016758),-0.31145953906782137,-1.1710661589612483,0.1291390728476821,0.612902596965304,1.0,17/101,12.19%,TMTC2;CSGALNACT1;MGAT4C;GCNT2;CHSY3;FUT9;EXT1;MGAT4A;DPY19L1;B4GALT5;B3GALT1;HEXB;B3GALNT1;EXT2;LFNG;MFNG;B3GALT5
prerank,MAP kinase phosphatase activity (GO:0033549),0.5558848141623024,1.1706696616549395,0.28932038834951457,0.8033336605360749,1.0,4/12,18.08%,DUSP29;DUSP10;DUSP2;DUSP4
prerank,non-membrane spanning protein tyrosine kinase activity (GO:0004715),-0.3903865229365918,-1.1683043498437047,0.24029126213592233,0.6142939219166136,1.0,14/35,22.70%,PEAK1;PTK2B;LYN;BMX;PTK2;TEC;FES;SYK;PKDCC;BTK;TXK;SLA;YES1;FYN
prerank,I-SMAD binding (GO:0070411),0.537576107124542,1.168249036918664,0.30579964850615116,0.8045164272629217,1.0,3/13,4.77%,SMAD3;TGFBR1;SMAD6
prerank,cytokine activity (GO:0005125),0.36342037407508937,1.1682198545145086,0.21879194630872484,0.7987486927521099,1.0,9/131,6.47%,WNT5B;BMP6;BMP7;WNT4;WNT6;IL18;IFNK;IL17D;IL12B
prerank,leucine zipper domain binding (GO:0043522),0.5529092038205262,1.1674346555199335,0.299009900990099,0.7953764463891329,1.0,1/10,0.75%,PAWR
prerank,protein kinase A catalytic subunit binding (GO:0034236),-0.4932967559762579,-1.1653902075820708,0.26556016597510373,0.616470448069617,1.0,5/13,11.97%,RYR2;GSK3B;KCNQ1;PRKAR1B;PRKAR2B
prerank,mRNA 3'-UTR AU-rich region binding (GO:0035925),0.4803731229268626,1.164233720316697,0.3021702838063439,0.799366461541439,1.0,1/22,0.33%,CPEB2
prerank,nucleoside monophosphate kinase activity (GO:0050145),-0.43451933778437907,-1.1591445633328434,0.2623318385650224,0.6275495823721778,1.0,5/20,11.31%,DLG2;MAGI3;CASK;MPP1;CMPK1
prerank,cholesterol transfer activity (GO:0120020),-0.46131946886959285,-1.1533493446468241,0.2891832229580574,0.6376933778686387,1.0,6/16,12.10%,PLTP;ABCG1;NPC2;STARD5;MTTP;STARD4
prerank,"catalytic activity, acting on a tRNA (GO:0140101)",0.4285630096766168,1.1522571294331485,0.28664495114006516,0.8298688711353016,1.0,11/35,20.86%,TRMT9B;PTRH1;TARS2;DUS4L;PUS10;LCMT2;NT5C3A;DUS3L;DTWD2;DUS2;DUS1L
prerank,transaminase activity (GO:0008483),0.537534303280985,1.151005586628586,0.31721470019342357,0.8278688006216544,1.0,5/11,19.84%,BCAT2;GOT2;ABAT;GOT1;GOT1L1
prerank,copper ion binding (GO:0005507),0.41620792504052,1.150247659080238,0.2866043613707165,0.8243001440268111,1.0,5/42,6.50%,MOXD1;LACC1;SOD3;LOXL3;TP53
prerank,phosphatidylinositol phosphate kinase activity (GO:0016307),-0.4818939041413597,-1.1449608559249653,0.3111587982832618,0.6540000313238137,1.0,3/13,3.18%,PIP5K1B;PIP4K2A;PIK3C2B
prerank,epidermal growth factor receptor binding (GO:0005154),-0.39514163815585696,-1.1440910888157996,0.2623762376237624,0.6507368730529579,1.0,3/25,4.40%,HIP1;ERBB4;CCDC88A
prerank,ephrin receptor activity (GO:0005003),-0.44486065103909506,-1.1438240731749312,0.28104575163398693,0.640494984115282,1.0,5/17,7.96%,EPHB1;EPHA5;EPHA6;EPHA7;EPHB2
prerank,transmembrane-ephrin receptor activity (GO:0005005),-0.44486065103909506,-1.1438240731749312,0.28104575163398693,0.640494984115282,1.0,5/17,7.96%,EPHB1;EPHA5;EPHA6;EPHA7;EPHB2
prerank,phospholipase binding (GO:0043274),0.5197100911172299,1.1431282446825501,0.33270676691729323,0.8404119868933678,1.0,3/13,8.75%,PRKN;ARHGAP6;PDPK1
prerank,phospholipase activity (GO:0004620),-0.33559580088051955,-1.142081773028016,0.20666666666666667,0.6394584050764622,1.0,13/67,14.40%,PLCB4;PLCL1;PLA2G4A;PLCE1;MGLL;GDPD1;PDIA3;PLA2G12A;ENPP2;SMPDL3A;PITPNM3;PNPLA3;ABHD4
prerank,ATPase binding (GO:0051117),-0.32073569014643577,-1.140277117554641,0.2152317880794702,0.638666588961519,1.0,15/71,8.80%,PDE4D;CAV1;SLC2A13;ESR1;ATP6V0A1;ATP1B1;AR;NKD2;TRPC1;PSEN1;ATP6V0A4;PPP3CA;RDX;RALB;DNAJC10
prerank,translation elongation factor activity (GO:0003746),-0.4715154827472581,-1.139332840928552,0.3080260303687636,0.635838248563497,1.0,10/14,37.79%,EEF1A1;EIF5A2;EEFSEC;EEF2;TUFM;EEF1A2;GTPBP2;GFM1;EEF1B2;GTPBP1
prerank,m7G(5')pppN diphosphatase activity (GO:0050072),0.5422472537259754,1.1390043497567426,0.31992337164750956,0.8472725377654412,1.0,1/11,1.47%,NUDT4
prerank,ribosome binding (GO:0043022),0.4062318863306874,1.13803190289025,0.28270676691729324,0.8442996696529971,1.0,6/46,12.07%,CPEB2;CPEB4;CPEB3;YTHDF3;IGHMBP2;ETF1
prerank,cardiolipin binding (GO:1901612),0.5498031468598504,1.1360208116254813,0.34944237918215615,0.8447162513840948,1.0,2/10,7.06%,GSDME;OPA1
prerank,RNA polymerase II CTD heptapeptide repeat kinase activity (GO:0008353),-0.4860173014608279,-1.1336830361330335,0.3201581027667984,0.6450126551422571,1.0,2/12,13.37%,CDK19;CDK8
prerank,Tat protein binding (GO:0030957),-0.5013481429989701,-1.1335640037031387,0.328740157480315,0.6401621907087691,1.0,2/10,2.48%,ACTB;MDFIC
prerank,peptidase activator activity involved in apoptotic process (GO:0016505),-0.4661553069173774,-1.1306530594614523,0.3177966101694915,0.6421545403671108,1.0,4/14,9.26%,MAL;APAF1;NOD1;ATP2A3
prerank,voltage-gated calcium channel activity (GO:0005245),0.42025484175243955,1.1305938045037196,0.304857621440536,0.8552826701270704,1.0,5/37,6.76%,CACNA1D;CACNA2D3;CACNG4;CACNA1C;CACNB3
prerank,phosphatase activity (GO:0016791),0.37361069090622484,1.1287328811805561,0.29814550641940085,0.8551401904145627,1.0,11/73,11.59%,ATP1A2;PPP1CB;CILP2;LHPP;HDDC2;PXYLP1;PTPN22;PRUNE1;DUSP10;OCRL;NOCT
prerank,"4 iron, 4 sulfur cluster binding (GO:0051539)",0.5071700016960277,1.1265781087190925,0.34600760456273766,0.8558146847708388,1.0,7/14,18.94%,RSAD2;NDUFS1;NFU1;ACO2;CIAO3;SDHB;ETFDH
prerank,intracellular cyclic nucleotide activated cation channel activity (GO:0005221),-0.4850856228527539,-1.1264925562044439,0.3237250554323725,0.647483510202881,1.0,1/11,2.10%,HCN1
prerank,endopeptidase inhibitor activity (GO:0004866),0.3677514585054855,1.1228974408622618,0.2918454935622318,0.8608316101747345,1.0,10/82,8.46%,ITIH2;TIMP3;TFPI;SERPIND1;RENBP;COL4A3;KNG1;SERPINE1;SERPINA9;HRG
prerank,"phosphatidylinositol-3,4,5-trisphosphate binding (GO:0005547)",-0.3696451783280407,-1.1214658728267233,0.2733812949640288,0.655016445911029,1.0,6/34,5.31%,CYTH3;ARAP2;MYO10;MYO1B;IQGAP1;ARAP3
prerank,"racemase and epimerase activity, acting on carbohydrates and derivatives (GO:0016857)",0.554704687743667,1.1197692321924826,0.34462151394422313,0.8645552666785696,1.0,3/10,6.71%,RENBP;GALM;DSE
prerank,transcription corepressor binding (GO:0001222),0.4473642094805934,1.1156594705637903,0.32006920415224915,0.8712852260799546,1.0,9/27,17.01%,RORA;LCOR;USP11;PHF1;PER2;EHMT2;PER3;EHMT1;CTBP2
prerank,SH2 domain binding (GO:0042169),0.4290794167950124,1.115614439511385,0.30528052805280526,0.8656787397708948,1.0,5/31,6.84%,AFAP1;INPPL1;DAG1;SH3PXD2B;AFAP1L2
prerank,sterol transfer activity (GO:0120015),-0.43561075397884114,-1.1141795202315066,0.3268398268398268,0.6688564324665737,1.0,6/17,12.10%,PLTP;ABCG1;NPC2;STARD5;MTTP;STARD4
prerank,calcium ion transmembrane transporter activity (GO:0015085),0.3869472786465307,1.1139205928413796,0.31029411764705883,0.8650139916947107,1.0,5/55,3.20%,CACNA1D;SLC24A3;ITPR2;ITPR1;MCU
prerank,sequence-specific double-stranded DNA binding (GO:1990837),0.3044093166270375,1.1128146080766104,0.18522483940042828,0.8628500366759883,1.0,120/597,17.60%,HLF;MAF;THRB;SMAD3;OSR1;NFYC;CUX1;PKNOX2;CREB5;HOXB4;GLI2;ZBTB20;HOXB6;GABPB1;GABPB2;HOXA1;ZNF568;ARID4A;NFAT5;SOX5;ELF1;NR6A1;GLI3;ARNT2;FOXC1;NFIB;MAFG;ATOH1;MBNL2;NFYB;CREB3L2;NHLH2;SMAD6;CUX2;BNC2;TEF;ESRRA;HOXB9;HOXB5;TP53;TBL1X;BHLHE41;RORC;SOX12;ZSCAN29;ZIC5;BCOR;ELF2;NR1D2;HOXC4;TBL1XR1;ZIC1;IRX1;TEAD2;KLF3;CALCOCO1;HDAC4;GLI1;ZBTB26;ZIC4;TCF7;NR2C2;SOX13;ASH2L;FOXC2;TCF7L2;TCF4;ABL1;PRDM5;NFATC3;RARG;ATF2;HNRNPL;SKOR1;MYBL2;TEAD1;HES6;HOXB2;BRD7;FOXA2;NR3C2;IRF1;KMT2D;KAT7;ZBTB48;FOXJ2;DHX33;MCM7;MCM2;BEND3;TBP;ORC3;ATF6B;NCOR1;ZBTB32;SNAI1;PER2;HOXA7;E2F4;NFKB1;TAF7;HOXB8;HSF2;MZF1;NKX2-1;TGIF2;RXRA;RFX2;PER3;CENPC;HSF4;KLF15;HIVEP1;SMAD4;MEF2D;TCF7L1;MBD4;POU1F1;ELF4;BARX2
prerank,L-amino acid transmembrane transporter activity (GO:0015179),-0.33675166657275807,-1.1128114579732602,0.26253687315634217,0.66745206434081,1.0,16/53,13.21%,SLC47A1;SLC1A5;SLC7A5;SLC1A2;SLC38A6;SLC1A1;SLC7A1;SLC25A13;SLC1A4;SLC38A5;SLC17A6;SLC43A2;SLC6A7;SLC43A1;SFXN1;SLC38A7
prerank,vinculin binding (GO:0017166),-0.48221677586006495,-1.112473146594451,0.33877551020408164,0.6632812541641361,1.0,3/11,6.69%,UTRN;ACTN1;CORO2B
prerank,1-phosphatidylinositol-3-kinase regulator activity (GO:0046935),-0.4452567127682011,-1.1092815558088756,0.3208791208791209,0.6663160955224741,1.0,6/15,19.85%,PIK3R1;SOCS2;PIK3R6;SOCS5;PIK3R5;CCKBR
prerank,titin binding (GO:0031432),0.5140949970013688,1.1063044037252574,0.36127744510978044,0.8765771293531323,1.0,2/13,2.82%,ACTN2;TRIM63
prerank,gated channel activity (GO:0022836),-0.4551035788086165,-1.1047165000689392,0.34273318872017355,0.6728795249340419,1.0,4/14,19.04%,PIEZO2;PIEZO1;TMEM266;TMEM63A
prerank,excitatory extracellular ligand-gated ion channel activity (GO:0005231),-0.40901873979379944,-1.1033863756884585,0.31072210065645517,0.6712500579928911,1.0,2/21,3.80%,GRIK2;GLRB
prerank,phosphatidylinositol-5-phosphate binding (GO:0010314),-0.4455724397897348,-1.1019388656215239,0.34496919917864477,0.6702695919069525,1.0,6/15,18.32%,PLA2G4A;PLEKHA5;JPH2;SESTD1;PHLDA3;PLA2G4E
prerank,peptide hormone receptor binding (GO:0051428),-0.48054104995148406,-1.0968218848974909,0.36363636363636365,0.6783083479052416,1.0,8/11,50.78%,PTHLH;GNRH1;VIP;UCN2;CCK;GPHB5;ADCYAP1;GHRH
prerank,general transcription initiation factor binding (GO:0140296),-0.3926361970074631,-1.096572422059559,0.32272727272727275,0.6740453704623335,1.0,12/25,29.04%,ESR1;AR;GTF2A2;YEATS2;TAF1B;HHEX;RUVBL2;RELA;DR1;THRA;DRAP1;AHR
prerank,RNA polymerase II-specific DNA-binding transcription factor binding (GO:0061629),0.3278202235947832,1.095577274714157,0.29343629343629346,0.9037245690158769,1.0,60/181,18.96%,SMAD3;PPARGC1A;PPARA;NCOR2;ARNT2;RERE;IFI27;NHLH2;CHD4;PIAS1;NCOA3;TEAD3;TP53;BCAS3;BHLHE41;SMARCD3;LDB2;LDB1;MEF2A;SMARCA4;RBL2;SPEN;CDK5RAP3;PARP9;SMARCE1;HDAC4;SIRT1;HDAC1;TCF7L2;ATN1;MKKS;RBL1;ATF2;RBBP8;WWP2;BBS10;HES6;TBP;SIN3A;TAF4;NCOR1;MIER3;CTDP1;FAF1;MTA2;PIAS3;HIF1AN;BBS2;RXRA;RB1;CREBBP;GTF2I;MED1;POU1F1;RNF25;KDM1A;CRY1;TAF1;MAPK14;PIAS4
prerank,mitogen-activated protein kinase kinase kinase binding (GO:0031435),0.5213839880802197,1.095381162465129,0.3674698795180723,0.8985510088868321,1.0,2/11,2.95%,SASH1;PPEF2
prerank,symporter activity (GO:0015293),0.5337162801509922,1.0953027571423835,0.36507936507936506,0.8931439137314944,1.0,2/10,6.87%,SLC5A5;SLC5A8
prerank,protein tyrosine phosphatase activity (GO:0004725),0.37163616982717507,1.0949878854874808,0.3269513991163476,0.8885192387411772,1.0,15/71,9.29%,EYA1;PTPN13;EYA2;PTPN14;PTPN9;MTMR3;EYA4;TNS2;PTPN23;PTPRU;PTPN22;CDC14A;PTEN;PTPN21;CDC25A
prerank,ATP hydrolysis activity (GO:0140603),0.40696003831046995,1.0947364157590087,0.3344262295081967,0.8838015881847953,1.0,6/41,8.12%,ABCA4;RNF213;MYO18A;DDX3X;CLPX;MYO19
prerank,SUMO transferase activity (GO:0019789),0.47328749708082457,1.0921976740193289,0.37383177570093457,0.8861166923701743,1.0,6/16,20.99%,PIAS1;HDAC4;NSMCE2;PIAS3;PIAS4;UBE2I
prerank,enoyl-CoA hydratase activity (GO:0004300),0.5296573642286667,1.0921183714065519,0.3712574850299401,0.8808950403653274,1.0,5/10,21.89%,ECHDC3;ECHDC1;EHHADH;HADHA;ECHS1
prerank,protein phosphatase binding (GO:0019903),-0.29229890508541573,-1.0903679385327238,0.29411764705882354,0.684809666678019,1.0,30/117,16.19%,PIK3R1;MAP3K5;PTPRT;IQGAP1;PPP1R16B;STAT3;GRIN3A;DAB2IP;MET;FOXO1;KCNQ1;PTK2;PPP1R16A;CEACAM1;FBXL2;MFHAS1;JAK1;FLT4;ERBB2;AKAP11;ATP2B4;MTMR9;CTNNB1;MAPT;SMG5;KIF3A;STRN4;MYO16;EIF2AK3;SKAP1
prerank,purine ribonucleotide transmembrane transporter activity (GO:0005346),0.5020569560465077,1.087678715333814,0.38011695906432746,0.8888794090942217,1.0,4/11,16.57%,SLC25A23;SLC19A1;SLC25A42;SLC25A17
prerank,1-acylglycerol-3-phosphate O-acyltransferase activity (GO:0003841),0.4929528259663452,1.086789986044189,0.3700361010830325,0.8861870095075678,1.0,2/13,4.25%,AGPAT4;GPAT2
prerank,ankyrin binding (GO:0030506),-0.41248763327647786,-1.0851727099784683,0.35462555066079293,0.6924203846781615,1.0,6/19,13.54%,SLC8A1;SPTBN1;PTPRC;NRCAM;CDH1;SPTB
prerank,chemokine receptor binding (GO:0042379),-0.3561315657375685,-1.0833497413798021,0.32160804020100503,0.6920184165848506,1.0,23/35,47.13%,CXCL12;CXCL16;CX3CR1;CCL13;CCL19;CXCL10;CCL2;CCL28;CCRL2;CXCL5;CCL11;CXCL1;CCL4;PF4;PPBP;CCL8;CCL14;CKLF;CCL1;CCL3;XCL1;CXCL13;CXCL2
prerank,peptidoglycan binding (GO:0042834),-0.48290347207678425,-1.0831734428023727,0.3817427385892116,0.6875398318260806,1.0,3/10,17.24%,NOD1;PGLYRP1;NOD2
prerank,G protein-coupled photoreceptor activity (GO:0008020),0.4944035042665581,1.0831479804265773,0.3884462151394422,0.8912583521530772,1.0,2/12,5.76%,GNAT2;RHO
prerank,kinase binding (GO:0019900),-0.24548236682273497,-1.0821011829863072,0.16666666666666666,0.6852769109722792,1.0,93/434,12.98%,UTRN;DLG2;FRMD5;GHR;PTPRJ;UNC5C;RHOBTB1;SLC12A7;CAV1;GSN;ACTB;PDE8A;ESR1;CADPS;TTC28;POLA1;PTPRK;NBEA;IQGAP1;RND3;STAT3;BCAR3;SLC12A2;CIT;CAV2;RPS6;ACSL3;ACVRL1;TFRC;HDAC7;ARHGEF7;HSP90AB1;PPP1R12A;PPP2R5A;GSK3B;DAB2IP;RPS19;TIAM1;CNKSR2;CALM1;PTPRC;FLNA;LAPTM4B;SNAP91;CALM2;RPS3;PLCG2;RHOB;DCX;CSPG4;CRK;DNM1;RPS7;SMAD1;EEF1A1;PTK2;WWC1;PEBP1;PTN;IRAK3;CEACAM1;BTG1;VDAC1;NSF;TRPV4;MYOM1;RHOH;ADD2;CDK5RAP2;ACTA2;TRIM14;BCAR1;CALM3;PKD1;SLC12A4;MSN;DUSP3;PIK3IP1;CNTLN;TRIM27;EIF4ENIF1;ATF4;CTNNB1;ILK;ADIPOR1;FAS;IKBKB;INKA2;EMP2;CDKN1A;MAPT;HIF1A;AXIN1
prerank,N-acetyltransferase activity (GO:0008080),0.46672244044755407,1.0817790689626174,0.3791208791208791,0.8899465661885919,1.0,9/19,26.48%,NAA80;SAT1;SMARCE1;KAT2B;EP300;ESCO1;NAT1;AANAT;NAA50
prerank,syntaxin binding (GO:0019905),0.37619834598761615,1.0811931045995453,0.3611940298507463,0.8861825684228063,1.0,10/61,12.00%,SYT9;UNC13C;SYT12;STXBP4;LRRK2;STXBP2;VPS54;BLOC1S6;ABL1;VAMP1
prerank,mRNA binding (GO:0003729),0.3104042188813871,1.080796227213171,0.302491103202847,0.8820744531612231,1.0,65/249,18.67%,CPEB2;CELF2;SRRM2;DDX5;RBM47;CPEB4;RBMS2;LARP4B;SNRNP70;PCBP2;HNRNPR;IGF2BP1;SRSF5;DDX3X;ZC3H12B;TP53;ZCCHC13;CLUH;SNIP1;HNRNPA2B1;PABPC4L;SAMD4A;RBM15;LARP1;CPEB3;IGF2BP2;NOVA1;CSDC2;RBMS1;LSM14A;YTHDF3;LUC7L3;SCAF8;NUP98;HNRNPL;MRPS7;NOCT;DDX6;ETF1;DCP1A;RBPMS2;DHX33;ZC3H12C;HNRNPC;RSL1D1;PURB;NYNRIN;PABPC5;ZFP36L1;FUBP3;RBM4;SLC4A1AP;DAZAP1;HNRNPM;MARF1;GRSF1;CRYZ;RBMS3;SRSF1;EIF4G1;BOLL;RNF20;LARP4;SRBD1;PCF11
prerank,protein heterodimerization activity (GO:0046982),0.3219755482553883,1.0802451179073407,0.32188295165394404,0.878407528385074,1.0,17/178,6.93%,ATP1A2;EPAS1;BMP6;TOP2B;NPAS3;ZHX2;ARNT2;ADRA2A;KRT1;BDKRB2;MIGA2;TLR4;TPM1;IL12B;TP53;MICU1;BHLHE41
prerank,aspartic-type peptidase activity (GO:0070001),0.505975498017318,1.078698907166191,0.3713163064833006,0.8778703811473741,1.0,1/10,1.47%,BACE2
prerank,adenine nucleotide transmembrane transporter activity (GO:0000295),0.4996529676757683,1.0784362488607597,0.3849129593810445,0.8735655073584251,1.0,4/12,16.57%,SLC25A23;SLC19A1;SLC25A42;SLC25A17
prerank,"phosphatidylinositol-4,5-bisphosphate binding (GO:0005546)",0.35387900692738,1.077908788581422,0.3435114503816794,0.8700120111876901,1.0,7/72,2.78%,ACTN2;TULP3;GSDME;PICALM;SNX21;AVIL;FRMPD4
prerank,aspartic-type endopeptidase activity (GO:0004190),0.48639851874453693,1.0767651410966688,0.3861788617886179,0.8681323629483194,1.0,1/12,1.47%,BACE2
prerank,cAMP response element binding (GO:0035497),0.5233841518749123,1.0764871334397292,0.3783783783783784,0.8639056822591363,1.0,3/10,11.20%,CREB5;CREB3L2;ATF2
prerank,Notch binding (GO:0005112),0.4359979838882023,1.0760598854649914,0.3767605633802817,0.8602155594556473,1.0,4/22,3.66%,SNED1;NCOR2;AAK1;DTX1
prerank,clathrin adaptor activity (GO:0035615),0.4792486952479438,1.0699777223731226,0.38686131386861317,0.8722797484065011,1.0,3/15,7.68%,DAB2;STON1;AP1G2
prerank,histone deacetylase activity (GO:0004407),0.45652513988678145,1.0681860324848609,0.38010657193605685,0.8724458986448447,1.0,6/19,14.58%,HDAC8;SIRT3;HDAC4;SIRT1;HDAC1;MIER3
prerank,DNA-binding transcription factor binding (GO:0140297),0.316589179814814,1.0667700794177015,0.34394904458598724,0.8714976558588469,1.0,57/189,19.50%,SMAD3;FHL2;ZMYND8;PPARA;CXXC5;RERE;IFI27;NFYB;NHLH2;CHD4;PIAS1;TEAD3;TP53;SIK1;BHLHE41;LDB2;LDB1;MEF2A;RBL2;SPEN;HDAC4;SIRT1;TLE1;HDAC1;TCF7L2;ATN1;MKKS;RBL1;PRDM5;ATF2;RBBP8;WWP2;CBX5;BBS10;HES6;TBP;SIN3A;TLE2;NCOR1;MIER3;PURB;MTA2;PIAS3;BBS2;RB1;CREBBP;GTF2I;MEF2D;POU1F1;KDM1A;CRTC1;TAF1;NBN;PIAS4;YAP1;MTA1;RUNX1T1
prerank,bicarbonate transmembrane transporter activity (GO:0015106),-0.4294274332492527,-1.0657631579005882,0.3638297872340426,0.7217710604363189,1.0,2/15,2.84%,SLC26A7;SLC26A2
prerank,"oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor (GO:0016646)",0.48629874838374926,1.0653392959630734,0.4163424124513619,0.87068355537868,1.0,5/14,16.82%,ALDH4A1;MTHFR;ALDH1L1;AASS;MTHFD1
prerank,metallopeptidase activity (GO:0008237),0.33433074548853103,1.0648058553185118,0.35570469798657717,0.8673542645499023,1.0,24/113,15.78%,ADAM12;ACE;ADAMTS10;TRABD2B;ADAMTS2;ADAMTS15;ADAMTSL5;METAP2;ADAMTS9;ADAM30;MMP19;RCE1;CHMP1A;BMP1;ADAM28;MMP14;ADAM18;ADAM17;ERAP1;PITRM1;ADAMTS7;ZMPSTE24;NRDC;ANPEP
prerank,GTPase inhibitor activity (GO:0005095),0.4811553108300216,1.0647179118027525,0.40823970037453183,0.8627732941060117,1.0,2/13,5.71%,CPEB2;GPS2
prerank,C4-dicarboxylate transmembrane transporter activity (GO:0015556),0.4687268889214079,1.0641446935347114,0.3891992551210428,0.8595958537711643,1.0,1/16,0.19%,SLC13A3
prerank,voltage-gated potassium channel activity (GO:0005249),0.3487251452665648,1.0637390519352654,0.36484490398818314,0.8560411614087095,1.0,6/80,1.93%,KCNK2;KCNT1;KCNJ13;KCND3;KCNA5;LRRC38
prerank,phosphatidylinositol kinase activity (GO:0052742),0.4655524016434661,1.0622196411806695,0.40370370370370373,0.855704682731507,1.0,7/15,18.64%,PI4KA;ATM;PIK3CA;PIKFYVE;PIK3R3;PI4K2B;PI4KB
prerank,nucleotidyltransferase activity (GO:0016779),0.4545154952050243,1.0621193218337912,0.3929889298892989,0.8513292002720001,1.0,7/19,16.40%,DNTT;REV1;TUT4;TERT;TENT2;TENT4B;TUT7
prerank,double-stranded RNA binding (GO:0003725),-0.29850693956956986,-1.0597109323391343,0.30097087378640774,0.7332922973197026,1.0,20/70,19.42%,MBNL1;ACTN1;LRRFIP1;RFTN1;ADARB1;ADARB2;TFRC;HSP90AB1;MSN;DROSHA;FXR1;STAU2;VIM;STRBP;MTDH;DHX15;DHX9;EIF4A1;SLC3A2;TLR7
prerank,ligand-gated calcium channel activity (GO:0099604),-0.40474989329127004,-1.0596049575573785,0.3930232558139535,0.7285636361791954,1.0,9/19,19.38%,RYR2;GRIN2B;RYR3;GRIN2A;TRPM2;GRIN1;ITPR3;TRPA1;RASA3
prerank,chloride transmembrane transporter activity (GO:0015108),-0.42617112483084973,-1.055915319715401,0.38461538461538464,0.7332734155528541,1.0,3/16,4.70%,SLC26A7;SLC26A2;SLC1A1
prerank,disordered domain specific binding (GO:0097718),-0.38175420340735483,-1.0550056955900158,0.3931818181818182,0.7306683328615935,1.0,6/23,10.44%,FN1;HSP90AB1;CALM1;CALM2;HSP90AA1;CALM3
prerank,ubiquitin-dependent protein binding (GO:0140036),-0.4649384284341684,-1.054354492798082,0.43248945147679324,0.7274144849507173,1.0,4/10,14.21%,ANKRD13A;DNAJC2;LAPTM5;FAAP20
prerank,TBP-class protein binding (GO:0017025),-0.3917665061180518,-1.0533396658996081,0.3611738148984199,0.7249902606932379,1.0,10/21,29.04%,ESR1;GTF2A2;YEATS2;TAF1B;HHEX;RUVBL2;DR1;THRA;DRAP1;AHR
prerank,protein kinase C binding (GO:0005080),0.38117554040026125,1.0521238312597374,0.39203675344563554,0.8737581710665289,1.0,10/43,13.89%,PARD6G;TOP2B;GRK5;PRKCB;DACT2;PICK1;ABL1;ITGAV;ADCY6;PRKCSH
prerank,cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:0097200),0.5162277252645135,1.0514101477498081,0.4260700389105058,0.8711982561892879,1.0,2/10,3.53%,CFLAR;CASP3
prerank,chemokine activity (GO:0008009),-0.35245642076136896,-1.0504648022434488,0.38717339667458434,0.7275737200957928,1.0,21/31,47.13%,CXCL12;CXCL16;CCL13;CCL19;CXCL10;CCL2;CCL28;CXCL5;CCL11;CXCL1;CCL4;PF4;PPBP;CCL8;CCL14;CKLF;CCL1;CCL3;XCL1;CXCL13;CXCL2
prerank,kinase activity (GO:0016301),0.333643712274076,1.0493189009270414,0.38081805359661497,0.8723923989313177,1.0,28/109,18.85%,NADK2;EPHA4;SPHK1;PI4KA;LRRK2;GK5;TKFC;GK;PANK1;PIK3CA;COQ8B;ITPKB;DCAKD;PPIP5K2;ABL1;CSNK2A1;COQ8A;SPHK2;CERK;FN3K;FCSK;SCYL3;NADK;IP6K3;PKN2;TAF1;PI4KB;CHKA
prerank,mitogen-activated protein kinase binding (GO:0051019),0.4094645892246469,1.0457570642282172,0.3985890652557319,0.8780203047793903,1.0,9/29,18.76%,ACE;MAPKAPK3;CDK5RAP3;SIRT1;ABL1;DUSP10;DUSP2;DUSP4;MAPK14
prerank,cation channel activity (GO:0005261),0.3365439662208229,1.0438607140202694,0.3863013698630137,0.8787321374023496,1.0,5/94,3.20%,TRPM3;CACNA1D;SLC24A3;TRPM6;MCU
prerank,protein-lysine N-methyltransferase activity (GO:0016279),0.39383760540976676,1.0435497609139792,0.40034071550255534,0.8749682573303494,1.0,13/34,22.70%,SMYD3;KMT5B;SETD7;NSD3;KMT5A;DOT1L;EHMT2;EHMT1;KMT2E;SETD3;N6AMT1;CAMKMT;EEF1AKMT1
prerank,acetylgalactosaminyltransferase activity (GO:0008376),-0.36398225176556287,-1.0421056673290516,0.3991031390134529,0.7440629272984589,1.0,5/26,12.19%,CSGALNACT1;CHSY3;B3GALT1;B3GALNT1;B3GALT5
prerank,hydro-lyase activity (GO:0016836),0.38538588683387515,1.041406941898889,0.4052718286655684,0.8764791400175609,1.0,14/41,22.46%,ECHDC3;GMDS;HACD4;HACD1;UROC1;ACO2;HACD3;ECHDC1;EHHADH;L3HYPDH;HADHA;ECHS1;CBS;PCBD1
prerank,beta-tubulin binding (GO:0048487),0.4020038761942482,1.0401056492075595,0.4184514003294893,0.8754326528088593,1.0,4/31,8.60%,GJB6;EML4;BCAS3;HTT
prerank,small GTPase binding (GO:0031267),0.31338754908874056,1.039685641514021,0.37957124842370743,0.872034153249377,1.0,54/170,19.16%,RNF152;AFDN;PICALM;ARHGEF16;SRGAP2;FGD4;ALS2;AKAP13;GCC1;LRRK2;NOX1;RAB34;BRAF;RIN3;EXOC2;TRIOBP;RABGGTA;DNM1L;DOCK7;CYRIB;RNF41;FGD1;MTSS2;OCRL;PDE6D;RALBP1;MYO1C;MAPKAP1;RGP1;ANKRD27;RAP1GAP;GOLGA4;SGSM2;RUSC2;MICALL1;EXOC4;SPHK2;RAB29;ARFIP2;GOLGA5;TMEM127;KCTD13;SGSM3;OPTN;RABGEF1;PEX5;RANBP9;PAK2;TBC1D7;EVI5;RTKN;ARHGAP1;USP33;UNC13D
prerank,acyl-CoA hydrolase activity (GO:0047617),0.44950971064868217,1.039599076887296,0.42105263157894735,0.8678147786572858,1.0,6/17,17.08%,ACSBG2;PLA2G6;ACOT11;ACOT8;THEM4;ACOT12
prerank,postsynaptic neurotransmitter receptor activity (GO:0098960),-0.38075386659524457,-1.036051318382881,0.3981264637002342,0.7547136021824411,1.0,5/21,16.78%,GRM5;GRIA1;GRM1;CHRNA7;CHRFAM7A
prerank,protein kinase binding (GO:0019901),0.28090677596432834,1.0355950122407316,0.3800217155266015,0.8740087056754254,1.0,64/479,11.35%,PRKAG2;MAPK4;PARD6G;SMAD3;ACE;ANK2;OXSR1;ERRFI1;KIF13B;SASH1;DLG1;TOP2B;KCNA5;RHOBTB2;PRKN;EPHA4;RHOD;GRK5;CCNA2;PRKAG3;TOM1L2;PPEF2;CEP250;PPP1CB;SUFU;NISCH;ADRA2A;TPRKB;EZR;NBEAL1;PRKCB;DACT2;GYS1;FZD5;PTPN23;EXOC2;TRIB2;PDGFRB;TP53;SIK1;CACUL1;RICTOR;CCND3;MAPKAPK3;CDK5RAP3;GPRC5B;CDH5;MVP;CDC25A;SIRT1;PICK1;MAVS;TCF7L2;BECN1;NOX4;IRGM;ABL1;CASS4;DUSP10;JTB;RNF13;ATF2;TRIB1;CDC42
prerank,triglyceride lipase activity (GO:0004806),0.4386258010299058,1.0349873885909793,0.4162348877374784,0.8711896607766211,1.0,3/20,8.93%,CEL;PNLIP;DDHD2
prerank,UDP-glycosyltransferase activity (GO:0008194),-0.29175299327558035,-1.0325368749627104,0.41210374639769454,0.7590305002012998,1.0,13/70,12.19%,CSGALNACT1;MGAT4C;GCNT2;CHSY3;EXT1;MGAT4A;B3GALT1;HEXB;B3GALNT1;EXT2;LFNG;MFNG;B3GALT5
prerank,cholesterol binding (GO:0015485),-0.3173634159777802,-1.03182662007547,0.3802083333333333,0.7560994706955712,1.0,13/47,12.20%,CAV1;OSBPL6;PROM1;ABCG1;PTCH1;NPC2;APOD;STARD5;VDAC1;OSBP2;STARD3NL;STARD4;ERLIN1
prerank,transcription regulatory region nucleic acid binding (GO:0001067),0.305889769050787,1.0318064342190478,0.39097744360902253,0.8752782939295292,1.0,45/188,16.98%,SMAD3;NFYC;ZBTB20;GABPB1;GABPB2;ZNF568;ARID4A;SOX5;FOXC1;NFYB;CREB3L2;SMAD6;BNC2;TP53;TBL1X;SOX12;BCOR;TBL1XR1;CALCOCO1;HDAC4;GLI1;TCF7;SOX13;ASH2L;FOXC2;TCF7L2;PRDM5;HNRNPL;BRD7;FOXA2;IRF1;KMT2D;ZBTB48;TBP;ATF6B;NCOR1;PER2;NFKB1;TAF7;MZF1;NKX2-1;RXRA;PER3;KLF15;SMAD4
prerank,histone methyltransferase activity (GO:0042054),0.3941996274842016,1.0315752210655316,0.41567291311754684,0.8716073107605664,1.0,10/32,17.67%,SMYD3;KMT5B;SETD7;NSD3;KMT2C;KMT5A;DOT1L;EHMT2;EHMT1;KMT2E
prerank,voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization (GO:0086008),0.4666547180263254,1.0278354560214513,0.4468503937007874,0.8773869853716281,1.0,2/14,1.80%,KCND3;KCNA5
prerank,iron ion binding (GO:0005506),0.36384327909453196,1.022145213510698,0.41756548536209553,0.8884703597939112,1.0,10/48,15.71%,KDM7A;TET2;SCD5;JMJD6;CYP2R1;NFU1;ACO2;PHF2;TET1;HIF1AN
prerank,gap junction channel activity (GO:0005243),0.4207819703077068,1.0212177582953963,0.4295774647887324,0.8866447748371885,1.0,1/22,0.56%,GJB6
prerank,PDZ domain binding (GO:0030165),0.3541380807978396,1.0192387892901673,0.43787878787878787,0.8876102150829449,1.0,11/61,7.94%,TGFBR3;ARHGAP29;PRKN;ARHGEF16;CXXC4;FZD8;SYNJ2;PLEKHA2;SLC22A5;SRR;PTEN
prerank,"acyltransferase activity, transferring groups other than amino-acyl groups (GO:0016747)",0.34729678632575123,1.0191324176379537,0.417027417027417,0.8835844050164365,1.0,13/69,16.31%,LPGAT1;SPHK1;MOGAT3;ASPG;CERS6;CERS5;KAT6B;ZDHHC18;ZDHHC1;PORCN;KAT2B;NAA16;CREBBP
prerank,protein serine/threonine kinase activator activity (GO:0043539),0.386272211878615,1.0187749711867036,0.4358974358974359,0.8802745603318852,1.0,9/34,15.17%,FAM20A;ALS2;DDX3X;RICTOR;CCNT2;IRGM;MAP2K1;MAP2K2;STK4
prerank,receptor ligand activity (GO:0048018),0.29456455318467145,1.017936378916963,0.43719806763285024,0.8783095004477132,1.0,25/245,10.32%,FGF1;WNT5B;BMP6;BMP7;WNT4;IGF1;WNT6;IL18;METRNL;EDA;DPP4;TNFSF13;SEMA3B;F2;IFNK;IL17D;IL12B;OSGIN2;GDNF;NRG1;APLN;NBL1;HBEGF;CCL25;SLURP1
prerank,5'-3' RNA polymerase activity (GO:0034062),0.40542267196126763,1.017831467325202,0.4258289703315881,0.8743286924322157,1.0,9/27,23.45%,POLR2A;POLR2D;TERT;TENT2;POLR3A;POLR2G;POLRMT;POLR2F;POLR3H
prerank,metalloendopeptidase inhibitor activity (GO:0008191),-0.40755252838722134,-1.0168547610320389,0.47291666666666665,0.7907647703066241,1.0,5/14,8.46%,SPOCK2;SPOCK3;NGF;TIMP2;SPOCK1
prerank,wide pore channel activity (GO:0022829),0.41631555856094127,1.0150687807741892,0.4524647887323944,0.8772149369574423,1.0,1/23,0.56%,GJB6
prerank,RNA polymerase II complex binding (GO:0000993),0.3948950722950834,1.0142615623071018,0.4514003294892916,0.8752109581704155,1.0,6/32,12.71%,CTR9;ELOF1;NCOA3;RPRD2;SCAF8;WDR43
prerank,fibroblast growth factor binding (GO:0017134),0.42146710169110324,1.0125506038246934,0.4355716878402904,0.8756577561257857,1.0,6/21,11.96%,FGFR2;KL;FGFR1;FIBP;KLB;ITGAV
prerank,chemokine binding (GO:0019956),0.3952786621794099,1.0118285151542852,0.4503424657534247,0.8732370904016528,1.0,3/30,3.73%,CCR9;ACKR2;PDPN
prerank,serine-type endopeptidase activity (GO:0004252),0.32848846817183824,1.0110736862058647,0.4224137931034483,0.8711332425369774,1.0,6/80,5.34%,CORIN;KLK2;F11;DPP4;CTSH;F2
prerank,calcium:sodium antiporter activity (GO:0005432),0.4909868938737567,1.009069668407564,0.45030425963488846,0.8721356197931652,1.0,2/10,1.99%,SLC24A3;SLC8A3
prerank,"inositol 1,4,5 trisphosphate binding (GO:0070679)",0.4814576278239907,1.0090284994233898,0.4688128772635815,0.8681964420090809,1.0,2/11,1.46%,ITPR2;ITPR1
prerank,cysteine-type endopeptidase activity involved in apoptotic process (GO:0097153),0.48090834559630924,1.0079185278445155,0.4923954372623574,0.8670851651053412,1.0,2/11,3.53%,CFLAR;CASP3
prerank,insulin-like growth factor receptor binding (GO:0005159),-0.4284825447070045,-1.0042746326641063,0.46361746361746364,0.8187384506690375,1.0,4/12,7.77%,PIK3R1;GNAS;SOCS2;YWHAG
prerank,transition metal ion binding (GO:0046914),0.2794299792289687,1.0041509134178814,0.46051167964404893,0.8726344969667916,1.0,57/397,12.42%,KDM7A;SMAD3;ACE;UPB1;MOXD1;SORD;ZMYND8;KMT2A;PRKN;LACC1;MPPED2;NAPEPLD;GLI2;LARGE1;CXXC5;CXXC4;SOD3;LOXL3;NAALADL1;CHD4;FBXL19;NSD1;TET2;BBOX1;SOD2;B4GALT1;BAZ1B;TP53;ENPP3;SIRT5;KNG1;SCD5;PLSCR1;RNF8;SAMHD1;KDM2B;ADAM30;KDM2A;SIRT3;HRG;JMJD6;CYP2R1;HDAC4;TAB2;NPEPPS;CHMP1A;PTGR2;DHH;ABL1;ZKSCAN5;FNTB;DHX58;NFU1;PHF5A;ACO2;ZMYM2;LARGE2
prerank,ATP binding (GO:0005524),0.28586933661587755,1.0032192866345326,0.46246973365617433,0.8708413151268961,1.0,42/266,15.29%,PRKAG2;ATP1A2;WNK4;KSR1;OXSR1;SPHK1;BMPR1A;OAS2;TGFBR1;DMPK;MYO18A;P2RX3;NUAK2;CLPX;CDC42BPG;SIK1;MOV10L1;GCK;SRR;PPIP5K2;MKNK1;ABCC6;BRSK1;SRPK2;ABL1;TRIB1;IGHMBP2;GALK1;PNKP;TDG;PRKCI;KIFC1;WNK1;OAS3;HSPA4;CAD;ATP5F1D;SYN3;STK17B;ACVR1B;STK4;CARS2
prerank,protein tyrosine/serine/threonine phosphatase activity (GO:0008138),0.4211372395515788,1.0010841913212591,0.45729537366548045,0.8722416541715471,1.0,2/22,2.72%,DUSP29;MTMR3
prerank,GTP binding (GO:0005525),-0.2445682741675066,-0.9982767990445672,0.49145299145299143,0.8296868199437555,1.0,59/172,25.51%,RHOBTB1;RHOJ;RIT2;RND3;RAB31;KRAS;RAP1B;RAP1A;GCH1;RASL12;RAB27A;RHOB;GNAI1;RERG;EEF1A1;RALB;TUBA1A;MFHAS1;GLUD1;RAP2A;RHOH;GBP4;TUBB4A;ARL5A;ARL1;RAB27B;ARL5B;ATL2;MTG2;RAB38;RAB6A;RAB32;TUBB2B;RRAS;ARF5;ARF6;RAB39A;ARL8B;RHOBTB3;TUBB3;ATL3;RHEB;RAN;TUBA4A;MMAA;PIP4K2B;RND2;RAC3;GNL2;GEM;RAB14;TUBA1B;RHOC;RND1;TUBA1C;TUBG2;RNF112;ARF3;RAB1B
prerank,cation:chloride symporter activity (GO:0015377),0.48645000304235475,0.9950578225539012,0.4805447470817121,0.8833647563696436,1.0,1/10,0.37%,SLC6A1
prerank,phosphatidylinositol phosphate binding (GO:1901981),-0.2645580351212796,-0.9945349210778895,0.45016077170418006,0.8345106423968641,1.0,13/100,6.44%,HIP1;CYTH3;ARAP2;MYO10;MYO1B;CERT1;PLA2G4A;IQGAP1;CLVS1;ARAP3;DAB2IP;LAPTM4B;PLEKHA5
prerank,cysteine-type endopeptidase inhibitor activity (GO:0004869),-0.3392748045627475,-0.9898480914896097,0.4745762711864407,0.8417330061538639,1.0,9/30,14.18%,CST3;GAS6;SPOCK1;RPS6KA3;SERPINB9;SNCA;RPS6KA1;CARD16;MT3
prerank,lysophosphatidic acid acyltransferase activity (GO:0042171),0.43698196047735344,0.9884615310601341,0.48663101604278075,0.8955884422721725,1.0,2/15,4.25%,AGPAT4;GPAT2
prerank,basic amino acid transmembrane transporter activity (GO:0015174),0.458011232422029,0.9870588397003514,0.4843462246777164,0.8949565057487587,1.0,2/13,2.89%,SLC38A3;SLC7A2
prerank,phosphatidylinositol bisphosphate binding (GO:1902936),0.31071764461237533,0.9864033022793514,0.47756874095513746,0.8925099869902896,1.0,12/91,9.26%,ACTN2;TULP3;GSDME;PICALM;SNX21;AVIL;FRMPD4;TTPAL;SH3PXD2B;WIPI1;ANXA9;PLCD1
prerank,phospholipase A2 activity (GO:0004623),-0.35471262874327536,-0.9854793168074972,0.47465437788018433,0.848449512116454,1.0,6/26,23.28%,PLA2G4A;PLA2G12A;PNPLA3;PLA2G4E;PLA2G15;PLA2G4F
prerank,zinc ion binding (GO:0008270),0.27797451702709697,0.983457012771211,0.5201845444059977,0.895499209450458,1.0,37/293,10.07%,KDM7A;SMAD3;ACE;UPB1;SORD;ZMYND8;KMT2A;PRKN;NAPEPLD;GLI2;CXXC5;CXXC4;NAALADL1;CHD4;FBXL19;NSD1;TET2;BBOX1;BAZ1B;TP53;ENPP3;SIRT5;KNG1;PLSCR1;RNF8;SAMHD1;KDM2B;ADAM30;KDM2A;SIRT3;HRG;HDAC4;TAB2;NPEPPS;CHMP1A;PTGR2;DHH
prerank,"phosphotransferase activity, phosphate group as acceptor (GO:0016776)",0.4031735944583361,0.9832382736003121,0.4823321554770318,0.8920713727546181,1.0,7/24,17.98%,ITPKB;AK3;AK4;PPIP5K2;NME6;AK8;IP6K3
prerank,G protein-coupled receptor activity (GO:0004930),-0.23451745594700366,-0.981777833053828,0.4971751412429379,0.8530299264110206,1.0,55/239,23.19%,ADGRL3;ADGRB3;ADGRL4;ADGRL2;CALCRL;GRM5;ADGRG6;GRM3;ADRA1B;ADGRE5;GRM8;RORB;XPR1;PDGFRL;AGTR1;GRM1;S1PR1;GPR156;GABBR2;P2RY12;LGR5;PTH1R;CYSLTR1;HCRTR2;CYSLTR2;GPR63;CMKLR1;ADGRA1;ADGRB1;GPR26;ADGRG1;P2RY1;HRH1;GPR34;APLNR;VIPR2;ADGRD1;CX3CR1;S1PR3;C3AR1;GPR45;PAX8;ADGRG2;GPR176;S1PR2;ADCYAP1R1;ADGRE1;GRM4;DRD2;P2RY14;MC5R;LANCL1;CXCR4;LHCGR;GPR37L1
prerank,phosphatidylinositol binding (GO:0035091),0.3157204693602969,0.9798324494890692,0.4957627118644068,0.8967694313254073,1.0,6/91,1.86%,APPL2;TULP3;ITPR2;PICALM;ITPR1;PARD3B
prerank,protein serine/threonine kinase activity (GO:0004674),0.27494282950275506,0.9789142350548301,0.5228604923798359,0.8949808987881979,1.0,62/335,15.42%,MAPK4;WNK4;ROCK2;OXSR1;PRKCZ;FAM20A;PRKAA2;GRK5;STK32B;BMPR1A;TGFBR1;DMPK;AAK1;LRRK2;TP53RK;SMG1;PRKCB;IKBKE;ATM;CAMK1;BRAF;CLK4;NUAK2;CDC42BPG;SIK1;EIF2AK2;CPNE3;TGFBR2;MAPKAPK3;PDPK1;CSNK1A1;RIPK2;PIKFYVE;RIPK1;MKNK1;BRSK1;AURKB;SRPK2;DYRK1A;MYLK3;ARAF;PRKDC;MYLK;MAPK6;CSNK2A2;CSNK2A1;PRKCA;HIPK3;MAPK10;MAP3K1;PRKCI;RPS6KC1;WNK1;BMP2K;MAP2K1;GRK3;ACVR2B;STK17B;CLK1;ACVR1B;STK4;MAPK9
prerank,calcium channel activity (GO:0005262),0.31955540458466875,0.978100964860494,0.49857954545454547,0.8931328429529742,1.0,9/84,8.36%,CACNA1D;SLC24A3;CACNA2D3;CACNG4;MCU;CACNA1C;CACNB3;TRPM5;ANXA9
prerank,CXCR chemokine receptor binding (GO:0045236),-0.4263965246839089,-0.97806248923461,0.4939516129032258,0.8578049618395265,1.0,6/11,37.00%,CXCL12;CXCL10;CXCL5;CXCL1;PF4;PPBP
prerank,zinc ion transmembrane transporter activity (GO:0005385),0.4113638627917391,0.9767626801326154,0.4972677595628415,0.8925531226068905,1.0,3/20,8.11%,SLC30A10;SLC30A2;SLC39A13
prerank,cation transmembrane transporter activity (GO:0008324),0.35281838505644497,0.9747217492116408,0.5184049079754601,0.893650916712506,1.0,7/48,7.87%,SLC41A1;SLC38A3;SLC7A2;SFXN2;SLC6A9;SLC25A2;SLC38A1
prerank,protein homodimerization activity (GO:0042803),0.2646739713660989,0.9740285626910122,0.5435952637244349,0.8914525105624304,1.0,64/589,9.89%,NADK2;MAPK4;SMAD3;APPL2;UPB1;DUSP29;TPD52L1;PAXX;KIT;CPQ;MTUS2;KMT2A;ST6GAL1;FGFR2;SRGAP2;ZHX2;SNX6;ALS2;CRYL1;NPR3;NR2F2;FGFR1;BMPR1A;NR6A1;PGRMC1;ADRA2A;DPYD;LRRK2;PEX11A;ZBTB38;NACC2;DPP4;FOXP2;NAALADL1;LHPP;MIGA2;TPM1;IL17D;GBP3;ZNF318;GALM;BHLHE41;LDB1;PANK1;RNF8;GBP2;PON3;SRR;PEX11B;IDH1;CLN6;SLC39A13;TERT;GDNF;KLHL7;SLC51A;CYP2R1;DNM1L;SSBP1;RIPK2;CBY1;BLOC1S6;RIPK1;CHMP1A
prerank,alpha-tubulin binding (GO:0043014),-0.33114178212367124,-0.9717077533196314,0.48325358851674644,0.8696084230584493,1.0,12/31,18.83%,TTLL7;DIP2B;TRPV4;PACRG;SETD2;TRIM36;SNCA;CDK5R1;ARL8B;EFHC2;SPAST;TBCE
prerank,serine-type endopeptidase inhibitor activity (GO:0004867),0.36719382689589714,0.9707854323971725,0.4900662251655629,0.8956569804555561,1.0,5/38,8.46%,TFPI;SERPIND1;SERPINE1;SERPINA9;HRG
prerank,calmodulin-dependent protein kinase activity (GO:0004683),-0.3431361228852937,-0.9707591959955207,0.5011286681715575,0.8668112023418478,1.0,5/24,12.22%,CAMK2D;PTK2B;EEF2K;CAMK4;DAPK1
prerank,protein binding involved in heterotypic cell-cell adhesion (GO:0086080),-0.4295585998030311,-0.9702478763074811,0.5170940170940171,0.8628208883262278,1.0,2/10,9.63%,CD200;CD47
prerank,ion channel inhibitor activity (GO:0008200),0.364578310114065,0.9701694591490986,0.4757929883138564,0.8932305712047379,1.0,3/35,3.86%,WNK4;ITPR1;NEDD4
prerank,translation initiation factor activity (GO:0003743),-0.3132895056074412,-0.9696659040520719,0.49061032863849763,0.8591536599048629,1.0,10/36,20.88%,EIF3M;EIF3F;EIF2B3;EIF3B;EIF1;EIF4E;EIF4A1;EIF3L;COPS5;EIF3D
prerank,ion gated channel activity (GO:0022839),-0.3451406323280629,-0.9690688396479126,0.5023696682464455,0.85551252238078,1.0,8/24,15.40%,KCNT2;ANO4;ANO1;ANO3;TTYH2;TTYH1;ANO5;ANO2
prerank,ferrous iron binding (GO:0008198),-0.34941536889693436,-0.9648973239821559,0.5173210161662818,0.8618921540480925,1.0,7/21,20.30%,FTH1;FTL;SNCA;EGLN2;ISCU;EGLN3;ALKBH3
prerank,N-methyltransferase activity (GO:0008170),0.40059757152915054,0.963699055143215,0.5025906735751295,0.9051958483128955,1.0,9/20,27.49%,HNMT;ZCCHC4;SETD3;GNMT;FDXACB1;N6AMT1;TRMT1L;METTL5;PEMT
prerank,transforming growth factor beta-activated receptor activity (GO:0005024),0.4478155611768646,0.9636800466269578,0.5160680529300568,0.9013747442328656,1.0,4/12,7.34%,TGFBR3;BMPR1A;TGFBR1;TGFBR2
prerank,cGMP binding (GO:0030553),0.45157790977947737,0.9636457680101128,0.5026548672566372,0.8975904377479405,1.0,1/11,0.72%,PDE5A
prerank,protein phosphatase 1 binding (GO:0008157),0.40018353761520786,0.9635832596443904,0.4991243432574431,0.8939574658404703,1.0,3/21,10.16%,SH3RF2;PPP1R3B;PHACTR4
prerank,"DNA-binding transcription activator activity, RNA polymerase II-specific (GO:0001228)",0.2775278018566554,0.962838341665248,0.5495818399044206,0.8919329760948369,1.0,36/254,13.63%,HLF;SMAD3;TFDP2;NFYC;PPARA;CREBRF;HOXA1;NFAT5;ELF1;MITF;FOXC1;NFIB;HOXB3;VEZF1;NFYB;RREB1;MEIS1;TP53;SOX12;SMARCD3;PLSCR1;MEF2A;HOXC4;TFDP1;NR2C2;FOXC2;TCF4;MYBL1;NFATC3;ATF2;MYBL2;HOXB2;IRF1;FOXJ2;NFIA;ATF6B
prerank,poly(A) binding (GO:0008143),0.4047871290313061,0.9610874278376283,0.506108202443281,0.892531485706303,1.0,9/21,18.47%,RBMS2;DDX3X;TIA1;PABPC4L;RBMS1;PABPC5;HNRNPDL;RBMS3;LARP4
prerank,hormone activity (GO:0005179),0.3343095927809231,0.960164630510366,0.5151515151515151,0.8909294708357315,1.0,9/54,17.49%,IGF1;METRNL;APLN;AGRP;SPX;CCL25;NPFF;INHA;NMB
prerank,GTPase activity (GO:0003924),-0.23515838466179834,-0.958677470860206,0.5846153846153846,0.872841309017842,1.0,51/192,19.68%,DNM3;RHOBTB1;RHOJ;GNAS;RIT2;RND3;RAB31;KRAS;RAB3C;RAP1B;RAP1A;SRPRA;GCH1;RASL12;RAB27A;RHOB;GNAI1;DNM1;RERG;ARHGDIB;EEF1A1;RALB;GNA12;RAP2A;RHOH;GBP4;RAB18;ARL1;GNA14;RAB27B;GNB2;ATL2;HBS1L;MTG2;RAB38;GNAO1;GNAL;GNB1;RAB6A;RAB32;RRAS;SEPTIN9;TPPP;ARL8B;RHOBTB3;ATL3;RHEB;RAN;EEF2;MMAA;GPN3
prerank,phosphatidylinositol 3-kinase regulator activity (GO:0035014),-0.3728667304101242,-0.9575769232860665,0.5327102803738317,0.8705791450086097,1.0,6/18,19.85%,PIK3R1;SOCS2;PIK3R6;SOCS5;PIK3R5;CCKBR
prerank,alanine transmembrane transporter activity (GO:0022858),-0.4051337856456165,-0.957067139858387,0.5307017543859649,0.8669389536131579,1.0,4/12,13.21%,SLC6A6;SLC1A4;SLC38A5;SLC38A7
prerank,RNA stem-loop binding (GO:0035613),0.45100870510830715,0.9562767035935285,0.5167910447761194,0.8966831493678813,1.0,2/12,8.32%,DDX3X;CPEB3
prerank,histone deacetylase binding (GO:0042826),0.30760777959353386,0.9559721646713534,0.5512465373961218,0.8937716590293722,1.0,15/88,9.56%,TOP2B;PRKN;NCOR2;GLI3;NACC2;CHD4;LCOR;TP53;CAMTA2;BHLHE41;NIPBL;BCOR;MEF2A;HDAC4;HDAC1
prerank,double-stranded DNA binding (GO:0003690),0.2621961702351223,0.9559502537347544,0.6075675675675676,0.8901282336626206,1.0,69/531,12.98%,HLF;MAF;THRB;OSR1;CUX1;PKNOX2;CREB5;HOXB4;GLI2;ZBTB20;HOXB6;HOXA1;NFAT5;ELF1;NR6A1;GLI3;ARNT2;NFIB;MAFG;ATOH1;MBNL2;NHLH2;CUX2;TEF;ESRRA;HOXB9;HOXB5;CAMTA2;BHLHE41;RORC;SOX12;ZSCAN29;ZIC5;ELF2;FBH1;NR1D2;HOXC4;ZIC1;IRX1;TEAD2;KLF3;ZBTB26;RBMS1;ZIC4;TCF7;NR2C2;DDX60;FOXC2;TCF4;ABL1;MAU2;NFATC3;RARG;ATF2;RBBP8;PRKDC;MSH3;SKOR1;MYBL2;TEAD1;HES6;HOXB2;FOXA2;RAD50;NR3C2;PNKP;TDG;ZBTB48;FOXJ2
prerank,peptide N-acetyltransferase activity (GO:0034212),0.45146311009027384,0.9554861461835945,0.5029940119760479,0.8875241587608974,1.0,3/10,15.40%,NAA80;NAA20;NAA16
prerank,phosphatase binding (GO:0019902),0.3010922338972974,0.9552855794807136,0.5420689655172414,0.8842451856594074,1.0,14/105,10.45%,SH3RF2;SMAD3;DLG1;CHCHD3;MTMR3;MAGI2;IKBKE;TP53;SH2D4A;DLG3;CDH5;MVP;ELL;GTF2F1
prerank,adrenergic receptor binding (GO:0031690),-0.38577877951202405,-0.9550715178470512,0.5302663438256658,0.8669472879372226,1.0,2/16,1.55%,PDE4D;GNAS
prerank,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen (GO:0016709)",0.3789295938324596,0.9529018740118137,0.5053003533568905,0.8861380991497225,1.0,4/25,5.35%,MICAL3;CYP27A1;CYP26B1;POR
prerank,sulfate transmembrane transporter activity (GO:0015116),-0.3931110039785969,-0.9527631920246108,0.5333333333333333,0.8677127524300958,1.0,2/14,2.84%,SLC26A7;SLC26A2
prerank,phospholipase activator activity (GO:0016004),0.4587546231536773,0.9519392684941124,0.5146771037181996,0.8849590801570303,1.0,2/10,8.75%,ARHGAP6;PDPK1
prerank,dicarboxylic acid transmembrane transporter activity (GO:0005310),0.3777312204273446,0.951787138103208,0.5345699831365935,0.8817506662918013,1.0,6/29,12.14%,SLC13A3;SLC26A3;SLC19A1;SLC26A1;SLC25A12;SLC25A11
prerank,cysteine-type endopeptidase activator activity involved in apoptotic process (GO:0008656),-0.40892623850861864,-0.9504196880763816,0.49896907216494846,0.8688458558019361,1.0,5/12,21.18%,APAF1;NOD1;ATP2A3;RPS27L;PYCARD
prerank,protein phosphatase activator activity (GO:0072542),-0.3949115831018507,-0.94818075562267,0.5202558635394456,0.8693932380368402,1.0,4/13,10.44%,PPP2R5A;CALM1;CALM2;CALM3
prerank,endopeptidase activator activity (GO:0061133),-0.42928818140769537,-0.9472203184988555,0.5246252676659529,0.8666413512197652,1.0,3/10,18.42%,VSIR;PSMD14;APH1A
prerank,transmembrane receptor protein serine/threonine kinase activity (GO:0004675),0.4030426332066124,0.946310356802321,0.5335753176043557,0.8908821536798389,1.0,4/18,7.34%,TGFBR3;BMPR1A;TGFBR1;TGFBR2
prerank,methyl-CpG binding (GO:0008327),0.39028504454999186,0.9457558192387042,0.5246478873239436,0.8886082824632482,1.0,8/22,21.15%,CXXC5;CXXC4;ZBTB38;TET1;LRWD1;TET3;MBD1;MBD2
prerank,lipase activator activity (GO:0060229),0.4642714399357941,0.944566232170348,0.5341365461847389,0.8878202331832422,1.0,2/10,8.75%,ARHGAP6;PDPK1
prerank,L-glutamate transmembrane transporter activity (GO:0005313),-0.3943839301541212,-0.944149842398897,0.5538461538461539,0.8699984655048678,1.0,6/14,15.38%,SLC1A2;SLC1A1;SLC25A13;SLC17A6;SLC38A7;SLC1A6
prerank,adenyl ribonucleotide binding (GO:0032559),0.2666701190362848,0.943714743663285,0.6030805687203792,0.8862655199489033,1.0,52/291,16.25%,PRKAG2;ATP1A2;WNK4;KSR1;OXSR1;MPPED2;SPHK1;PRKAG3;BMPR1A;OAS2;TGFBR1;DMPK;MYO18A;P2RX3;SLC19A1;NUAK2;CLPX;CDC42BPG;SIK1;MOV10L1;GCK;SRR;PPIP5K2;MKNK1;ABCC6;BRSK1;CNBD2;SRPK2;ABL1;TRIB1;IGHMBP2;GALK1;PNKP;TDG;PRKCI;KIFC1;WNK1;OAS3;HSPA4;COQ8A;CAD;ATP5F1D;POPDC2;SYN3;STK17B;ACVR1B;STK4;CARS2;APRT;STK36;VPS4A;TLK2
prerank,hyaluronic acid binding (GO:0005540),-0.41604138781409633,-0.9433811573843297,0.5160599571734475,0.8670622324567558,1.0,3/10,9.92%,CEMIP;LAYN;CD44
prerank,protein kinase C activity (GO:0004697),0.42443697038318107,0.9432216065500573,0.5288808664259927,0.8839093907692679,1.0,5/14,12.99%,PRKCZ;SMG1;PRKCB;PRKCA;PRKCI
prerank,syntaxin-1 binding (GO:0017075),-0.33628970610624315,-0.9407894252598133,0.5576923076923077,0.8683780016297404,1.0,7/22,12.22%,SYT1;SNAP25;UNC13B;SYPL1;NSF;SYNPR;DAPK1
prerank,carbohydrate:cation symporter activity (GO:0005402),0.4460477806501534,0.939272710988022,0.5304990757855823,0.8895779415815412,1.0,2/11,12.28%,SLC5A3;SLC5A11
prerank,peptide alpha-N-acetyltransferase activity (GO:0004596),0.43864263334973586,0.9383246933637867,0.52834008097166,0.8883710657484735,1.0,3/11,15.40%,NAA80;NAA20;NAA16
prerank,transforming growth factor beta binding (GO:0050431),-0.3412758573810654,-0.9371774313973072,0.5492610837438424,0.8728714537027519,1.0,7/23,7.29%,LTBP1;LTBP4;ENG;THBS1;ACVRL1;TGFB3;CD109
prerank,inward rectifier potassium channel activity (GO:0005242),-0.34374407743625035,-0.9366293546346641,0.5599078341013825,0.8694471282387263,1.0,8/24,15.39%,KCNJ3;KCNJ2;KCNN2;ABCC9;KCNK1;KCNJ8;KCNJ6;KCNJ12
prerank,SH3 domain binding (GO:0017124),0.31706646017990436,0.9338847545165857,0.5649546827794562,0.8951918167325139,1.0,9/62,7.94%,ADAM12;AFAP1;PRKN;SYNJ2;REPS1;AFAP1L2;PTPN22;PLSCR1;CNTNAP1
prerank,RNA polymerase core enzyme binding (GO:0043175),0.35627521214276114,0.9313214664080923,0.5640194489465153,0.8976242405004855,1.0,6/33,12.71%,CTR9;ELOF1;NCOA3;RPRD2;SCAF8;WDR43
prerank,"exodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016895)",-0.4096214388141054,-0.9311525558914556,0.5626283367556468,0.878493017985534,1.0,5/10,29.90%,EXD2;POLD1;TATDN1;MGME1;APEX1
prerank,cyclin-dependent protein serine/threonine kinase regulator activity (GO:0016538),0.34129694805779365,0.9297155657963913,0.5737179487179487,0.8978043324112133,1.0,11/42,17.75%,CCNA2;CCNA1;CCNT2;CCND3;CCNB2;KAT2B;CCNG1;CCNL1;CCNE1;CNPPD1;HEXIM2
prerank,GTPase binding (GO:0051020),0.27516317716357697,0.9286625091936815,0.6082089552238806,0.8966972731924931,1.0,59/195,19.16%,RNF152;AFDN;PICALM;ARHGEF16;SRGAP2;FGD4;ALS2;AKAP13;GCC1;LRRK2;NOX1;RAB34;BRAF;RIN3;EXOC2;TRIOBP;AMBRA1;RABGGTA;DNM1L;DOCK7;CYRIB;BECN1;RNF41;FGD1;MTSS2;OCRL;PDE6D;RALBP1;MYO1C;MAPKAP1;RGP1;ANKRD27;RAP1GAP;GOLGA4;SGSM2;RADIL;RUSC2;MICALL1;EXOC4;SPHK2;RAB29;ARFIP2;GOLGA5;TMEM127;KCTD13;SGSM3;OPTN;RRAGD;RABGEF1;PEX5;RANBP9;PAK2;TBC1D7;EVI5;RTKN;ARHGAP1;USP33;LAMTOR1;UNC13D
prerank,cytokine receptor binding (GO:0005126),0.30851163794858993,0.9272002844956725,0.5673758865248227,0.8966195141197525,1.0,4/83,2.00%,TGFBR3;SMAD3;IL13RA1;IL18
prerank,cadherin binding involved in cell-cell adhesion (GO:0098641),-0.356292593917399,-0.9263995887905075,0.5657015590200446,0.8857100794984477,1.0,3/18,8.96%,STXBP6;ANXA1;PDLIM1
prerank,"endodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016888)",0.4170366115704581,0.92634691452695,0.5416666666666666,0.8951389020847494,1.0,5/13,19.02%,DNASE1L1;DICER1;DNASE1L2;FEN1;SLX4
prerank,nucleoside-diphosphatase activity (GO:0017110),-0.4026791219872262,-0.9263186568337448,0.5555555555555556,0.881069033529964,1.0,1/12,1.49%,ENTPD1
prerank,"phosphotransferase activity, for other substituted phosphate groups (GO:0016780)",-0.4037143445052013,-0.9257813253365121,0.5969162995594713,0.8776958941453497,1.0,2/11,2.45%,SGMS1;SGMS2
prerank,receptor tyrosine kinase binding (GO:0030971),0.32603911007494,0.9248384575889603,0.5803432137285491,0.8949521663398422,1.0,12/56,12.34%,LRP4;PTPN14;ARHGEF16;FRS2;TP53;GAB2;CPNE3;NRG1;ALKAL2;FLT3LG;RNF41;PITPNM2
prerank,aminopeptidase activity (GO:0004177),0.36421401630919925,0.9216501640877082,0.5897435897435898,0.8987302116707826,1.0,8/26,17.61%,CTSH;NAALADL1;METAP2;NPEPPS;MMP14;ERAP1;ANPEP;XPNPEP1
prerank,protein kinase A regulatory subunit binding (GO:0034237),-0.3285248061189482,-0.921333357108817,0.5897435897435898,0.883520287806492,1.0,6/21,18.07%,AKAP6;RYR2;KCNQ1;WASF1;WASF2;ACBD3
prerank,nucleoside-triphosphatase activity (GO:0017111),-0.21925867109176356,-0.9205748946454376,0.754601226993865,0.8805946835969382,1.0,90/248,27.02%,DNM3;RHOBTB1;RHOJ;GNAS;RIT2;RND3;MYL6;RAB31;MYH9;KRAS;RAB3C;RAP1B;RAP1A;SRPRA;GCH1;RASL12;RAB27A;RHOB;GNAI1;DYNC1I1;DNM1;RERG;ARHGDIB;EEF1A1;RALB;MYO6;GNA12;ABCD2;RAP2A;RHOH;GBP4;RAB18;KIF26A;HSP90AA1;ARL1;GNA14;RAB27B;ATP2B1;GNB2;ATL2;HBS1L;MTG2;RAB38;GNAO1;CLU;GNAL;GNB1;RAB6A;RAB32;RRAS;DHX9;SEPTIN9;TPPP;KIF15;ARL8B;RHOBTB3;ATAD1;DNA2;ATL3;RHEB;RAN;EEF2;MMAA;GPN3;CFTR;MYO1E;RND2;RAC3;GNL2;GEM;GPN2;RAB14;KIF5A;RHOC;RUVBL2;KIF14;RND1;MMUT;SAR1B;EEF1A2;RNF112;RAB1B;RHOG;GNG3;ABCA3;RAB5B;RAP2C;GNG8;KIF1A;TDRD9
prerank,basal RNA polymerase II transcription machinery binding (GO:0001099),0.3527108604111365,0.9194688050772468,0.5652173913043478,0.9001671230173701,1.0,7/33,13.46%,CTR9;ELOF1;NCOA3;RPRD2;SCAF8;WDR43;TBP
prerank,CoA hydrolase activity (GO:0016289),0.40532517830872683,0.9191489528630479,0.5711678832116789,0.8974884730226373,1.0,4/16,17.08%,ACSBG2;ACOT11;ACOT8;ACOT12
prerank,serine-type peptidase activity (GO:0008236),0.292043901005535,0.9171352222808918,0.5888111888111888,0.8985171348856579,1.0,7/96,6.07%,CORIN;KLK2;F11;DPP4;CTSH;F2;TPP1
prerank,phosphatidic acid binding (GO:0070300),-0.34869591249687737,-0.9153931304277818,0.5744186046511628,0.8885060290990366,1.0,6/19,14.65%,MARK1;PITPNC1;PLTP;RAPGEF6;JPH2;SESTD1
prerank,cytokine receptor activity (GO:0004896),-0.2494486691701722,-0.913422509272714,0.6632996632996633,0.8881789632276098,1.0,21/83,18.18%,GHR;IL1R1;OSMR;LIFR;IL1RAP;IL1RAPL2;F3;IL6ST;FZD4;IL17RD;IFNGR2;CD44;IL4R;CMKLR1;CNTFR;IL31RA;GFRA1;CX3CR1;GFRA2;CD74;CRLF1
prerank,signal sequence binding (GO:0005048),-0.30187593671145474,-0.9127517656140213,0.6206896551724138,0.8850034221896305,1.0,11/35,21.77%,PEX5L;CEMIP;NFKBIA;KDELR3;AP2B1;CABP1;AP2M1;CAT;RANBP6;TOMM20;POM121
prerank,guanyl ribonucleotide binding (GO:0032561),-0.22266435078023414,-0.9126998849278969,0.7525252525252525,0.8805205788498985,1.0,50/196,19.52%,RHOBTB1;RHOJ;PDE10A;PDE11A;RIT2;RND3;RAB31;KRAS;RAP1B;RAP1A;GCH1;RASL12;RAB27A;RHOB;GNAI1;RERG;EEF1A1;RALB;TUBA1A;MFHAS1;GLUD1;PDE2A;RAP2A;RHOH;GBP4;RAB18;TUBB4A;ARL5A;ARL1;RAB27B;ARL5B;ATL2;MTG2;RAB38;RAB6A;RAB32;TUBB2B;RRAS;ARF5;ARF6;RAB39A;ARL8B;RHOBTB3;TUBB3;ATL3;RHEB;RAN;TUBA4A;MMAA;PIP4K2B
prerank,phosphatase activator activity (GO:0019211),-0.372776603069638,-0.9118555208193049,0.5782881002087683,0.8778418522443588,1.0,5/14,10.44%,PPP2R5A;CALM1;CALM2;BMP2;CALM3
prerank,lipase activity (GO:0016298),0.3368555169082879,0.9099925479587646,0.589622641509434,0.9110906112842292,1.0,9/43,15.31%,CEL;LIPA;PLA1A;PNLIP;LYPLA1;DDHD2;ABHD12;SEC23IP;SMPD3
prerank,"DNA-binding transcription repressor activity, RNA polymerase II-specific (GO:0001227)",0.2690290257965014,0.9099827125203687,0.6545226130653267,0.9077008762612087,1.0,24/173,12.35%,AEBP1;MXI1;PPARA;FOXP4;ZBTB20;KCNIP3;MITF;NACC2;FOXP2;OTP;BHLHE41;RORC;IRX1;ZBTB26;SOX13;ZFP90;ZNF219;PRDM5;ZBTB6;NFATC3;MNT;ZBTB1;ZNF148;DEAF1
prerank,lipoprotein particle receptor binding (GO:0070325),-0.32113830324147036,-0.9083395964817991,0.5961123110151187,0.8813408383289925,1.0,9/27,19.16%,SYT1;APOE;HSPG2;RELN;AP2M1;SNX17;CLU;DNAJA1;LDLRAP1
prerank,cysteine-type peptidase activity (GO:0008234),-0.25571459078909897,-0.9071302562731366,0.6900958466453674,0.8793709892127057,1.0,25/73,21.03%,USP29;OTUD7B;CTSC;USP13;CTSB;PDIA3;CAPN2;UCHL1;CTSL;CTSS;CASP6;ATG4A;USP50;USP46;CTSO;USP14;USP8;CASP2;USP2;CTSZ;OTULINL;CASP4;ATG4B;USP42;SFRP1
prerank,polynucleotide adenylyltransferase activity (GO:0004652),0.4155923447906759,0.9038645608163686,0.5500945179584121,0.9175956778720282,1.0,6/12,23.74%,TENT2;TENT4B;PAPOLG;TENT5C;TUT1;TENT5D
prerank,neurexin family protein binding (GO:0042043),0.435902345853209,0.9033606294012742,0.5766990291262136,0.9153429812025546,1.0,3/10,3.74%,SYTL3;NLGN2;CEL
prerank,intracellular ligand-gated ion channel activity (GO:0005217),-0.39278570050923767,-0.90245306230427,0.5864197530864198,0.885711915006194,1.0,6/11,19.38%,RYR2;RYR3;TRPM2;ITPR3;TRPA1;RASA3
prerank,protein phosphatase 2A binding (GO:0051721),-0.32180002247083156,-0.9013726581381226,0.6086956521739131,0.8834107442230447,1.0,7/23,13.82%,GRIN3A;DAB2IP;FOXO1;MFHAS1;MAPT;SMG5;STRN4
prerank,cytochrome-c oxidase activity (GO:0004129),-0.3676313333916341,-0.9010569221033922,0.6085972850678733,0.8796367405409069,1.0,7/15,26.45%,COX4I1;COX6A1;CYB5A;COX5B;COX5A;NDUFA4L2;COX4I2
prerank,sodium ion transmembrane transporter activity (GO:0015081),0.3579528215353301,0.9008938338861993,0.5961538461538461,0.9173512616423811,1.0,2/27,1.99%,SLC41A1;SLC8A3
prerank,potassium ion antiporter activity (GO:0022821),0.40492044866223453,0.9007266074373341,0.5977443609022557,0.9142926221111805,1.0,1/15,0.61%,SLC24A3
prerank,ATPase regulator activity (GO:0060590),0.3335504843357861,0.9000957317103007,0.5909822866344605,0.9122653949525161,1.0,2/38,2.20%,ATP1B3;FNIP1
prerank,magnesium ion binding (GO:0000287),0.2786794648416528,0.8982765789998082,0.6803170409511229,0.9126685090492039,1.0,26/135,15.74%,EYA2;OXSR1;SPHK1;CLYBL;LRRK2;ATP4A;NUAK2;CDC42BPG;SIK1;MOV10L1;OPA1;PLSCR1;SRR;IDH1;BRSK1;SRPK2;ABL1;TDG;PGM1;THTPA;CERK;TDP2;STK4;XXYLT1;NT5C3A;RP2
prerank,tRNA-specific ribonuclease activity (GO:0004549),0.4056873127414251,0.8963958120417826,0.5831739961759083,0.9134502266040214,1.0,5/14,20.86%,TSEN2;RPP21;PRORP;POP7;POP1
prerank,K63-linked polyubiquitin modification-dependent protein binding (GO:0070530),0.3674727070946837,0.8962728427120289,0.5806451612903226,0.9103734991916608,1.0,8/22,19.97%,PARP10;IKBKE;TAB2;ZBTB1;UIMC1;OPTN;SQSTM1;WDR81
prerank,myosin V binding (GO:0031489),-0.3500770740255633,-0.8960920351172729,0.5964523281596452,0.8864767073722297,1.0,9/15,38.60%,RAB3C;RAB27B;RAB6A;RAB14;RAB3A;RAB3B;RAB6B;RAB25;RAB11A
prerank,mRNA 5'-UTR binding (GO:0048027),-0.31983011597240296,-0.8954857798312623,0.6330275229357798,0.8833585836083803,1.0,5/24,7.78%,RPL41;RPL26;SYNCRIP;RPL5;RPS7
prerank,adenylate cyclase binding (GO:0008179),0.42833558883590667,0.8952868981261527,0.5835010060362174,0.9091838352572442,1.0,2/10,3.92%,ADCY5;AKAP12
prerank,tubulin binding (GO:0015631),-0.21250656328362597,-0.8949985933659973,0.8466666666666667,0.8800880423340434,1.0,70/295,17.70%,DNM3;MTUS1;SGIP1;UNC5C;MAP1B;SYBU;AGBL4;STARD9;NAV3;TTLL7;REEP1;MID1;CLASP2;KIF21A;DST;MID2;CCDC88A;ARHGEF7;ARHGEF2;PAK1;RPS3;STMN2;DCX;DIP2B;DYNC1I1;KIF5C;DNM1;KIF26B;MTCL1;TUBGCP2;MAP6;FGF13;TRPV4;RP1;PACRG;CDK5RAP2;KIF26A;CLIP2;EML5;SETD2;SPEF1;MAP4;TRIM36;MAPT;RAB11FIP5;CLIP1;SNCA;KIF3A;CETN3;CDK5R1;GAS2L3;CCDC88C;ATF5;TERF1;STMN1;ALDOA;TTLL5;MAP1LC3A;KIF21B;MAP7D3;TPPP;GABARAPL2;APC;NUSAP1;CENPE;KIF15;ARL8B;EMD;FAM161A;CAPN6
prerank,estrogen receptor binding (GO:0030331),0.33972933066577465,0.8930061886772003,0.5929054054054054,0.9108478790937105,1.0,4/32,7.19%,PPARGC1B;NSD1;LCOR;WIPI1
prerank,tau-protein kinase activity (GO:0050321),0.3684628103211906,0.8907332676654951,0.5865724381625441,0.9121311272106994,1.0,3/20,10.71%,ROCK2;BRSK1;DYRK1A
prerank,solute:proton symporter activity (GO:0015295),-0.3557769262168089,-0.8904466929333865,0.6125290023201856,0.8855152529282685,1.0,1/16,1.50%,SLC2A13
prerank,lysophospholipase activity (GO:0004622),-0.33928063247894347,-0.8891143278421663,0.6028708133971292,0.8839368361069725,1.0,5/20,14.40%,PLA2G4A;MGLL;GDPD1;ENPP2;ABHD4
prerank,anion:anion antiporter activity (GO:0015301),-0.3468280627719791,-0.8879107255476044,0.6074561403508771,0.8822175287060957,1.0,2/17,2.84%,SLC26A7;SLC26A2
prerank,low-density lipoprotein particle receptor binding (GO:0050750),-0.33035839299007674,-0.8867729521262746,0.6487068965517241,0.880242646685274,1.0,8/22,19.16%,SYT1;APOE;HSPG2;AP2M1;SNX17;CLU;DNAJA1;LDLRAP1
prerank,heme binding (GO:0020037),0.30215556968638213,0.8857554379811812,0.6351145038167939,0.9196959498934616,1.0,11/65,11.43%,CYP27A1;FLVCR2;PGRMC1;CYP21A2;CYP26B1;SLC48A1;HRG;CYP2R1;CYB561D2;NOX4;CYB5B
prerank,nuclear import signal receptor activity (GO:0061608),0.3894753767120765,0.8838950253994826,0.6072106261859582,0.9203604263530818,1.0,7/15,28.30%,TNPO1;KPNA6;TNPO2;HIKESHI;KPNA4;IPO4;KPNA1
prerank,ribonuclease P activity (GO:0004526),0.4163094240737639,0.8821595754112194,0.5830258302583026,0.920787647696172,1.0,4/11,20.86%,RPP21;PRORP;POP7;POP1
prerank,Wnt-activated receptor activity (GO:0042813),-0.35302512715750084,-0.8815642309479499,0.6337078651685393,0.8875286932477104,1.0,4/15,10.70%,ROR1;FZD4;TSPAN12;PKD1
prerank,protein tyrosine kinase binding (GO:1990782),0.2955703455494548,0.8774539152869331,0.6607142857142857,0.9275354991978012,1.0,15/71,12.34%,LRP4;PTPN14;EPHA4;ARHGEF16;TP53;CPNE3;NRG1;CDH5;ALKAL2;FLT3LG;NOX4;CASS4;RNF41;PTPN11;PITPNM2
prerank,ATPase activator activity (GO:0001671),0.3680293853227956,0.8761857765367186,0.609009009009009,0.9269575373070484,1.0,1/20,0.71%,ATP1B3
prerank,solute:sodium symporter activity (GO:0015370),-0.3026473301127871,-0.8753153542889701,0.6506024096385542,0.896661406420643,1.0,2/27,5.45%,SLC4A10;SLC5A6
prerank,exopeptidase activity (GO:0008238),0.31075293659976744,0.8751987201834214,0.6342592592592593,0.9256969766345853,1.0,14/50,17.61%,ACE;DPP4;CTSH;NAALADL1;DPP8;METAP2;RCE1;NPEPPS;FOLH1;ERAP1;ZMPSTE24;ANPEP;DPP7;XPNPEP1
prerank,CARD domain binding (GO:0050700),-0.3583008959694433,-0.8744049251912276,0.6241758241758242,0.8942426452328749,1.0,6/14,19.14%,NOD1;CARD14;CARD16;NOD2;CARD19;CASP4
prerank,miRNA binding (GO:0035198),0.3392457001684278,0.8739994005575055,0.6239600665557404,0.9249214220128039,1.0,13/30,26.19%,ZC3H7B;HNRNPA2B1;TUT4;ZNF346;RBM4;TUT7;ZC3H10;FMR1;AGO1;SPOUT1;AGO4;AGO2;PUM2
prerank,nuclear export signal receptor activity (GO:0005049),-0.38290829723061237,-0.872803350215221,0.6338329764453962,0.8934359766845403,1.0,4/11,21.24%,XPO1;EIF4ENIF1;RAN;XPO6
prerank,calcium-dependent phospholipid binding (GO:0005544),0.31180570859953366,0.8725207789442443,0.6501597444089456,0.9245554903929469,1.0,7/49,8.36%,SYT9;SYT11;SYT12;FER1L5;CPNE3;ANXA5;ANXA9
prerank,endopeptidase activity (GO:0004175),0.249414407967869,0.8717439916040928,0.7562425683709869,0.923001247932558,1.0,52/257,19.77%,ACE;CORIN;ADAMTS10;BACE2;KLK2;F11;TRABD2B;ADAMTS2;ADAMTS15;CASP3;ADAMTSL5;DPP4;CTSH;F2;ADAMTS9;USP9X;USP24;TPP1;USP11;MMP19;RCE1;ADAM28;USP34;MMP14;ADAM17;USP49;USP12;USP7;MBTPS1;PCSK7;USP18;PITRM1;PREP;ADAMTS7;ZMPSTE24;NRDC;PLAT;CELA3A;USP37;TYSND1;PIDD1;PRSS36;USP48;USP1;ADAMTSL4;CLPP;USP33;PCSK4;USP16;USP35;AFG3L2;ECEL1
prerank,purine ribonucleoside triphosphate binding (GO:0035639),0.2379774789039494,0.8706697166912944,0.7850779510022272,0.9217824032744464,1.0,70/431,16.25%,PRKAG2;ATP1A2;WNK4;KSR1;OXSR1;RHOQ;RHOBTB2;RHOD;SPHK1;BMPR1A;OAS2;TGFBR1;DMPK;LRRK2;MYO18A;GNAT2;P2RX3;ATL1;GBP3;NUAK2;CLPX;CDC42BPG;SIK1;GBP7;MOV10L1;GCK;GBP2;SRR;RRAS2;GTPBP4;PPIP5K2;ARL4A;RAB11B;MKNK1;ABCC6;BRSK1;RAB13;SRPK2;ABL1;RAB22A;RABL6;TRIB1;CDC42;IGHMBP2;GALK1;PNKP;TDG;PRKCI;KIFC1;WNK1;OAS3;HSPA4;DNM2;TUBB2A;CAD;GBP6;ATP5F1D;SYN3;REM1;STK17B;RAB29;ACVR1B;STK4;RAB21;CARS2;ARFIP2;ARL6;STK36;VPS4A;TLK2
prerank,O-methyltransferase activity (GO:0008171),0.42274171961880047,0.8674964725795271,0.6321138211382114,0.9249372512972869,1.0,3/10,13.33%,LRTOMT;ASMT;CMTR2
prerank,histone methyltransferase activity (H3-K36 specific) (GO:0046975),0.42227896571693674,0.8670988977527955,0.5923694779116466,0.9225519938514098,1.0,4/10,18.15%,NSD1;NSD3;ASH1L;SETD3
prerank,poly-purine tract binding (GO:0070717),0.35099223968780674,0.8647001681239337,0.6323777403035413,0.9240485892597654,1.0,10/27,18.47%,RBMS2;DDX3X;TIA1;PABPC4L;RBMS1;PABPC5;HNRNPDL;DAZAP1;RBMS3;LARP4
prerank,signaling receptor complex adaptor activity (GO:0030159),-0.2819012306237553,-0.8611558359388864,0.6864197530864198,0.9130268638536645,1.0,16/38,20.50%,PIK3R1;SHANK3;GRIP1;NCK2;G3BP2;SHANK2;SH2B2;AXIN1;SHANK1;NCK1;BLNK;LDLRAP1;SPATA2;IRS1;SHC1;SPAG9
prerank,voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1902282),0.40274567160537056,0.86070063205294,0.6410748560460653,0.9285988098837006,1.0,1/11,1.34%,KCND3
prerank,phosphatidylinositol-3-phosphate binding (GO:0032266),-0.27924160155335054,-0.8604481290162286,0.6985294117647058,0.9102480946017951,1.0,9/38,15.98%,HIP1;PLA2G4A;DAB2IP;PLEKHA5;JPH2;SESTD1;PHLDA3;ZFYVE28;SNX27
prerank,phosphatidylinositol-3-phosphatase activity (GO:0004438),-0.3479129932740654,-0.8590212408505484,0.6446469248291572,0.9089584339778327,1.0,5/14,11.53%,MTMR6;MTMR2;MTMR11;MTMR7;MTMR9
prerank,ubiquitin-like protein-specific protease activity (GO:0019783),0.3592648784445845,0.8585438374606943,0.6461824953445066,0.9298141030559073,1.0,4/20,12.65%,SENP3;USP9X;DESI2;USP7
prerank,steroid hydroxylase activity (GO:0008395),0.3787504301725292,0.8561468631402623,0.6186915887850467,0.9313733001828315,1.0,3/16,8.78%,CYP27A1;CYP21A2;CYP2R1
prerank,polyubiquitin modification-dependent protein binding (GO:0031593),0.30129524658328405,0.8532154072830667,0.6741214057507987,0.9340907154802215,1.0,11/49,17.89%,PARP10;ZFAND6;BABAM2;IKBKE;TAB2;ZBTB1;UIMC1;DZIP3;UFD1;OPTN;SQSTM1
prerank,nuclease activity (GO:0004518),0.30140714202575764,0.8532144340057797,0.6808510638297872,0.9309350036035992,1.0,16/52,24.86%,DNASE1L1;PLSCR1;SAMHD1;SND1;REXO5;PNKP;DFFB;DIS3;DNASE1L2;OGG1;FEN1;RNASE12;MAP1S;REXO4;N4BP2;REXO1
prerank,cysteine-type endopeptidase inhibitor activity involved in apoptotic process (GO:0043027),-0.3270556092593859,-0.8494778521052438,0.6954545454545454,0.9243883324179254,1.0,6/18,14.18%,GAS6;RPS6KA3;SERPINB9;SNCA;RPS6KA1;MT3
prerank,protease binding (GO:0002020),0.27125722518182055,0.8475355330406249,0.7075208913649025,0.9389088049226041,1.0,17/99,9.72%,TIMP3;PRKN;CFLAR;DPP4;BDKRB2;POLG;CD28;LCOR;TP53;SERPINE1;COMP;PTEN;COL1A2;TWNK;ANXA9;RIPK2;STIM1
prerank,retinoid X receptor binding (GO:0046965),0.3930128829875335,0.845750011444716,0.6330798479087453,0.9392763976486307,1.0,3/11,11.14%,NSD1;HMGA1;RARG
prerank,endonuclease activity (GO:0004519),0.30323670681181547,0.8451116991954092,0.6773211567732116,0.9373957408291009,1.0,16/49,24.43%,ZC3H12B;SND1;DICER1;PNKP;ZC3H12C;DIS3;NYNRIN;CPSF3;MBD4;OGG1;FEN1;AGO1;REXO4;SMG6;N4BP2;LACTB2
prerank,ubiquitin conjugating enzyme binding (GO:0031624),0.33419848172387756,0.8427463080695721,0.6683937823834197,0.9388716758425194,1.0,6/27,12.36%,PPARA;PRKN;RNF217;RNF19A;DCUN1D5;ZMYM2
prerank,palmitoyltransferase activity (GO:0016409),-0.29128853625161905,-0.8406353329478945,0.7068965517241379,0.9374648526310289,1.0,5/28,12.48%,ZDHHC9;HHAT;ZDHHC2;GOLGA7;ZDHHC14
prerank,peptidase activator activity (GO:0016504),-0.3041044930752796,-0.8354970892028072,0.7076167076167076,0.9429806073863699,1.0,7/22,19.65%,CAV1;MAL;VSIR;PSMD14;PINK1;APH1A;PCOLCE
prerank,single-stranded DNA helicase activity (GO:0017116),-0.32065346478761125,-0.8353582218310295,0.6864035087719298,0.9388439114726632,1.0,12/19,30.71%,WRNIP1;DHX9;DNA2;RFC4;RFC2;POLQ;MCM6;RFC5;HELB;CHTF18;RAD51;PIF1
prerank,chemoattractant activity (GO:0042056),-0.29003671961312094,-0.8322038797476232,0.7352941176470589,0.9403738583002557,1.0,6/26,15.04%,VEGFC;FGF2;BMP4;FGF7;VEGFA;SCG2
prerank,receptor antagonist activity (GO:0048019),0.3475963275985527,0.8311421649365415,0.6684684684684684,0.957940959729641,1.0,1/17,2.82%,DKK3
prerank,Hsp70 protein binding (GO:0030544),0.32017622530902673,0.8299226612844894,0.6892857142857143,0.9570623512177925,1.0,3/31,3.01%,PRKN;PPEF2;HDAC8
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines (GO:0016813)",0.39091111092656156,0.8288825255382037,0.658252427184466,0.9559738994128683,1.0,3/11,22.07%,PADI6;PADI4;ARG1
prerank,poly(A)-specific ribonuclease activity (GO:0004535),0.3823657303186202,0.8237963049688746,0.6653771760154739,0.9624615686479463,1.0,3/12,11.59%,PAN3;PNLDC1;NOCT
prerank,phosphatidylinositol monophosphate phosphatase activity (GO:0052744),-0.3238458638622977,-0.8236176314523423,0.7149532710280374,0.9519557359859606,1.0,5/16,11.53%,MTMR6;MTMR2;MTMR11;MTMR7;MTMR9
prerank,growth factor activity (GO:0008083),0.27374386644529297,0.8213593819680928,0.7595307917888563,0.9640486494273623,1.0,16/74,18.91%,FGF1;F2;IL12B;OSGIN2;GDNF;NRG1;HBEGF;OSGIN1;VEGFD;TGFA;INHA;AMELX;NRTN;ARTN;VEGFB;BTC
prerank,SUMO binding (GO:0032183),0.3735325506937033,0.8206638932751172,0.6901140684410646,0.9622417509522943,1.0,13/13,62.68%,TDG;PML;USPL1;SIMC1;USP25;UBA2;CASP8AP2;HERC2;HABP4;RNF111;RNF4;CBX4;SERBP1
prerank,microtubule plus-end binding (GO:0051010),-0.30547746438867046,-0.8201745195275207,0.7293064876957495,0.953948685154681,1.0,6/20,16.95%,CLASP2;DST;CLIP4;CLIP2;CLIP1;APC
prerank,glucuronosyltransferase activity (GO:0015020),-0.3098303727373896,-0.8184545513153115,0.7192982456140351,0.9526289431946846,1.0,3/19,9.43%,CSGALNACT1;EXT1;EXT2
prerank,ubiquitin-like protein ligase binding (GO:0044389),0.23199543520294705,0.816146301479209,0.8672150411280846,0.9674930336922825,1.0,33/269,11.88%,SMAD3;SNCAIP;PPARGC1A;SYT11;FHIT;PRKN;POLR2A;DTX1;FZD8;PCBP2;SLC22A18;SMAD6;IKBKE;FZD5;ARRB1;STAT2;TRIB2;TP53;TRIOBP;PTPN22;RNF8;AMBRA1;CDK5RAP3;RNF34;DNM1L;PARP9;RIPK1;BECN1;TRIB1;MAGEC2;GLMN;AXIN2;CUL4A
prerank,single-stranded DNA binding (GO:0003697),0.2669479233026537,0.8152411736839472,0.7627586206896552,0.9659641017149523,1.0,25/93,21.23%,SSBP2;PCBP2;POLR2D;SAMHD1;FBH1;TWNK;SSBP1;RBMS1;RTF1;RBBP8;MSH3;IGHMBP2;TOP3A;MCM7;MCM2;PURB;TDP2;FUBP3;RAD51D;APTX;POU4F1;MCM9;POLR2G;MLH1;MCM5
prerank,tRNA binding (GO:0000049),0.28905660274132416,0.8128406471793124,0.7448275862068966,0.9672004929417216,1.0,6/43,17.96%,TRMT9B;TERT;IGHMBP2;SEPSECS;NEMF;RPUSD4
prerank,motor activity (GO:0003774),-0.23782985063916998,-0.8103511419762449,0.808955223880597,0.9627070278881279,1.0,24/60,26.90%,STARD9;KIF21A;MYL6;MYH9;DYNC1I1;KIF5C;KIF26B;MYO6;KIF26A;KIF3A;KIF21B;CENPE;DNAH3;KIF15;KIF11;MYO1E;KIF5A;KIF22;KIF4A;KIF3B;KIF14;KIF23;KIF1A;KIF17
prerank,"intramolecular oxidoreductase activity, transposing C=C bonds (GO:0016863)",-0.34205070782706726,-0.809472651334193,0.7306034482758621,0.959882186820539,1.0,4/13,30.18%,SREBF2;IDI1;EBP;DDT
prerank,tumor necrosis factor receptor superfamily binding (GO:0032813),0.3182356705142215,0.8091314798219328,0.7409948542024014,0.9709646728421454,1.0,4/28,9.73%,BID;BABAM2;EDA;RIPK1
prerank,1-phosphatidylinositol binding (GO:0005545),-0.3291964957945664,-0.8073638274584989,0.7130977130977131,0.9593492804131607,1.0,6/15,15.83%,EPB41;SCARB1;SNAP91;SESTD1;ZFYVE9;WDFY3
prerank,calcium channel inhibitor activity (GO:0019855),-0.3536653563595047,-0.8071420469610076,0.7137096774193549,0.9554121935259929,1.0,5/11,12.96%,CALM1;CALM2;FKBP1A;SLC30A1;MCUB
prerank,phosphatidylinositol-4-phosphate binding (GO:0070273),-0.2891564336319065,-0.8068412195082421,0.729490022172949,0.951687478069165,1.0,7/24,14.65%,CERT1;PLA2G4A;DAB2IP;PLEKHA5;JPH2;PLEKHA3;SESTD1
prerank,galactosyltransferase activity (GO:0008378),0.3861051857642833,0.8050245632973463,0.7059961315280464,0.9750989790973389,1.0,4/11,13.28%,B4GALT1;A3GALT2;A4GALT;B4GALT2
prerank,C2H2 zinc finger domain binding (GO:0070742),0.3775067847938965,0.8036259339867499,0.6728280961182994,0.974641378840646,1.0,1/11,1.08%,SRRM2
prerank,voltage-gated chloride channel activity (GO:0005247),0.3802795849856533,0.802294325523287,0.6954813359528488,0.9737595614938361,1.0,2/10,7.30%,CLCN2;ANO6
prerank,microtubule binding (GO:0008017),0.2335445366363529,0.8015936858057705,0.8719512195121951,0.9719421613060835,1.0,22/222,9.72%,FMN1;GJB6;MTUS2;EML4;KIF13B;HOOK2;KIF2A;EML2;CLASP1;LRRK2;EZR;CCDC69;MAP2;KIF3C;APC2;OPA1;KIF1B;FBXW11;CEP57L1;DNM1L;KIF1C;STIM1
prerank,RNA binding (GO:0003723),0.21133880791209414,0.8007070849919281,0.9878787878787879,0.970388404638508,1.0,242/1321,18.00%,NSA2;CPEB2;PPARGC1B;CELF2;ROCK2;TRMT9B;BICC1;SRRM2;DDX5;PPARGC1A;NUDT4;POLR2A;HOXB6;MSI2;SON;SNTB2;RBM47;TNRC6A;CPEB4;IFIT1;IFIT2;MRPS23;ZC3H7B;OAS2;RBMS2;TDRD3;NXF2;FNDC3B;TNPO1;LARP4B;SNRNP70;IFIT3;KNOP1;PCBP2;PABPN1;MYO18A;PRRC2B;MBNL2;TLR3;EZR;SMG1;HNRNPR;KYAT3;RBM28;METAP2;IGF2BP1;FAM120A;HNRNPH1;SRSF5;DDX3X;ERI3;TRIM56;SIDT2;CCDC86;ZC3H12B;ANKRD17;PNO1;POLDIP3;EIF2AK2;ANXA11;MOV10L1;LGALS1;ZCCHC13;TNS1;CLUH;CPNE3;ZC3H4;TIA1;SNIP1;HNRNPA2B1;SIDT1;GOT2;MEX3A;MRPL37;MRPL2;TUT4;POLR2D;HUWE1;TNRC6B;PABPC4L;SAMHD1;SAMD4A;PARP12;TEP1;ATXN2;RBM15;SPEN;RBM39;LARP1;CPEB3;EXOSC7;TERT;SLTM;IGF2BP2;ARHGEF1;JMJD6;DIAPH1;NOVA1;SND1;FLYWCH2;RBM27;ZC3H18;DQX1;CSDC2;SSBP1;C1D;LRP1;RBMS1;KIF1C;ZC3HAV1;DDX60;SCAF4;LARP7;GPKOW;GTPBP4;CCAR1;KHDC4;MOV10;NUP42;PPAN;LSM14A;PTRH1;TRIP6;CRKL;YTHDF3;TBRG4;LUC7L3;GTF2F1;SCAF8;RRP36;KMT2C;SURF6;THRAP3;SRPK2;LRRC47;RTF1;ZNF346;SAP18;NOM1;EIF4A2;NUP98;DDX18;NXF1;ANKHD1;PNLDC1;PRKDC;HNRNPL;DHX58;RPP21;MRPS7;NOCT;CWC15;SUGP2;DICER1;NELFCD;PHF5A;SRSF11;NOP2;IGHMBP2;DDX6;ETF1;DCP1A;SLC25A11;CLTC;NOC4L;ALDH6A1;WDR43;POLR1G;CAST;AKAP1;RBPMS2;GSPT2;LBR;DHX33;OAS3;PNISR;ZC3H12C;PSIP1;RAMAC;ILF2;HNRNPC;RSL1D1;SCAF11;UBAP2L;MRPS26;DZIP3;IMMT;PUS10;SEC23IP;FCF1;RBM34;PURB;ATP5F1C;NYNRIN;PABPC5;PRPF3;LGALS3;ANXA7;ZFP36L1;SARNP;TENT4B;VIRMA;FUBP3;SNRNP40;SEPSECS;RBM4;HNRNPDL;SLC4A1AP;DAZAP1;DUSP14;FARSA;HNRNPM;CPSF3;RPP25L;DIDO1;TUT7;NEMF;EXD1;FRG1;GRSF1;ALKBH5;MRPL1;POP7;ILF3;ATXN2L;ZCRB1;PCDHGA9;DUS3L;RBMS3;DYNC1LI1;CHD2;PRPF6;KDM1A;HEXIM2;DDX55;FAM120C;FUS;EXOSC3;SRSF1;RPUSD4;EIF4G1;PKN2
prerank,pyrophosphate hydrolysis-driven proton transmembrane transporter activity (GO:0009678),-0.2966395843285514,-0.7979533340098628,0.7640449438202247,0.9626661279213052,1.0,4/22,9.26%,ATP6V0A1;ATP2C1;ATP6V0A4;ATP2A3
prerank,DNA polymerase activity (GO:0034061),0.330167409190004,0.7976778932203069,0.7557117750439367,0.9723850429674117,1.0,6/22,15.97%,POLM;POLG;REV1;TERT;POLE2;POLL
prerank,3'-5'-exoribonuclease activity (GO:0000175),0.3017096283762148,0.7951411510310679,0.7491582491582491,0.9738617142710858,1.0,9/34,17.83%,ERI3;EXOSC7;ERI2;PAN3;PNLDC1;NOCT;DIS3;DIS3L;EXOSC3
prerank,G protein-coupled peptide receptor activity (GO:0008528),0.2665226571924552,0.794179455266428,0.8139880952380952,0.9724272175128643,1.0,10/73,13.62%,LGR4;NPR1;NPR3;BDKRB2;MC2R;NMUR1;NLRP6;KISS1R;SORCS2;VIPR1
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines (GO:0016814)",0.3835312102964488,0.7938292476619095,0.6866537717601547,0.9699996389559464,1.0,1/10,2.05%,LACC1
prerank,nucleobase-containing compound kinase activity (GO:0019205),0.34318521580183553,0.793150888810545,0.7014652014652014,0.9680552914423657,1.0,4/17,13.56%,AK3;AK4;NME6;AK8
prerank,alcohol dehydrogenase (NADP+) activity (GO:0008106),0.3751448034758385,0.7929926151007757,0.7075471698113207,0.9653714868867828,1.0,1/11,3.07%,AKR1B10
prerank,ubiquitin-ubiquitin ligase activity (GO:0034450),0.37914439760291696,0.7922541297099535,0.7212475633528265,0.9635815839116211,1.0,3/11,19.14%,UBR5;AMFR;UBE4B
prerank,ubiquitin binding (GO:0043130),0.26252068793831057,0.7916188597649005,0.8050221565731167,0.9616720533357972,1.0,4/73,5.61%,SMAD3;PRKN;NEDD4;ASCC2
prerank,growth factor receptor binding (GO:0070851),0.25576509531663644,0.79132564766278,0.8253521126760563,0.959212748162225,1.0,17/95,13.89%,FGF1;KL;FRS2;PDGFRB;IL12B;PLSCR1;ATXN2;HBEGF;FER;TRIP6;KLB;ADAM17;GLMN;VEGFD;TGFA;ERAP1;TLR5
prerank,ubiquitin protein ligase binding (GO:0031625),0.22598229990134885,0.7901600676805349,0.8972520908004779,0.9582470336593845,1.0,30/254,11.88%,SMAD3;SNCAIP;PPARGC1A;SYT11;FHIT;PRKN;POLR2A;DTX1;FZD8;PCBP2;SLC22A18;SMAD6;IKBKE;FZD5;ARRB1;TRIB2;TP53;TRIOBP;PTPN22;RNF8;AMBRA1;RNF34;DNM1L;RIPK1;BECN1;TRIB1;MAGEC2;GLMN;AXIN2;CUL4A
prerank,metalloendopeptidase activity (GO:0004222),0.25915886844759645,0.7891451867580126,0.8110014104372355,0.9569727250052064,1.0,14/76,15.37%,ADAMTS10;TRABD2B;ADAMTS2;ADAMTS15;ADAMTSL5;ADAMTS9;MMP19;RCE1;MMP14;ADAM17;PITRM1;ADAMTS7;ZMPSTE24;NRDC
prerank,nucleosomal DNA binding (GO:0031492),0.3289553797608848,0.7879298746413986,0.7444253859348199,0.9560996935179403,1.0,11/21,24.41%,CHD4;SMARCA4;SMARCC2;SMARCE1;HDAC1;HNRNPC;MTA2;SMARCD2;MBD2;SMARCB1;H1-0
prerank,voltage-gated anion channel activity (GO:0008308),0.3488574789851951,0.7874924549173848,0.7025440313111546,0.9539080282899937,1.0,3/15,7.30%,CLCN2;VDAC2;ANO6
prerank,solute:anion antiporter activity (GO:0140323),0.3592604773003375,0.7860251881976856,0.6996124031007752,0.9533276605973953,1.0,3/14,7.86%,SLC7A11;SLC26A3;SLC26A1
prerank,hexose transmembrane transporter activity (GO:0015149),-0.3316677400962081,-0.7842402625777081,0.7841140529531568,0.9811620733679217,1.0,1/12,1.36%,SLC2A1
prerank,regulatory RNA binding (GO:0061980),0.29554153343809736,0.7839216069262468,0.7532679738562091,0.9537621292573439,1.0,14/38,26.19%,ZC3H7B;HNRNPA2B1;TUT4;ZNF346;DICER1;RBM4;TUT7;ZC3H10;FMR1;AGO1;SPOUT1;AGO4;AGO2;PUM2
prerank,telomeric DNA binding (GO:0042162),0.303173760090717,0.7811387614355824,0.7843803056027164,0.9553267508414924,1.0,10/32,19.46%,SMG1;ACD;HNRNPA2B1;TERT;RAD50;ZBTB48;TELO2;KDM1A;TINF2;UPF2
prerank,neuropeptide receptor activity (GO:0008188),-0.26715170886147066,-0.77930229485597,0.8190255220417634,0.9846217897172741,1.0,2/29,3.35%,SORCS1;SORCS3
prerank,mannosyltransferase activity (GO:0000030),-0.28568633987892583,-0.779124276484734,0.7818181818181819,0.9805774959769762,1.0,2/21,5.73%,TMTC2;DPY19L1
prerank,ephrin receptor binding (GO:0046875),0.3237166110773376,0.7774585446916993,0.748653500897666,0.9583958426113157,1.0,1/21,0.55%,EFNB2
prerank,"DNA binding, bending (GO:0008301)",-0.3180516532224005,-0.7733141364943394,0.7827956989247312,0.9855046883058284,1.0,5/14,16.80%,LEF1;TFAM;TERF1;HHEX;TOP2A
prerank,pyrophosphatase activity (GO:0016462),0.2783164807090506,0.771681203351902,0.792063492063492,0.9649934724495152,1.0,5/50,6.64%,NUDT4;CILP2;LHPP;DDX3X;ENPP3
prerank,deoxyribonuclease activity (GO:0004536),0.3457561674094231,0.7709805511089729,0.7219152854511971,0.9632599801631868,1.0,5/14,21.51%,DNASE1L1;DFFB;DNASE1L2;MBD4;MAP1S
prerank,tau protein binding (GO:0048156),0.2809319635641743,0.7693786793191898,0.8003095975232198,0.9629231497132145,1.0,3/40,5.21%,ROCK2;PICALM;MAP2
prerank,1-phosphatidylinositol-3-kinase activity (GO:0016303),0.36382015607443396,0.7676224133762827,0.7287128712871287,0.9629383585001053,1.0,3/10,10.43%,ATM;PIK3CA;PIK3R3
prerank,"hydrolase activity, hydrolyzing O-glycosyl compounds (GO:0004553)",-0.26776933830873706,-0.7675694646085063,0.83451536643026,0.9897245417774991,1.0,2/29,3.31%,ACER3;ACER2
prerank,protein kinase inhibitor activity (GO:0004860),-0.24614299499767256,-0.766454990039973,0.8436657681940701,0.9870940627275315,1.0,9/42,18.37%,CIT;YWHAB;INKA2;CDKN1A;SNCA;SPRED1;NCK1;MBIP;SPRY4
prerank,snoRNA binding (GO:0030515),0.29790451766161363,0.7658329099917521,0.7866894197952219,0.9628371451550403,1.0,1/30,1.47%,NUDT4
prerank,neuropeptide receptor binding (GO:0071855),0.3338852510457696,0.7650352233027522,0.7481203007518797,0.9611483914976395,1.0,2/14,9.11%,APLN;AGRP
prerank,carboxylic ester hydrolase activity (GO:0052689),0.25093443374910795,0.7631192359331422,0.8587412587412587,0.9610441596086917,1.0,11/85,10.53%,PAFAH2;CEL;LIPA;ASPG;PNLIP;LYPLA1;PON3;DDHD2;PLA2G6;PTRH1;ABHD12
prerank,death receptor binding (GO:0005123),0.3363093139655632,0.7624741454088574,0.74609375,0.9592434816724889,1.0,3/15,9.73%,BID;EDA;RIPK1
prerank,histone methyltransferase binding (GO:1990226),-0.33540055699035476,-0.7605674201283752,0.7906976744186046,0.9916856239931371,1.0,4/11,21.01%,HSP90AB1;CTNNB1;NOP56;LCORL
prerank,single-stranded telomeric DNA binding (GO:0043047),-0.3283050562648782,-0.7570631778895253,0.7836644591611479,0.992438443558323,1.0,4/11,15.93%,TERF2IP;TERF1;STN1;RPA1
prerank,hexosaminidase activity (GO:0015929),-0.3201990917923728,-0.7551517777046255,0.774,0.9907588993635843,1.0,2/12,8.51%,CEMIP;HEXB
prerank,kinase inhibitor activity (GO:0019210),-0.24950343967024963,-0.7546075330192616,0.8771498771498771,0.9872185981173022,1.0,9/33,21.98%,YWHAB;RHOH;CDKN1A;SNCA;NCK1;MBIP;SPRY4;NPM1;LRP6
prerank,3'-5' DNA helicase activity (GO:0043138),0.33092607684192693,0.7519657045301413,0.7732342007434945,0.9722694040234587,1.0,4/16,13.35%,FBH1;FANCM;MCM7;MCM2
prerank,omega peptidase activity (GO:0008242),-0.2031428757084669,-0.7502234825291896,0.9337539432176656,0.9889858172640374,1.0,19/89,17.73%,USP29;OTUD7A;ASRGL1;OTUD7B;USP13;PSMD14;UCHL3;UCHL1;USP31;YOD1;USP53;USP50;USP46;USP22;VCPIP1;APEH;USP14;USP8;USP2
prerank,ubiquitin-like protein conjugating enzyme binding (GO:0044390),0.2852772171306119,0.7500468726902607,0.7976588628762542,0.9721482651654733,1.0,6/33,12.36%,PPARA;PRKN;RNF217;RNF19A;DCUN1D5;ZMYM2
prerank,manganese ion binding (GO:0030145),0.2678592375101974,0.7479765909069234,0.8302752293577982,0.9722300502704617,1.0,10/48,18.70%,MPPED2;LARGE1;SOD2;B4GALT1;ABL1;LARGE2;TDP2;XXYLT1;XPNPEP1;FEN1
prerank,WW domain binding (GO:0050699),0.2928747728768175,0.7455636228878388,0.7828282828282829,0.9728870274907003,1.0,7/26,19.43%,PMEPA1;TCEAL8;TCEAL6;SCNN1A;PRRG4;NDFIP1;WBP1
prerank,phosphatidylglycerol binding (GO:1901611),0.34308382018557837,0.7438656344451465,0.7618181818181818,0.9724941776500239,1.0,2/13,7.06%,GSDME;OPA1
prerank,gamma-tubulin binding (GO:0043015),-0.2754375056769776,-0.7379933179652383,0.8551724137931035,1.0,1.0,5/21,12.79%,ARHGEF7;PAK1;TUBGCP2;CDK5RAP2;RAB11FIP5
prerank,cysteine-type endopeptidase activity (GO:0004197),0.24494717725841633,0.737989879502057,0.8668596237337193,0.9778647677665933,1.0,25/78,22.45%,CFLAR;CASP3;CAPNS2;CTSH;USP9X;USP24;USP11;USP34;USP49;USP12;USP7;USP18;CAPN15;USP37;USP48;USP1;USP33;USP16;USP35;CASP12;GPAA1;CAPN8;USP5;CASP9;USP20
prerank,deubiquitinase activity (GO:0101005),-0.20194210796579376,-0.737704150000904,0.9638157894736842,0.9974545115649907,1.0,24/88,23.65%,USP29;OTUD7A;OTUD7B;USP13;PSMD14;EIF3F;UCHL3;UCHL1;USP31;YOD1;USP53;USP50;USP46;USP22;VCPIP1;USP14;USP8;USP2;COPS5;MINDY1;USP42;MYSM1;BAP1;JOSD2
prerank,aminoacyl-tRNA ligase activity (GO:0004812),-0.2443775899673164,-0.7353617771271915,0.8609112709832134,0.9962458814965157,1.0,4/37,12.09%,LARS2;WARS2;GARS1;DARS2
prerank,dynactin binding (GO:0034452),0.3465570725742485,0.7340482494426328,0.7664783427495292,0.98042626976909,1.0,2/12,8.60%,SNX6;HTT
prerank,water transmembrane transporter activity (GO:0005372),-0.3209914459405967,-0.7335667070119162,0.8307086614173228,0.9944229221973722,1.0,2/11,7.57%,AQP4;AQP11
prerank,DNA-directed DNA polymerase activity (GO:0003887),0.3025291321371456,0.7310753239262985,0.8178633975481612,0.9815460907696341,1.0,3/21,7.10%,POLM;POLG;REV1
prerank,glucose transmembrane transporter activity (GO:0005355),-0.27876019878764774,-0.7309095773220677,0.8305439330543933,0.993541629675598,1.0,1/17,1.36%,SLC2A1
prerank,neuropeptide hormone activity (GO:0005184),0.2919600798170926,0.7297815338915941,0.7937062937062938,0.9805971955759878,1.0,4/22,17.49%,AGRP;SPX;NPFF;NMB
prerank,ribonuclease P RNA binding (GO:0033204),0.3500757710107159,0.7294320519329818,0.7550274223034735,0.9782435331988606,1.0,3/10,20.86%,RPP21;POP7;POP1
prerank,"exoribonuclease activity, producing 5'-phosphomonoesters (GO:0016896)",0.27651525280711337,0.7291901754558234,0.8542372881355932,0.9758173651922903,1.0,8/33,17.83%,ERI3;EXOSC7;ERI2;PNLDC1;NOCT;DIS3;DIS3L;EXOSC3
prerank,MAP kinase tyrosine/serine/threonine phosphatase activity (GO:0017017),0.3559352231661491,0.7262393426396639,0.766798418972332,0.9742981709957094,1.0,3/10,18.08%,DUSP10;DUSP2;DUSP4
prerank,protein tyrosine/threonine phosphatase activity (GO:0008330),0.3559352231661491,0.7262393426396639,0.766798418972332,0.9742981709957094,1.0,3/10,18.08%,DUSP10;DUSP2;DUSP4
prerank,NAD-retinol dehydrogenase activity (GO:0004745),-0.29271626062937506,-0.7218805243096071,0.8571428571428571,1.0,1.0,2/14,10.96%,RDH10;ADH1A
prerank,E-box binding (GO:0070888),-0.24257701206256888,-0.7213289489008635,0.8922651933701657,0.9971100780490859,1.0,18/34,35.52%,HES1;SREBF2;ATOH8;TWIST1;TAL1;ZEB1;TFAP4;SNAI2;TCF3;BHLHE40;AHR;PRMT5;PER1;PPARG;ASCL1;GATA3;NEUROD2;CIART
prerank,UDP-galactosyltransferase activity (GO:0035250),-0.3332818902030668,-0.7213117239041564,0.8237791932059448,0.9930398306089757,1.0,4/10,18.97%,B4GALT5;B3GALT1;B3GALT5;B3GALT6
prerank,"phosphatidylinositol-3,4-bisphosphate binding (GO:0043325)",0.2859457918301421,0.7165357902218117,0.8411867364746946,0.9836824667597207,1.0,4/25,6.71%,FCHSD2;DAPP1;PLEKHA2;GAB2
prerank,proton transmembrane transporter activity (GO:0015078),-0.22817201537068957,-0.7165151686822285,0.9112271540469974,0.9946576106136887,1.0,14/39,32.33%,COX4I1;COX6A1;CLCN3;CYB5A;UQCR11;COX5B;COX5A;ATP6V1F;NDUFA4L2;ATP6V1B2;COX4I2;UQCR10;CLCN4;SLC4A11
prerank,3'-5' exonuclease activity (GO:0008408),0.2552966572546018,0.7139955959678864,0.8706070287539937,0.9838422615681763,1.0,11/45,17.83%,POLG;ERI3;EXOSC7;ERI2;PNLDC1;NOCT;RAD50;DIS3;EXD1;DIS3L;EXOSC3
prerank,DNA-directed 5'-3' RNA polymerase activity (GO:0003899),0.28161437828876634,0.7132845422616862,0.8203389830508474,0.9819850579327868,1.0,7/27,23.45%,POLR2A;POLR2D;POLR3A;POLR2G;POLRMT;POLR2F;POLR3H
prerank,ubiquitination-like modification-dependent protein binding (GO:0140035),-0.31514693793503734,-0.7103604961553911,0.8306122448979592,0.9975209241453965,1.0,3/10,14.21%,ANKRD13A;LAPTM5;FAAP20
prerank,ubiquitin conjugating enzyme activity (GO:0061631),0.273954817540389,0.7097506314497455,0.8336283185840708,0.9835819345458054,1.0,1/31,0.77%,UBE2E2
prerank,RNA polymerase binding (GO:0070063),0.3099701041475263,0.7096153285500564,0.8025134649910234,0.9809552384930347,1.0,4/18,10.47%,NEDD4;PABPN1;CCNT2;SCAF8
prerank,phosphate ion binding (GO:0042301),-0.3152984030728473,-0.7094292434338689,0.8241106719367589,0.9945511439951524,1.0,4/10,36.31%,PDE2A;RELA;RPH3A;MTHFD2
prerank,transmembrane receptor protein tyrosine kinase adaptor activity (GO:0005068),-0.31046413123173344,-0.7090446689734746,0.8404255319148937,0.9908970098832105,1.0,5/12,20.08%,PIK3R1;SH2B2;BLNK;IRS1;SHC1
prerank,lysine N-methyltransferase activity (GO:0016278),0.2914054500607077,0.7065610775285466,0.8214285714285714,0.9819608718973686,1.0,5/20,18.15%,SETD7;KMT5A;EHMT2;EHMT1;SETD3
prerank,NADP binding (GO:0050661),0.27055348891556674,0.7048300731303887,0.8467874794069192,0.9813330096715361,1.0,9/32,17.19%,GMDS;DPYD;NOX1;TM7SF2;MTRR;PGD;LBR;DECR1;CRYZ
prerank,phospholipase inhibitor activity (GO:0004859),0.33401945185679427,0.7023245109079652,0.8056603773584906,0.9815579171542557,1.0,4/10,21.31%,ANXA5;ANXA9;ANXA2;ANXA4
prerank,nucleoside diphosphate kinase activity (GO:0004550),0.3174353352008319,0.6988724577355228,0.8298676748582231,0.9827396019655802,1.0,3/14,13.56%,AK4;NME6;AK8
prerank,endoribonuclease activity (GO:0004521),0.27140373276950025,0.6969680751591901,0.8611570247933884,0.9822338598616849,1.0,10/32,26.19%,ZC3H12B;SND1;DICER1;ZC3H12C;NYNRIN;CPSF3;AGO1;SMG6;LACTB2;AGO2
prerank,DNA secondary structure binding (GO:0000217),0.26924073238896484,0.6963163874181353,0.875605815831987,0.9802092484671979,1.0,5/31,11.25%,KMT2A;HMGA1;FANCM;ABL1;RBBP8
prerank,O-acyltransferase activity (GO:0008374),0.2735162251305343,0.6962097284279197,0.8509212730318257,0.9776476757345018,1.0,3/30,5.99%,MOGAT3;GPAT2;PIGW
prerank,protein phosphatase regulator activity (GO:0019888),0.24116500904690402,0.6953172893277686,0.9154078549848943,0.9759377895750322,1.0,11/53,17.09%,PPP2R2B;PPP4R4;DMPK;EIF2AK2;PPP2R1B;PHACTR4;PPP2R5E;LGALS3;PPP4R2;SAG;PPP6R3
prerank,acetylcholine-gated cation-selective channel activity (GO:0022848),0.3322745127548341,0.6952121827801383,0.7980582524271844,0.9733908590701265,1.0,2/11,17.53%,CHRNA5;CHRNB1
prerank,adenyl nucleotide binding (GO:0030554),-0.3077591242811785,-0.6944634176413903,0.8673684210526316,0.9985469470505463,1.0,3/11,21.77%,HSPH1;BAG5;BAG2
prerank,adenyl-nucleotide exchange factor activity (GO:0000774),-0.3077591242811785,-0.6944634176413903,0.8673684210526316,0.9985469470505463,1.0,3/11,21.77%,HSPH1;BAG5;BAG2
prerank,S-adenosylmethionine-dependent methyltransferase activity (GO:0008757),0.2542072356006498,0.6937563313466562,0.8970588235294118,0.9723792685845977,1.0,17/40,28.43%,DNMT3A;HNMT;LRTOMT;TPMT;ASMT;SETD3;GNMT;METTL4;N6AMT1;METTL9;ICMT;PCMT1;PEMT;DNMT1;THUMPD3;FBLL1;AS3MT
prerank,DNA polymerase binding (GO:0070182),0.3024149556402628,0.6923866030355461,0.8315217391304348,0.9712206062463644,1.0,3/18,7.97%,ACD;FANCI;SMARCA4
prerank,oxidoreduction-driven active transmembrane transporter activity (GO:0015453),-0.2067676408559771,-0.692054779041431,0.9555555555555556,0.9968540191128361,1.0,20/57,29.56%,COX4I1;COX6A1;CYB5A;NDUFB7;NDUFS6;UQCR11;COX5B;COX5A;NDUFA4L2;CYBRD1;NDUFS7;NDUFB8;NDUFB5;NDUFA6;NDUFA7;NDUFA13;COX4I2;NDUFA8;UQCR10;NDUFB10
prerank,"proton-transporting ATPase activity, rotational mechanism (GO:0046961)",0.3059778409023758,0.6888150329577599,0.8563432835820896,0.9699435037694073,1.0,3/16,11.07%,ATP6V0E1;ATP6V0B;ATP6V1D
prerank,"ATPase activity, coupled to transmembrane movement of ions, rotational mechanism (GO:0044769)",0.3059778409023758,0.6888150329577599,0.8563432835820896,0.9699435037694073,1.0,3/16,11.07%,ATP6V0E1;ATP6V0B;ATP6V1D
prerank,transition metal ion transmembrane transporter activity (GO:0046915),0.2691280659626482,0.6876966830561436,0.8555008210180624,0.968427826561985,1.0,3/30,8.11%,SLC30A10;SLC30A2;SLC39A13
prerank,ubiquitin-like protein conjugating enzyme activity (GO:0061650),0.2617247128938587,0.6866449702678047,0.8726003490401396,0.9669633959536215,1.0,1/34,0.77%,UBE2E2
prerank,CCR chemokine receptor binding (GO:0048020),0.2728379465915412,0.6841590975055886,0.8711864406779661,0.9669877588404447,1.0,5/28,18.06%,DEFB1;CCL25;CCL15;CCR2;MSMP
prerank,RNA 7-methylguanosine cap binding (GO:0000340),0.32531354198271445,0.6814978365592088,0.8349514563106796,0.9671513832261662,1.0,6/12,27.72%,LARP1;NCBP3;GEMIN5;CYFIP2;AGO2;EIF4E2
prerank,NF-kappaB binding (GO:0051059),-0.2532784333412044,-0.6807216522671502,0.9033816425120773,1.0,1.0,7/24,24.03%,NFKBIA;GSK3B;TAF4B;MTDH;NPM1;SETD6;RELA
prerank,protein-cysteine S-palmitoyltransferase activity (GO:0019706),-0.24810138477737192,-0.6799835144204676,0.9212410501193318,1.0,1.0,4/24,12.48%,ZDHHC9;ZDHHC2;GOLGA7;ZDHHC14
prerank,Hsp90 protein binding (GO:0051879),0.26092626116974194,0.6751199318423556,0.9006734006734006,0.9709714513954917,1.0,3/33,3.01%,PTGES3L;PPEF2;HDAC8
prerank,FMN binding (GO:0010181),-0.28838001981060046,-0.6694276721915728,0.869198312236287,1.0,1.0,2/11,12.66%,NOS3;NOS1
prerank,carboxy-lyase activity (GO:0016831),0.27206995720223365,0.6690351987596638,0.8769230769230769,0.9743286342416968,1.0,7/23,22.17%,AZIN1;MLYCD;ACOD1;ECHDC1;AZIN2;MVD;GGCX
prerank,mannose binding (GO:0005537),-0.28149343551037137,-0.6663773214196355,0.8915401301518439,1.0,1.0,3/12,18.91%,LMAN2L;LMAN2;CLN5
prerank,death domain binding (GO:0070513),-0.287859047812006,-0.6618791669813577,0.906183368869936,1.0,1.0,3/11,15.69%,DAPL1;DAP;CRADD
prerank,kinesin binding (GO:0019894),-0.2300677921130881,-0.657630445213408,0.9360613810741688,1.0,1.0,9/27,28.83%,ACTB;SNCA;NEFH;NEK6;SPAG9;PRC1;CLSTN1;AP1AR;TTBK2
prerank,methyltransferase activity (GO:0008168),0.23489738610291752,0.6552040090353343,0.9350237717908082,0.9844520047057327,1.0,13/46,22.70%,LRTOMT;COQ5;ASMT;MGMT;METTL27;EHMT1;BUD23;NSUN4;METTL4;NDUFAF7;N6AMT1;AMT;EEF1AKMT1
prerank,microtubule motor activity (GO:0003777),0.22937154553297903,0.6486111286352407,0.9487951807228916,0.9875728931968277,1.0,7/51,13.39%,KIF13B;KIF2A;KIF3C;KIF1B;KIF1C;KIFC1;KIF5B
prerank,antiporter activity (GO:0015297),0.2691640698075936,0.6416216398512381,0.8794964028776978,0.9905345079557598,1.0,4/20,15.67%,TMEM241;SLC25A11;SLC35D1;SLC25A10
prerank,"hydrolase activity, hydrolyzing N-glycosyl compounds (GO:0016799)",0.28334661105003245,0.6416115426054352,0.8983666061705989,0.9879373182411505,1.0,1/16,2.38%,MACROD1
prerank,phosphatidylinositol 3-kinase activity (GO:0035004),0.29664349686275426,0.6404537407393992,0.8895582329317269,0.9862484307618857,1.0,3/12,10.43%,ATM;PIK3CA;PIK3R3
prerank,organic cation transmembrane transporter activity (GO:0015101),0.290889333226269,0.6403975858842674,0.9017013232514177,0.9837416095168944,1.0,5/16,19.67%,SLC22A5;SLC25A42;SLC25A17;SLC25A26;SLC22A4
prerank,DNA replication origin binding (GO:0003688),-0.2309868252653294,-0.634777912771963,0.9497607655502392,1.0,1.0,5/23,17.83%,POLA1;DHX9;ORC5;ORC2;CDC45
prerank,glutathione transferase activity (GO:0004364),0.26159858004797576,0.6336632965077367,0.8985765124555161,0.9862059158569008,1.0,2/23,10.04%,GSTT1;GSTA3
prerank,single-stranded RNA binding (GO:0003727),0.23227669073774934,0.6312561504832315,0.9423076923076923,0.9855085806375115,1.0,15/43,26.19%,DDX3X;ZCCHC13;POLR2D;JMJD6;DDX60;DHX58;ILF3;SNRPC;POLR2G;FMR1;U2AF2;AGO1;LACTB2;AGO4;AGO2
prerank,calcium-dependent cysteine-type endopeptidase activity (GO:0004198),-0.25994907990865235,-0.6281629403954982,0.9260969976905312,1.0,1.0,4/14,17.70%,CAPN2;CAPN10;CAPNS1;CAPN6
prerank,channel activity (GO:0015267),-0.19790240840101336,-0.6281487484654564,0.9668367346938775,1.0,1.0,8/41,18.73%,AQP4;AQP11;TRPV4;MCUB;CHRNA7;TMEM266;PANX1;TRPA1
prerank,NADPH binding (GO:0070402),0.2870551602163427,0.627286736273168,0.8864059590316573,0.9859424833120242,1.0,5/13,19.29%,MTRR;LBR;DECR1;CRYZ;DUS2
prerank,endodeoxyribonuclease activity (GO:0004520),-0.23149828862307936,-0.6235623160782823,0.9297423887587822,1.0,1.0,4/20,18.55%,RPS3;ERCC1;ENDOV;DNA2
prerank,protein-arginine N-methyltransferase activity (GO:0016274),0.30004393948904673,0.6214117357610602,0.8841698841698842,0.98754560932419,1.0,11/11,70.02%,FBXO11;NDUFAF7;PRMT2;PRMT7;PRMT6;PRMT9;CARM1;PRMT3;PRMT1;PRMT5;PRMT8
prerank,ribonuclease activity (GO:0004540),0.21826730307304407,0.6199753730321227,0.9666160849772383,0.9860833390843418,1.0,12/56,22.90%,ZC3H12B;SAMHD1;EXOSC7;SND1;DICER1;ZC3H12C;NYNRIN;CPSF3;EXOSC3;RNASE12;AGO1;SMG6
prerank,superoxide-generating NAD(P)H oxidase activity (GO:0016175),0.2974015104860363,0.6176639363927552,0.8735632183908046,0.9851221558321491,1.0,2/10,10.42%,NOX1;NOX4
prerank,MHC protein binding (GO:0042287),-0.2291797512875267,-0.6168234263603771,0.9548532731376975,1.0,1.0,20/20,77.12%,TAP1;CD74;CD81;ATP5F1B;CD8B;COL2A1;KIR3DL2;TUBB;PILRA;FCRL6;ATP5F1A;CD4;TUBB4B;CD8A;LILRB1;TAP2;TAPBP;LAG3;DERL1;ABCB9
prerank,thioesterase binding (GO:0031996),0.29531392488984903,0.610956454307318,0.9130434782608695,0.9873259220363263,1.0,2/11,11.35%,ADRA2A;CDC42
prerank,tRNA (guanine) methyltransferase activity (GO:0016423),-0.25799037455039125,-0.6092175712763974,0.9129464285714286,1.0,1.0,6/13,37.96%,METTL1;THUMPD2;TRMT11;TRMT10C;TRMT5;TRMT10A
prerank,sequence-specific mRNA binding (GO:1990825),-0.27368070751450163,-0.607785143660781,0.9102296450939458,1.0,1.0,3/10,26.22%,SHFL;DHX9;RBM24
prerank,acetylcholine receptor activity (GO:0015464),0.24945070925556745,0.6058125377968561,0.9230769230769231,0.9880658503580321,1.0,5/22,17.53%,CHRNA5;CHRNG;ANXA9;CHRM1;CHRNB1
prerank,transferrin receptor binding (GO:1990459),-0.2677255236442556,-0.6030322474269657,0.9305263157894736,1.0,1.0,3/10,27.61%,IKBKB;CD81;SNX4
prerank,neuropeptide binding (GO:0042923),0.2673013334044864,0.5990777171514122,0.9111969111969112,0.9897046560728615,1.0,2/18,9.20%,SSTR3;NMUR1
prerank,Lys48-specific deubiquitinase activity (GO:1990380),0.2658105145073373,0.5983102513647212,0.9053803339517625,0.9875853448960386,1.0,3/14,12.65%,USP9X;DESI2;USP7
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides (GO:0016812)",-0.263201728299996,-0.5939844605087802,0.9206680584551148,1.0,1.0,5/10,39.11%,DPYSL5;OPLAH;DPEP1;DPYS;DPYSL2
prerank,thiol-dependent deubiquitinase (GO:0004843),0.19188869356968719,0.5927908474821726,0.9896142433234422,0.9883419428430789,1.0,27/83,23.44%,USP3;USP9X;USP24;USP11;USP34;USP49;DESI2;USP12;USP7;USP18;USP37;UFD1;USP39;USP48;USP1;USP33;USP21;USP16;USP35;TANK;MPND;OTUD3;USP5;USP20;OTUD4;USP9Y;OTUB2
prerank,pseudouridine synthase activity (GO:0009982),-0.24448629820928938,-0.5919081231456297,0.9483471074380165,1.0,1.0,8/13,38.31%,PUS1;PUS7;TRUB1;DKC1;RPUSD3;RPUSD2;TRUB2;PUS7L
prerank,RNA cap binding (GO:0000339),-0.23196805479803564,-0.589116982739165,0.9484978540772532,1.0,1.0,5/16,23.46%,EIF4E;EIF4A1;LSM1;EIF3D;NCBP2
prerank,mRNA methyltransferase activity (GO:0008174),-0.2518718177732064,-0.5887097784695078,0.9502164502164502,1.0,1.0,2/12,15.42%,TRMT61B;METTL3
prerank,retinoic acid receptor binding (GO:0042974),-0.2305069607062975,-0.5868023986929164,0.9565217391304348,0.9974024964756417,1.0,1/17,0.92%,ACTN4
prerank,"oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor (GO:0050664)",-0.24186018796814635,-0.5827125281820263,0.9518599562363238,0.9954871705506133,1.0,3/14,10.68%,NCF2;AIFM1;CYBA
prerank,H4 histone acetyltransferase activity (GO:0010485),0.27809913068164094,0.5805381795417248,0.9230769230769231,0.9927898723279442,1.0,6/10,31.35%,ATF2;EP300;MSL3;NAA50;NAA60;NAA40
prerank,metalloaminopeptidase activity (GO:0070006),-0.2300448797640383,-0.5789589216970917,0.9546436285097192,0.9933852535970739,1.0,5/16,22.65%,ENPEP;MMP16;MMP15;TRHDE;RNPEPL1
prerank,snRNA binding (GO:0017069),0.20678692227291215,0.5654847874892214,0.9751243781094527,0.9975884898542365,1.0,12/42,25.95%,SNRNP70;CCNT2;LARP7;HEXIM2;EFTUD2;SNRPC;PRPF31;SNRPA1;TUT1;RNPC3;GEMIN5;SF3B3
prerank,"steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0033764)",0.2382459236783879,0.5594732278341893,0.9538188277087034,0.9977090119382551,1.0,2/18,12.67%,DHRS11;SRD5A2
prerank,exonuclease activity (GO:0004527),0.20096469652608484,0.5579137422723105,0.9825673534072901,0.9958917201652131,1.0,11/46,20.25%,POLG;ENPP3;EXOSC7;RAD50;REXO5;CPSF3;EXD1;EXOSC3;FEN1;DXO;RAD9A
prerank,MHC class I protein binding (GO:0042288),-0.2290790382321552,-0.5567517345618749,0.9574468085106383,0.9981184809016678,1.0,13/13,77.12%,TAP1;ATP5F1B;CD8B;TUBB;PILRA;ATP5F1A;TUBB4B;CD8A;LILRB1;TAP2;TAPBP;DERL1;ABCB9
prerank,purinergic nucleotide receptor activity (GO:0001614),-0.22388917021326143,-0.5560128351837008,0.9484536082474226,0.9947038981864404,1.0,5/15,27.74%,P2RY12;P2RY1;GPR34;P2RY14;P2RX7
prerank,core promoter sequence-specific DNA binding (GO:0001046),-0.17715486000430655,-0.5490620255204823,0.9974160206718347,0.993504702905455,1.0,13/35,29.52%,FOXP1;H3-3A;KLF10;TAF1B;ZBTB17;NPM1;RUVBL2;RELA;DR1;POU2F1;DRAP1;FOS;PARK7
prerank,RNA polymerase II core promoter sequence-specific DNA binding (GO:0000979),0.24219443667638377,0.5269457697166027,0.9591078066914498,1.0,1.0,5/12,23.15%,HDAC1;TBP;TAF1;GTF2A1;TBPL1
prerank,damaged DNA binding (GO:0003684),0.19076877866705644,0.5252504719374897,0.9967741935483871,1.0,1.0,11/44,19.52%,RBBP8;PNKP;TDG;DDB2;SDE2;CREBBP;OGG1;NBN;FEN1;APTX;XPA
prerank,telomerase RNA binding (GO:0070034),0.22084792208075,0.5214463636311741,0.9758812615955473,1.0,1.0,7/22,24.74%,TEP1;TERT;HNRNPC;TENT4B;SMG6;XRN1;PINX1
prerank,tumor necrosis factor receptor binding (GO:0005164),0.24217956285154296,0.5203718743409024,0.9535315985130112,0.9996704366287564,1.0,1/12,4.00%,BABAM2
prerank,four-way junction DNA binding (GO:0000400),0.22623333265486018,0.5176148059535184,0.9709090909090909,0.9980179920241079,1.0,5/17,21.99%,FANCM;ABL1;RAD51D;XRCC3;YY1
prerank,5'-3' exonuclease activity (GO:0008409),-0.20738424889775256,-0.49730121589184195,0.979296066252588,1.0,1.0,3/14,21.06%,TRIR;XRN2;DCP2
prerank,nuclear localization sequence binding (GO:0008139),0.21124302418946275,0.4938543812155553,0.9852941176470589,1.0,1.0,2/18,10.56%,TNPO1;KPNA6
prerank,microtubule minus-end binding (GO:0051011),-0.20070312009542346,-0.4821408154681602,0.9939148073022313,1.0,1.0,13/13,79.95%,TUBGCP2;HAUS4;TUBGCP6;CAMSAP3;CEP290;CAMSAP2;TUBGCP3;HAUS7;NUMA1;MACF1;TUBGCP5;CAMSAP1;TUBGCP4
prerank,U6 snRNA binding (GO:0017070),0.21496735308890003,0.47730277237108465,0.9718045112781954,1.0,1.0,14/14,78.52%,LARP7;TUT1;LSM3;DDX39B;PRPF4;METTL16;SART3;EIF5A;PRPF8;LSM2;RBM22;LSM8;LSM7;LSM4
prerank,"2 iron, 2 sulfur cluster binding (GO:0051537)",0.2203452244275811,0.4744998877251339,0.9848771266540642,1.0,1.0,4/12,21.99%,CISD3;ISCA1;SDHB;CISD2
prerank,"oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor (GO:0016655)",0.22567482736974281,0.4725599049329043,0.9767441860465116,0.9987482876421225,1.0,12/12,77.45%,CRYZ;CRYZL1;CBR4;NQO1;AIFM2;ADH4;AKR1C1;CBR1;DHRS4;NQO2;DCXR;NDUFS7
prerank,"endoribonuclease activity, producing 5'-phosphomonoesters (GO:0016891)",-0.16437827287323703,-0.47076462293214405,0.9976190476190476,1.0,1.0,10/28,33.72%,ELAC1;DROSHA;RNASEH2A;ENDOV;POP4;APEX1;NUDT16;RPP30;AGO3;RNASEH1
prerank,phosphatase inhibitor activity (GO:0019212),-0.17019271956803578,-0.46048291890689486,0.9886877828054299,0.9977897440531414,1.0,2/20,8.73%,MGAT5;PTN
prerank,exoribonuclease activity (GO:0004532),0.2119899560577525,0.45682384113409824,0.9808429118773946,0.9989464866053939,1.0,12/12,78.82%,EXOSC7;EXOSC3;EXOSC8;EXOSC9;CNOT6;EXOSC5;ZC3H12A;EXOSC2;EXOSC1;EXOSC4;EXOSC10;CNOT7
prerank,cyclin-dependent protein serine/threonine kinase inhibitor activity (GO:0004861),-0.2006065095280563,-0.44772508057610294,0.9923809523809524,0.9955943389204536,1.0,5/10,38.66%,CDKN1A;CDKN2B;HEXIM1;CDKN2D;CDKN1B
prerank,NADH dehydrogenase (quinone) activity (GO:0050136),0.16670857430223807,0.4446095822814423,0.9983739837398374,0.9958290459628585,1.0,34/34,83.36%,NDUFS1;NDUFV2;NDUFS4;NDUFA2;NDUFS5;NDUFA9;NDUFB2;NDUFS2;NDUFA12;NDUFB4;NDUFS8;NDUFV3;NDUFB9;NDUFA1;NDUFA10;NDUFV1;NDUFA5;NDUFS3;NDUFB6;NDUFA4;NDUFA3;NDUFC1;NDUFB3;NDUFC2;NDUFB10;NDUFA8;NDUFA13;NDUFA7;NDUFA6;NDUFB5;NDUFB8;NDUFS7;NDUFS6;NDUFB7
prerank,NADH dehydrogenase (ubiquinone) activity (GO:0008137),0.16670857430223807,0.4446095822814423,0.9983739837398374,0.9958290459628585,1.0,34/34,83.36%,NDUFS1;NDUFV2;NDUFS4;NDUFA2;NDUFS5;NDUFA9;NDUFB2;NDUFS2;NDUFA12;NDUFB4;NDUFS8;NDUFV3;NDUFB9;NDUFA1;NDUFA10;NDUFV1;NDUFA5;NDUFS3;NDUFB6;NDUFA4;NDUFA3;NDUFC1;NDUFB3;NDUFC2;NDUFB10;NDUFA8;NDUFA13;NDUFA7;NDUFA6;NDUFB5;NDUFB8;NDUFS7;NDUFS6;NDUFB7
prerank,Lys63-specific deubiquitinase activity (GO:0061578),0.1351368315340195,0.2844064790652841,1.0,0.9999877709648464,1.0,10/10,86.49%,DESI2;OTUD4;STAMBP;STAMBPL1;ATXN3;OTUD5;USP27X;CYLD;TNFAIP3;YOD1
